en
jalali
1396
11
1
gregorian
2018
2
1
32
1
online
1
fulltext
en
Correlation between important genes of mTOR pathway (PI3K and KIT) in Iranian women with sporadic breast cancer
Background: PI3K/Akt/mTOR pathway is a crucial pathway in the angiogenesis, tumour growth and cell differentiation of several cancers. The PI3K and KIT genes are key genes of this pathway. Previous studies have reported the importance of these genes in the development of gastrointestinal carcinoma, leukaemia, and melanomas. The role of mutations and overexpression of PI3K and KIT genes in breast cancer has been previously proved. This study investigates the correlation between PI3K and KIT gene mutations in sporadic breast cancer.
Methods: Multiplex Ligation-dependent Probe Amplification (MLPA) technique was used to determine the Copy Number Variation (CNV) of PI3K and KIT genes in 34 breast cancer tumours and PCR-sequencing was used to detect the mutation in PI3K exons 9 and 20.
Results: Our results reported that 27% of patients had CNV of the KIT gene; whereas, 20% and 17.5% of patients, had mutation and CNV in the PI3K gene, respectively. We did not found a significant correlation between the mutations of PI3K and KIT genes.
Conclusion: About two-tenth of the patients revealed CNV and lesser than two-tenth indicated mutation in the PI3K gene, whereas one-third of the patients demonstrated CNV in the KIT gene. Thus, administration of the PI3K and KIT gene inhibitor drugs might be proposed to suppress breast cancer in patients with mutation and CNV of each of these individual genes.
mTOR pathway, PI3K gene, KIT gene, Breast Cancer
789
793
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3996-1&slc_lang=en&sid=1
2018/01/16
1396/10/26
2018/03/5
1396/12/14
Maryam
Rahimi
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
maryamrahimi1986@yahoo.com
00319475328460042514
00319475328460042514
No
Farkhondeh
Behjati
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
fbehjati@gmail.com
00319475328460042515
00319475328460042515
No
Nazanin
Taheri
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
ntaheri67@yahoo.com
00319475328460042516
00319475328460042516
No
Shadi
Hosseini
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
shadihosseini7@gmail.com
00319475328460042517
00319475328460042517
No
Hamid Reza
Khorram Khorshid
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
hrkhkh@yahoo.com
00319475328460042518
00319475328460042518
No
Fatemeh
Aghakhani Moghaddam
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
shahla@hotmail.com
00319475328460042519
00319475328460042519
No
Masoud
Karimlou
Department of Epidemiology and Biostatistics, Tehran Medical Branch, Islamic Azad University, Tehran, Iran
mkarimlo@yahoo.com
00319475328460042520
00319475328460042520
No
Saghar
Ghasemi
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
ghasemisaghar@gmail.com
00319475328460042521
00319475328460042521
No
Niloofar
Bazazzadegan
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
ni.bazazadegan@uswr.ac.ir
00319475328460042522
00319475328460042522
No
Fereidoon
Sirati
Cancer Institute, Department of surgery- Tehran University of Medical Sciences, Tehran, Iran
f.sirati@tums.ac.ir
00319475328460042523
00319475328460042523
No
Elahe
Keyhani
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
ekeyhani1058@gmail.com
00319475328460042524
00319475328460042524
Yes
en
Human papilloma virus infection and fascin over-expression in squamous cell carcinoma of the cervix
Background: Human papilloma virus (HPV) is involved in development of almost all cervical cancers, mainly through the subversion of cellular mechanisms of growth control. Fascin plays central role in subsequent cell transformation events. Fascin mediates stabilization of parallel actin bundles where cellular protrusions are formed; this represents primary stages of cell migration and metastasis. Immunohistochemical assays have shown up-regulation of fascin expression in many epithelial and non-epithelial neoplasms. Therefore, the aim of this study was to investigate HPV infection and fascin expression in samples of cervical cancer.
Methods: Of 66 patients with confirmed SCC, formalin-fixed specimens, embedded in paraffin blocks were evaluated for HPV infection with nested multiplex polymerase chain reaction (NM-PCR) and for fascin expression with immunohistochemical assays. Statistical analysis was performed using Wilcoxon rank-sum test and SPSS software. A p<0.05 was considered for statistical significance.
Results: Of 66 samples, 52 (78.7%) were found positive for HPV infection and fascin over-expression was shown in all squamous cell carcinoma samples.
Conclusion: This study showed fascin overexpression in squamous cell carcinoma of the cervix which might be involved in metastasis of cancers induced by some types of HPV, hypothetically through attenuation of inter-cellular adhesions, and induction of cell motility.
Fascin, Human Papilloma Virus, Squamous Cell Carcinoma
784
788
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4384-1&slc_lang=en&sid=1
2018/01/162018/07/10
1397/4/19
2018/03/52018/10/31
1397/8/9
Zohreh
Yousefi Ghalejoogh
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
zohreh_y@yahoo.com
00319475328460042529
00319475328460042529
No
Simin
Mirakhor Samani
Department of Pathology, Qazvin University of Medical Sciences, Qazvin, Iran
ssamani@qums.ac.ir
00319475328460042530
00319475328460042530
No
Somayeh
Shatizadeh Malekshahi
Department of Virology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
shatizadeh@razi.tums.ac.ir
00319475328460042531
00319475328460042531
No
Reza
Shahsiah
Pathology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Shahsiah@yahoo.com
00319475328460042532
00319475328460042532
No
Jila
Yavarian
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
yavarian@sina.tums.ac.ir
00319475328460042533
00319475328460042533
No
Seyed Jalal
Kiani
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
kiani.j@iums.ac.ir
00319475328460042534
00319475328460042534
Yes
en
Association of circulating omentin-1 level with lung cancer in smokers
Background: Omentin has recently been considered as an adipokine secreted from visceral fat and is expressed in the lungs, heart, ovary etc. Various studies have shown that omentin may have an anti-inflammatory role in the inflammatory process and the amount of omentin alters in some cancers, such as colorectal, prostate and renal cells cancers, changes. The serum level of omentin, however, remains unknown in non-patient smokers and the smokers afflicted with lung cancer. Therefore, this study examines the serum levels of omentin in smokers suffering from lung cancer.
Methods: The amount of serum omentin was measured in 45 patients with lung cancer and 61 age - and sex - matched controls (30 smokers and 31 non-smokers) using enzyme-linked immunosorbent assay (ELISA) kit. Data were analyzed using SPSS-16, and one-way analysis of variance and Scheffe post hoc test were used to determine and compare the serum levels of omentin in different types of lung malignancies. Significance level was set at p≤0.05.
Results: The amount of circulating omentin for healthy non-smokers and non-patient smokers was 3.55±0.57 ng/l and 5.43±1.95 ng/l, respectively (p<0.001). The serum level of omentin was 3.63±0.70 ng/l for smokers afflicted with cancer (p<0.001 compared with non-patient smokers: 5.43±1.95).
Conclusion: The meaningful decrease in omentin levels in smokers with lung cancer can be considered as a risk factor in smokers and can use as a significant factor in the prognosis of lung cancer in these people.
Smoker, Omentin, Lung cancer
779
783
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4116-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/12
1396/12/21
2018/03/52018/10/312018/07/28
1397/5/6
Mohammad Hassan
Khadem Ansari
Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
mhansari@hotmail.com
00319475328460042393
00319475328460042393
No
Mahdia
Gholamnejad
Pulmonology Department, Urmia University of Medical Sciences, Urmia, Iran
Gholamnejad@gmail.com
00319475328460042394
00319475328460042394
No
Khadije
Meghrazi
Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
kmeghrazi@gmail.com
00319475328460042395
00319475328460042395
Yes
Hamid Reza
Khalkhali
Department of Epidemiology and Biostatistics, faculty of medicine, Urmia University of medical sciences, Urmia, Iran
Khalkhali@umsu.ac.ir
00319475328460042396
00319475328460042396
No
en
Universal health coverage in Iran: Health-related intersectoral actions
The majority of modifiable health outcomes are attributable to factors that are outside the direct reach of the health systems and can only be reached through intersectoral actions. In recent years, Iran implemented a series of reforms in the health sector called Health Transformation Plan (HTP). This paper aimed to review health-related intersectoral actions in Iran that have focused on interventions conducted after HTP implementation and to compare the interventions against the recommendations by World Health Organization (WHO) Commission on Social Determinants of Health. Findings showed that intersectoral governance interventions are the strongest points and have the most compatibility with the recommendations, while intersectoral environmental interventions are the weakest points. Also, many of the interventions have not yet been completely implemented. Moreover, continuity and sustainability of the policies and programs are still a concern.
Intersectoral collaboration, Health care reform, Universal health coverage, Iran
773
778
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2079-5&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/12
1397/6/21
2018/03/52018/10/312018/07/282019/01/29
1397/11/9
Sahand
Riazi-Isfahani
National Institute of Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
sahand1000@gmail.com
00319475328460047395
00319475328460047395
No
Maziar
Moradi-Lakeh
Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
mazmoradi@gmail.com
00319475328460047396
00319475328460047396
No
Shiva
Mafimoradi
Secretariat of Supreme Council of Health and Food Security, Ministry of Health & Medical Education, Tehran, Iran
mafimoradi@gmail.com
00319475328460047397
00319475328460047397
No
Reza
Majdzadeh
Knowledge Utilization Research Center (KURC) & Epidemiology and Biostatistics Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
rezamajd@tums.ac.ir
00319475328460047398
00319475328460047398
Yes
en
Changes in the size of the thyroid in patients with benign non-toxic multinodular goiter after radioactive iodine therapy
Background: Multinodular goiter (MNG) is regarded as one of the most common causes of hyperthyroidism, particularly in areas of mild-to-moderate iodine deficiency. The present study aims to explore the effects of the radioactive iodine (RAI) therapy on benign non-toxic MNG and evaluate its side effects.
Methods: Patients with benign non-toxic MNG entered the study. Ultrasonography was applied to calculate the percentage of the decrease in the size of the thyroid before and six months minimum after the treatment. Chi-square, Mann-Whiteny-U and T-test were done using SPSS v.18.0 (p<0.05).
Results: The volumes of the thyroid lobes and nodules decreased significantly due to RAI therapy (p<0.001). The total volume of the thyroid, volume of the right nodule, and volume of the left nodule decreased by 77.8%, 40.7%, and 34.6% respectively.
Conclusion: According to the results of the current study, RAI therapy is an effective treatment method although it has short-term side effects. This treatment option is recommended for patients with benign non-toxic MNG, notably those who cannot be a candidate for surgery. This treatment affects the size of the thyroid and its nodules significantly and decreases almost all of the complications.
Multinodular goiter, Nodule, Radioactive iodine therapy, Thyroid
769
772
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3607-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/2
1396/6/11
2018/03/52018/10/312018/07/282019/01/292018/10/2
1397/7/10
Iraj
Heydari
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
heydari.i@iums.ac.ir
00319475328460042344
00319475328460042344
No
Maryam
Honardoost
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
marymail79@gmail.com
00319475328460042345
00319475328460042345
No
Sedighe
Moradi
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
moradi.s@iums.ac.ir
00319475328460042346
00319475328460042346
No
Fatemeh
Golgiri
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
golgiri.f@iums.ac.ir
00319475328460042347
00319475328460042347
No
Hamidreza
Dehnad
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
alirezadehband@yahoo.com
00319475328460042348
00319475328460042348
No
Saba
Moradi
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sabamoradi1358@gmail.com
00319475328460042349
00319475328460042349
No
Amir
Ziaee
Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism ,Iran University of Medical Sciences Tehran, Iran
Aziaee1963@yahoo.com
00319475328460042350
00319475328460042350
Yes
en
Professionalism and its role in the formation of medical professional identity
Background: The honorable medical profession is on the verge of being reduced to a business. Evidence suggests that professionalism is fading and today's doctors are faced with value-threatening problems and gradually begin to forget their main commitment as medical professionals. Many of the problems faced by doctors are rooted in non-professionalism. Mere education in the science and practice of medicine produces an inefficient medical workforce and leads to the formation of a distorted professional identity. In the past decade, educational innovations targeting the formation of desirable professional identities have been presented and are considered a vital part of medical education for the development of professionalism. The present study was conducted to examine the relationship between the formation of professional identity and professionalism. Professionalism education is essential in the formation of a desirable professional identity.
Methods: This review article was done in 2015 through searching databases, such as PubMed, Elsevier, Google Scholar, Ovid, SID, and IranMedex, using keywords of professionalism and professional identity, and medical education. Among the 55 found articles, 30 were assessed and selected for review.
Results: The formation of professional identity is a process with the following domains: professionalism, and development of a personal (psychosocial) and a cultural identity, which is derived from the unification of professional, personal, and ethical development. The main components required for the formation of a desirable identity are, therefore, rooted in the dimensions of professionalism and professional development. The need for teaching professionalism has a reciprocal relationship with the formation of professional identity.
Conclusion: There is a reciprocal relationship between formation of a desirable professional identity and development and strengthening of professionalism. Modern medical education should be designed to develop professional identity, and professionalism acts as an essential part of its curricula throughout the entire course of a doctor’s education, with the aim of acquiring a desirable professional identity.
Professionalism, Professional identity, Medical education
765
768
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2995-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/3
1395/9/13
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/27
1396/7/5
Mina
Forouzadeh
Medical Ethics Department, Iran University of Medical Sciences, Tehran, Iran
foroozandeh.m@gmail.com
00319475328460042471
00319475328460042471
No
Mehrzad
Kiani
Medical Ethics Department, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
mehrkia55@gmail.com
00319475328460042472
00319475328460042472
No
Shabnam
Bazmi
Medical Ethics Department, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
sh_bazmi2003@yahoo.com
00319475328460042473
00319475328460042473
Yes
en
Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults?
Background: Hypertension was considered as a disease of the elderly but due to unhealthy dietary and lifestyle changes its incidence has increased in younger population. Smoking and obesity are emerging concerns the world is facing globally in younger age groups. This study is therefore aimed to identify these cardiovascular risk factors among Pathan and Persian young adults.
Methods: It was a cross-sectional study carried out at multiple undergraduate, postgraduate educational institutes and hospitals using non-probability convenient sampling among young adults aged between 15 to 40 years for a period of six months from Apr 1st, 2017 to Sep 30th, 2017. Mean±SD was calculated for continuous variables and categorical variables were expressed as frequencies. Chi-square test and Fisher exact test were used for statistical analysis.
Results: A total of 708 subjects were included. Mean±SD age was 26.12±3.7 years. Out of 708, 300(42.37%) were smokers with 209 (29.52%) active and 91 (12.85%) passive smokers. Among smokers, 216 (30.5%) were males while 84 (11.87%) were females. A total of 432 (61.02%) subjects were not doing any exercise, and 636 (89.83%) were consuming junk food. A total of 165 (23.3%) subjects were overweight, and 15 (2.1%) were obese. Stage-1 hypertension was present in 72 (10.2%), while 16 (2.25%) subjects had stage-2 hypertension.
Conclusion: There is an increased prevalence of cardiovascular risk factors which includes hypertension, smoking, and obesity among Pathan and Persian young adults.
Cardiovascular, Risk factors, Hypertension, Smoking, Obesity, Young adults
760
764
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3961-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/30
1396/10/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/8
1397/6/17
Hammad
Shah
Cardiology Department, Rehman Medical Institute, Peshawar, Pakistan
drhammadshah@gmail.com
00319475328460042322
00319475328460042322
Yes
Afrasyab
Altaf
Cardiology Department, Rehman Medical Institute, Peshawar, Pakistan
afrasyabaltaf@gmail.com
00319475328460042323
00319475328460042323
No
Momin
Salahuddin
Cardiology Department, Rehman Medical Institute, Peshawar, Pakistan
momin.salahuddin@rmi.edu.pk
00319475328460042324
00319475328460042324
No
Muneeb Ullah
Jan
Medicine Department, Khyber Teaching Hospital, Peshawar, Pakistan
00319475328460042325
00319475328460042325
No
Adnan
Khan
Paediatric Department, Rehman Medical Institute, Peshawar, Pakistan
kingmuneeb.jan90@gmail.com
00319475328460042326
00319475328460042326
No
en
Extraction and purification of the H9N2 virus nucleoprotein: A simple and practical method
Background: Avian Influenza disease annually entails a significant economic loss to the poultry industry around the world. Influenza virus is a polymorphic virus of the orthomyxoviridae family (single-stranded RNA genome), and nucleoprotein (NP) is the structural and internal protein of the virus. The aim of the work was to purify nucleoprotein for further investigations with a simple, low-cost, fast and practical method.
Methods: In this study, H9N2 influenza virus was isolated in specific pathogen-free embryonated chicken eggs by allantoically inoculating 103 to 105 egg-infective doses (EID50) for 9 to 11 days, purified by 10% (W/V) polyethylene glycol (PEG) 6000 with a sucrose gradient of 60% to 30%. The influenza virus proteins were collected and prepared as fractions by preparative electrophoresis. Finally, the purified NP was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot procedures.
Results: The protein analysis with SDS-PAGE and silver nitrate staining indicated that the desired samples contained purified nucleoprotein and lacked other viral proteins. The results of the investigation of lyophilized fractions containing nucleoprotein on the SDS-PAGE revealed the absence of viral RNA in nucleoprotein and its high purity.
Conclusion: According to this study, purified nucleoprotein can be used to produce nucleoprotein vaccines, as well as to study structural, molecular and diagnostic and therapeutic materials.
Avian influenza virus, H9N2, Nucleoprotein, Extraction, Purification
754
759
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3061-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/30
1397/3/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/11
1397/6/20
Seyedeh Saeedeh
Hosseini
Department of Botany, Biotechnology and Bioinformatics, Payame Noor University, Tehran, Iran
EBRAHIM.MSPH@GMAIL.COM
00319475328460042311
00319475328460042311
No
Kayvan
Taheri
Department of Biology, Microbiology, Azad University, Damghan, Iran
00319475328460042312
00319475328460042312
No
Seyedeh Marzieh
Hosseini
Department of Biology, Microbiology, Azad University, Karaj, Iran
00319475328460042313
00319475328460042313
No
Mehrdad
Gholami
Department of Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
mehrdad_gholami90@yahoo.com
00319475328460042314
00319475328460042314
No
Ebrahim
Kouhsari
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
ekouhsari1987@gmail.com
00319475328460042315
00319475328460042315
No
Elahe
Edalati
Department of Botany, Biotechnology and Bioinformatics, Payame Noor University, Tehran, Iran
az1171355@gmail.com
00319475328460042316
00319475328460042316
Yes
Rasoul
Madani
Department of Botany, Biotechnology and Bioinformatics, Payame Noor University, Tehran, Iran
sabassian460@gmail.com
00319475328460042317
00319475328460042317
No
Rokhsareh
Mohammadzadeh
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
rokhsare.mohamadzade@gmail.com
00319475328460042318
00319475328460042318
No
Abed
Zahedi Bialvaei
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
abedzahedi@gmail.com
00319475328460042319
00319475328460042319
No
Mohammad
Sholeh
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
m.sholeh1000@gmail.com
00319475328460042320
00319475328460042320
No
Fariba
Golchin Far
Department of Botany, Biotechnology and Bioinformatics, Payame Noor University, Tehran, Iran
moqarabzadeh@gmail.com
00319475328460042321
00319475328460042321
No
en
Comparing the effectiveness of revascularization interventions with medical therapy in patients with ischemic cardiomyopathy: A systematic review and meta-analysis
Background: Determining the effectiveness of cardiovascular interventions plays an important role in reimbursement decisions, health care pricing, and providing clinical guidance on the use of existing clinical technologies. This study aimed to review and analyze the effectiveness of revascularization interventions (CABG and PCI) compared to medical therapy in patients with ischemic cardiomyopathy.
Methods: Different databases were searched up to December 2017. The articles were selected based on inclusion and exclusion criteria. Quality of all studies was evaluated by Jadad score and relevant checklists. The I2 test was used to test heterogeneity. Also, to integrate the results of similar studies, meta-analysis was done using STATA software.
Results: A total of 18 studies were included. Based on the random effects model, the overall results of comparing the effectiveness of revascularization interventions with medical therapy were as follow: 38.94 [95% CI: 26.95-50.94, p<0.001, I2 = 99.6%, p<0.001], [75.31, 95% CI: 74.06-76.57, p<0.001, I2= 88.8, p<0.001], and 75.76 [95% CI: 71.99-79.53, p<0.001, I2= 99.2, p<0.001] for cardiac mortality rate, quality of life, and 5-year survival, respectively. Also, in patient satisfaction index, revascularization interventions were shown to be more effective than medical therapy.
Conclusion: This study showed that revascularization interventions in all studied indices were more effective than medical therapy. Also, between revascularization interventions, PCI was more effective in cardiovascular mortality and 5-year survival than CABG in terms of quality of life. Moreover, CABG was more effective than PCI. In patient satisfaction index, the results of the 2 included studies were contradictory.
Effectiveness, Revascularization, Medical therapy, Ischemic cardiomyopathy
743
753
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3266-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/15
1397/5/24
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/25
1397/7/3
Saeed
Bagheri Faradonbeh
Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
s.bagheri88@yahoo.com
00319475328460042306
00319475328460042306
No
Farbod
Ebadi Fard Azar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
ebadi.f@iums.ac.ir
00319475328460042307
00319475328460042307
Yes
Aziz
Rezapour
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
rezapoor_a57@yahoo.com
00319475328460042308
00319475328460042308
No
Marjan
Hajahmadi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
dr.hajahmadi.m@gmail.com
00319475328460042309
00319475328460042309
No
Seyed Javad
Hajmiresmail
Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran
saeid_aseman2008@yahoo.com
00319475328460042310
00319475328460042310
No
en
Educational ranking of medical universities in Iran (ERMU)
Background: Several international ranking systems are available for examining the performance of universities internationally. However, it seems that in these rankings the educational functions are relatively discounted. In this study, we presented the theoretical framework, methodology, and results of 2 rounds of ERMU (educational ranking of medical universities) in Iran.
Methods: The indicators were designed through literature reviews, expert panels, and consensus among professionals using Delphi method. Six domains, including quantitative expansion, educational management scheme, educational management, qualitative development, and alignment with the National Master Plan for Science and Education were assessed. Nineteen educational processes and outcome-based indicators were defined at the end. Some of them, such as the number of educational disciplines, were normalized based on the number of academic staff. Using exploratory factorial analysis, the interval validity of the final instrument was assessed. Also, the internal consistency of the tool was evaluated by calculating Cronbach's alpha. Data were collected in 2 rounds in 2010 and 2014. The required data were collected and cross-validated from different sources in medical universities and in the Ministry of Health.
Results: The analysis yielded 2 factors, explaining a total of 61.6% of the variance for the entire set of variables. The calculated Cronbach’s alpha was 0.94. The correlation coefficient for all items was 0.88. The comparison of the results of the 2 rounds showed a significant improvement in the scores of universities in all domains.
Conclusion: The results showed a relatively fitted model with acceptable reliability. In addition, it seems that the ranking of medical universities has improved their performance in the study indictors. It seems that in the long-term, monitoring these indicators and the visibility of their scores may improve the educational performance of universities.
National, University, Ranking, Higher education, Academic performance
736
742
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3053-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/5
1397/1/16
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/15
1397/7/23
AliAkbar
Haghdoost
Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
ahaghdoost@kmu.ac.ir
00319475328460042397
00319475328460042397
No
Nader
Momtazmanesh
Shahid Beheshti University of Medical Sciences, Tehran, Iran
momtazmanesh@gmail.com
00319475328460042398
00319475328460042398
No
Farangis
Shoghi Shafagh Aria
Iran Ministry of Health and Medical Education, Tehran, Iran
shoghif@gmail.com
00319475328460042399
00319475328460042399
No
Hadi
Ranjbar
Mental Health Research Center, Tehran Institute of Psychiatry- School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran
Ranjbar.h@iums.ac.ir
00319475328460042400
00319475328460042400
Yes
en
Delivering clinical preventive services in the Islamic Republic of Iran: A model for screening and behavior consultation practices
Background: Screening and behavior consultation are considered to be limited, dispersed and expensive services across the country. To deliver efficient and equitable services current disordered practices need to be consolidated.
Methods: An analysis of current situation, learned lessons and future scopes of country’s preventive care delivery, along with a review of international experience and generous participation of various stakeholders, led to proposing a model for screening and behavior consultation practices in IR. Iran.
Results: Upon the results of the previous steps, the desired model was based on the network system and family physician. Comprehensive health centers and other centers affiliated to the network are the most appropriate service positions. However, private and academic preventive centers are playing their rules.
Conclusion: The proposed model matches the overall pattern of service delivery in the health system (network system with the private sector and the educational sector).
Preventive health service, Health care delivery, Health risk assessment, Behaviors, Risk reduction
732
735
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3441-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/13
1396/2/23
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/5
1397/7/13
Soodabeh
Hoveidamanesh
Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
hoveidamanesh@gmail.com
00319475328460042401
00319475328460042401
No
Farnoush
Davoudi
Preventive Medicine and Public Health Research Center, Department of Community Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
f.davoudi@gmail.com
00319475328460042402
00319475328460042402
Yes
Jalil
Koohpayehzadeh
Preventive Medicine and Public Health Research Center, Department of Community Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
jkuhpayeh@yahoo.com
00319475328460042403
00319475328460042403
No
Marzieh
Nojomi
Preventive Medicine and Public Health Research Center, Department of Community Medicine, School of Medicine, Iran University of Medical Sciences & Academy of Medical Sciences of Islamic Republic of Iran, Tehran, Iran
mnojomi@gmail.com
00319475328460042404
00319475328460042404
No
en
Trend forecasting of main groups of causes-of-death in Iran using the Lee-Carter model
Background: Authoritative information and description of the causes of mortality trends is one of the most basic principles of evaluation of the health sector in all countries. Therefore, this study aims to predict the trend in main groups of causes of death in the Islamic Republic of Iran.
Methods: The study population comprised all deaths recorded in the system of registration and classification of causes of death of Ministry of Health and Medical Education during the years 2006 to 2015. The information was collected via death certificate, burial permit, and information forms. In order to forecast the trends of causes-of-death, Lee Carter model was employed in a demographic package 18.1 of R software version 3.3.1.
Results: Based on the results, the crude death rate in the total population has reduced from 435.86 in 2006 to 405.01 per 100000 population in 2035. It is anticipated that endocrine, nutritional and metabolic diseases with the rate of 197.71 per 100000 population will be responsible for the highest causes of death in the year 2035 and from 2021 onwards, the mental and behavioral disorders will be responsible for the lowest rate of mortality.
Conclusion: Non-communicable diseases have a major role in the deaths of Iranian population; therefore, to reduce the impact of non-communicable diseases on individuals and society, a holistic approach is needed which requires all sectors to cooperate.
Prediction, Causes of death, Iran, Lee Carter
727
731
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4054-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/10
1396/11/21
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/28
1397/8/6
Katayuon
Jahangiri
Department of Health in Disasters and Emergency, School of Health, Safety, Environment (HSE), Shahid Beheshti University of Medical Sciences, Tehran, Iran
dr.katayon.jahangiri@gmail.com
00319475328460042281
00319475328460042281
No
Saeide
Aghamohamadi
Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran
Aghamohamadi@health.gov.ir
00319475328460042282
00319475328460042282
Yes
Ardeshir
Khosravi
Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran
ardeshir1344@yahoo.com
00319475328460042283
00319475328460042283
No
Elaheh
Kazemi
Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran
elaheh.kazemi.63@gmail.com
00319475328460042284
00319475328460042284
No
en
Availability of outpatient rehabilitation facilities in 2015 in Iran: A nationwide study
Background: Disability can involve many by diseases, injuries, or aging, and thus access to rehabilitation services has a key role in improving these patients’ social life. Since 2008, Iran has improved the access to rehabilitation facilities along with the global convention. Yet, nationwide studies are required to evaluate the fair distribution of centres in each province. Thus, the present study aimed to evaluate the distribution of outpatient rehabilitation services in 32 provinces of Iran to help policymakers make more appropriate decisions.
Methods: In this cross sectional study, which was conducted between April and October 2017, a master facilities list (MFL) of rehabilitation services that was developed in Iran was used to identify health facilities. Data were collected from the statistics of the Deputy for Rehabilitation of Social Welfare Organization offices and Red Crescent Organization in 32 provinces of Iran. Descriptive data were analysed by SPSS version 22 and reported by percentage and number in 1 000 000 population; distribution was drawn on Iran’s map by the GIS software.
Results: According to the MFL, outpatient rehabilitation services include physical medicine & rehabilitation, physiotherapy, occupational therapy, speech therapy, audiometry, and orthotics & prosthetics (90%); other rehabilitation centres include general rehabilitation centres, day care centres, and vocational centres (10%). The largest number of occupational therapy, physiotherapy, and audiology offices were found in Tehran, where general rehabilitation centres, day care centres, and vocational centres were less than 3 per 1 000 000 population. There were no rehabilitation centers in 14 provinces, and there were very few physical medicine and rehabilitation centres in most of the provinces.
Conclusion: There was significant difference in the distribution of outpatient rehabilitation facilities in different provinces of Iran and some provinces required urgent attention of policymakers, as they had the least number or no rehabilitation facilities.
Iran, Availability, Rehabilitation center, Outpatient facilities
721
726
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3845-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/13
1396/8/22
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/30
1397/3/9
Nahal
Ahmadzadeh
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
N. Ahmadzadeh@iums.ac.ir
00319475328460042250
0000000244974646
No
Farbod
Ebadi Fard Azar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
ebadifardazar.f@iums.ac.ir
00319475328460042251
0000000231250462
Yes
Hamid Reza
Baradaran
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
baradaran.hr@iums.ac.ir
00319475328460042252
00319475328460042252
No
Reza
Salman Roghani
Physical Medicine & Rehabilitation Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
00319475328460042253
00319475328460042253
No
Marzieh
Shirazikhah
Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
m.shirazikhah@uswr.ac.ir
00319475328460042254
0000000205052796
No
Mohammad Taghi
Joghataei
Department of Anatomy and Neuroscience, Cellular and Molecular Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
joghataei@iums.ac.ir
00319475328460042255
0000000231826214
No
Saiedeh
Bahrampouri
Health in Emergency and Disaster Research Center, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran
s.bahrampouri@uswr.ac.ir
00319475328460042256
0000000326536893
No
en
A brief guide to propensity score analysis
In the statistical analysis of observational data, propensity score is a technique that attempts to estimate the effect of a treatment (exposure) by accounting for the covariates that predict receiving the treatment (exposure). The aim of this paper is to provide a brief guide for clinicians and researchers who are applying propensity score analysis as a tool for analyzing observational data. We reviewed literature about how, when and why propensity score is used and then we discussed some important practical issues in using propensity score in observational studies. Appling propensity score as a method for analyzing observational studies is very useful but, we should know when and how we can use this method. Moreover, new methods of propensity score analysis such as Bayesian and doubly robust approaches were established in recent years, and these methods could be more useful for researchers in estimating causal effect from observational studies.
Propensity score, Observational study, Causal inference
717
720
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2158-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/6
1396/2/16
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/13
1396/6/22
Ameneh
Ebrahim Valojerdi
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
ebrahimi.am@tak.iums.ac.ir
00319475328460042279
00319475328460042279
No
leila
Janani
Department of Biostatistics, School of Public Health, Iran University of Medical Sci-ences, Tehran, Iran, & Preventive Medicine and Public Health Research Center, Iran University of medical sciences, Tehran, Iran
janani.l@iums.ac.ir
00319475328460042280
00319475328460042280
Yes
en
The effect of Iran's health transformation plan on utilization of specialized outpatient visit services: An interrupted time series
Background: Health Transformation Plan (HTP) has been one of the biggest reforms in Iran's health system over the past 3 decades. The plan has been implemented since May 2014 and includes several packages that can affect the utilization of health care services. We aimed to assess the effect of implementation of HTP on utilization of specialist outpatient visit rate in clinics affiliated to university hospitals.
Methods: We chose Kurdistan province to collect monthly specialist outpatient visit data for 50 months because this province was not a patient referral hub. An interrupted time series (ITS) analysis and segmented regression analysis were used to evaluate the effects of HTP on specialist outpatient visit rates. Statistical analyses were conducted using STATA version 13.
Results: A significant increase was observed in the specialist outpatient visit rate (12.1 outpatient visit per 1000 population) in the first month after the implementation of HTP (p= 0.000, 95% CI= 6.36-17.83). Also, after the implementation of HTP, a significant increase was observed in the monthly trend of specialist outpatient visit rate equivalent to about 0.53 every month per 1000 population compared to the monthly trend in specialist outpatient visit rate before the intervention (p= 0.033, 95% CI= 0.04-1.01).
Conclusion: HTP has significantly increased the specialist outpatient visit rate in clinics affiliated to university hospitals in Kurdistan province. Thus, it is necessary to perform some comprehensive studies on all public, private, and semi-private sectors in different parts of the country to provide a better and more comprehensive picture of the effects of HTP on utilization of specialist outpatient visit services.
Utilization, Health system reform, Outpatient, Outpatient health service, Clinic visit
712
716
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2534-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/28
1396/9/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/29
1397/8/7
Bakhtiar
Piroozi
1. Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
bpiroozi@gmail.com
00319475328460042221
00319475328460042221
No
Amirhossein
Takian
Department of Health Services Management and Economics, School of Public Health & Department of Global Health & Public Policy, School of Public Health & 4. Deputy for Research, Health Equity Research Centre, Tehran University of Medical Sciences, Tehran, Iran
Takiana@gmail.com
00319475328460042222
00319475328460042222
No
Ghobad
Moradi
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
moradi_gh@yahoo.com
00319475328460042223
00319475328460042223
Yes
Mohammad
Amerzadeh
Department of Health Services Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
mohammadamerzadeh@yahoo.com
00319475328460042224
00319475328460042224
No
Hossein
Safari
Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran
Hossein.comely@gmail.com
00319475328460042225
00319475328460042225
No
Obeid
Faraji
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
faraji.obeid@gmail.com
00319475328460042226
00319475328460042226
No
en
Health promoting hospitals in Iran: Persian translation, cultural adaptation, content and face validation of self-assessment form of the standards of health promoting hospitals affiliated to the World Health Organization
Background: According to the World Health Organization, hospitals should assess their internal wards to improve health promotion services using self-assessment tools. To achieve this goal, standards of health promoting hospitals have been developed by the World Health Organization, and measurable elements and indicators have been defined to facilitate the practical application of these standards in planning, implementation, and evaluation of health promotion in hospitals. Moreover, a form has been developed for this self-assessment. Considering linguistic and cultural differences in various countries, standards must be written in equivalent texts and, then, their content and face validity should be examined.
Performing this process in a systemic and scientific way can guarantee that the same tools have been used, and thus the results obtained from different hospitals are comparable.
Methods: After the preparation phase (considering research aim, obtaining permission from the original designers, and determining the time), the following activities were done: translating the form from its original language to the target language, combining and compiling initial translations to a single translation, reversing the final version of the translation from the target language to the original language, obtaining cognitive information, revising and concluding, and determining the content and face validity of the translated form and final report.
After filling in the form, face validity was calculated using impact score formula. Content validity was measured using content validity ratio (CVR) and content validity index (CVI).
Results: After calculating the impact score, all 40 items showed a high impact score greater than 1.5, representing the fact that all items are important. The minimum value of CVR for each of the 40 items was estimated to be 0.64; CVI of all items was greater than 0.79.
Conclusion: Given the input of the standards of health promoting hospitals affiliated to the World Health Organization in National Accreditation of Iranian hospitals, the form was translated and found to be valid according to content and face validity and is available in Persian to be used in Iranian hospitals (Appendix 1).
Health promotion, Hospital, Self-assessment
704
711
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3219-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/2
1396/5/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/22
1397/2/2
Akbar
Nikpajouh
Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
dr.nikpajouh@gmail.com
00319475328460042177
00319475328460042177
No
Mohamad Amin
Shahrbaf
Shahid Beheshti University of Medical Science, Tehran, Iran
aminshahrbaf41@gmail.com
00319475328460042178
00319475328460042178
No
Mahdyie
Doayie
Community Medicine Specialist, Iran University of Medical Sciences, Tehran, Iran
mahdyiedoayie@yahoo.com
00319475328460042179
00319475328460042179
No
Maryam
Mohseny
Department of Community Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
mohseny.maryam0@gmail.com
00319475328460042180
00319475328460042180
No
Ali
Ebadi
Vice Chancellor for Treatment, Tabriz University of Medical Sciences, Tabriz, Iran
Ebadimail@gmail.com
00319475328460042181
00319475328460042181
No
Mahasti
Alizadeh
Department of Family and Community Medicine, Faculty of Medicine, Tabriz University of Medical School, Tabriz University of Medical Sciences, Tabriz, Iran
alizadm@yahoo.com
00319475328460042182
00319475328460042182
No
Ali Hossein
Zeinalzadeh
Vice Chancellor for Treatment, Tabriz University of Medical Sciences, Tabriz, Iran
zenalali@gmail.com
00319475328460042183
00319475328460042183
No
Nastaran
Laal
laalnastaran@gmail.com
00319475328460042184
00319475328460042184
No
Tolou
Hasandokht
Department of Community Medicine, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
tolou.hasandokht@gmail.com
00319475328460042185
00319475328460042185
No
Termeh
Tarjoman
Department of Community Medicine, Faculty of Medicine, Tehran Medical Branch, Islamic Azad University, Tehran, Iran
termehtarjoman@gmail.com
00319475328460042186
00319475328460042186
No
Mina
Ahmadi
Community Medicine Specialist, Shahid Beheshti University of Medical Sciences, Tehran, Iran
minaahmadi193@gmail.com
00319475328460042187
00319475328460042187
No
Leila
Sabzmakan
Department of Health Education & Promotion, Alborz University of Medical Sciences, Karaj, Iran
sabzmakan@yahoo.com
00319475328460042188
00319475328460042188
No
Zahra
Yekta
Department of Community and Preventive Medicine, Urmia University of Medical Sciences, Urmia, Iran
mar.yekta@gmail.com
00319475328460042189
00319475328460042189
No
Zahra
Sanaei
Department of Community Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
zahrasanaei58@yahoo.com
00319475328460042190
00319475328460042190
No
Mohamad Ali
Seif-Rabiei
Department of Community Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
seifrabie@umsha.ac.ir
00319475328460042191
00319475328460042191
Yes
en
Evaluating fear of hypoglycemia, pediatric parenting stress, and self-efficacy among parents of children with type 1 diabetes and their correlation with glycemic control
Background: This study was designed to determine the level of fear of hypoglycemia (FoH), pediatric parenting stress and self-efficacy in parents of children with type 1 diabetes (T1D).
Methods: In this cross-sectional study, 61 families of children with T1D who had been diagnosed for at least 6 months recruited from "Gabric Diabetes Education Association" in Tehran. Sixty mothers and 41 fathers of 61 children (26 girls, age: 6.0-12.7 years) were assessed using the Hypoglycemia Fear Survey-Parent (HFS-P), Pediatric Inventory for Parents (PIP) and Self-Efficacy for Diabetes Scale-Parent (SED-P) questionnaires. Pearson correlation analysis was used to compute the correlation between HFS-P, PIP and SED-P scores separately for mother and fathers.
Results: Only 8.3% of children had controlled diabetes. Internal reliability of the Persian version of all questionnaires was good. FoH were higher for mothers. Mothers whose children had diabetes for less than two years had significantly lower mean HFS-Behavior subscale (HFS-B) scores than mothers whose children had diabetes for more than two years. There was a positive correlation between fathers’ mean HFS-B score and children’s total insulin dose per day. Parents' FoH score was positively correlated with increased pediatric parenting stress. Findings also showed considerable emotional distress in 51% of mothers and 29.7% of fathers. Frequency of self-monitoring blood glucose tests (SMBG) correlated negatively with HbA1c.
Conclusion: We concluded that parents with high levels of FoH and stress may benefit from diabetes education. Important implications for education are considering psychological adjustment, recognizing diabetes-related fear and stress in parents, encouraging fathers to become actively involved in the child’s diabetes management and emphasizing the importance of SMBG.
Hypoglycemia, Fear, Parenting stress, Self-efficacy, Type 1 diabetes
697
703
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1557-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/5
1396/8/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/10
1397/4/19
Fatemehsadat
Amiri
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
f.amiri58@yahoo.com
00319475328460042170
00319475328460042170
No
Mohammadreza
Vafa
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
vafa_reza@yahoo.com
00319475328460042171
00319475328460042171
Yes
Linda
Gonder-Frederick
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Virginia, USA
li_gf@yahoo.com
00319475328460042172
00319475328460042172
No
Karen
Vajda
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Virginia, USA
و
vajda.K@yahoo.com
00319475328460042173
00319475328460042173
No
Mohammadebrahim
Khamseh
3. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
me.khamseh@yahoo.com
00319475328460042174
00319475328460042174
No
Alireza
Abadi
Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
abadi.a@yahoo.com
00319475328460042175
00319475328460042175
No
Amin
Salehpour
Department of Nutrition, School of Public Health & Occupational Health Research Center, Iran University of Medical Sciences, Tehran, Iran
amin.s@yhoo.com
00319475328460042176
00319475328460042176
No
en
Differential serostatus of Epstein-Barr virus in Iranian MS patients with various clinical patterns
Background: Epidemiological evidence suggests a role of Epstein-Barr virus (EBV) in triggering the pathogenesis of Multiple Sclerosis (MS). The aim of this study was to assess the EBV-specific antibodies in MS patients with various clinical patterns and their association with the production of IFN-γ, IL-12, and IL-4 cytokines compared with healthy individuals.
Methods: We measured EBNA-1 IgG, VCA IgG, and production of IFN-γ, IL-12 and IL-4 cytokines in patients with different clinical patterns and healthy controls using ELISA method.
Results: There was a higher titer of anti-EBV antibodies in MS patients compared to healthy controls. SPMS patients generated higher EBNA-1 levels than those with RRMS and PPMS patients whereas; the level of VCA IgG was higher in the RRMS patients than PPMS. In PPMS patients, a significant increase was found in IFN-γ and IL-12 cytokines compared to other subtypes, whereas IL-4 cytokine had a decreased level compared to RRMS patients. Higher anti-EBV antibodies are associated with increased IL-12 cytokine in RRMS patients. However, no significant correlation was found between these antibodies and other secreted cytokines.
Conclusion: EBV infection is one of the strong risk factors for MS. Acting on these factors could be useful to decrease the incidence and disease exacerbation of MS. Study of the antibody levels to EBV virus could be useful for evaluating MS risk score in each clinical subtypes.
Multiple sclerosis, Epstein-Barr virus, Anti-EBNA-1, Anti-VCA, Cytokines
690
696
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3249-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/4
1395/11/16
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/26
1396/4/5
Bahareh
Laribi
Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
bahare.laribi@gmail.com
00319475328460042165
00319475328460042165
No
Mehdi
Shekarabi
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Shekarabi.m@iums.ac.ir
00319475328460042166
00319475328460042166
Yes
Amir Hassan
Zarnani
Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
A.H.zarnani@iums.ac.ir
00319475328460042167
00319475328460042167
No
Majid
Ghaffarpour
Sina MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
ghafarpour@tums.ac.ir
00319475328460042168
00319475328460042168
No
Mohsen
Marzban
Department of Neurosciences, Tehran University of Medical Sciences, Tehran, Iran
mohsen136051@yahoo.com
00319475328460042169
00319475328460042169
No
en
The relationship between embb306 and embb406 mutations and ethambutol resistant in Mycobacterium tuberculosis isolated from patiens in west of Iran
Background: Mutations in embB gene have been reported in ethambutol (EMB) resistance Mycobacterium tuberculosis (M. tuberculosis) isolates. The aim of this study was survey on embB 306 and 406 EMB resistant M. tuberculosis isolated from patients in West of Iran (2014-2015).
Methods: Fifty strains of M. tuberculosis from patients with pulmonary tuberculosis (TB) were considered. Drug susceptibility using proportional method was performed. Polymerase chain reaction (PCR) -DNA sequencing was applied for mutation in embB 306 and 406 codon detection. Data were analyzed in SPSS 16 software using descriptive statistics and Fisher's exact test (p<0.05).
Results: In this study 7 (14%) M. tuberculosis isolates were resistant to EMB. 6 (85.71%) and 1 (14.28%) resistant isolates had embB 306 and 304 codon mutations, respectively. Between embB306 mutations and resistance to EMB and MDR isolates had a significant relationship (p<0.001).
Conclusion: The data indicated that embB 306 mutations have effect on EMB resistant. Detection of EMB resistant and these mutations prominent for antibiotic prescription.
embB gene, Mutations, Ethambutol Resistance, Mycobacterium tuberculosis
686
689
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3342-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/17
1395/12/27
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/7
1396/5/16
Bahman
Mohammadi
Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
hamidmoqhtader@yahoo.com
00319475328460042161
00319475328460042161
No
Parviz
Mohajeri
Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
microbiol_sci2013@yahoo.com
00319475328460042162
00319475328460042162
No
Samaneh
Rouhi
Student Research Committee & Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
roohi.samaneh@yahoo.com
00319475328460042163
00319475328460042163
No
Rashid
Ramazanzadeh
Cellular and Molecular Research Center, Research Institute for Health Development & Department of Microbiology, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
microbiol_sci@yahoo.com
00319475328460042164
00319475328460042164
Yes
en
How to utilize tacit knowledge in health organizations: An Iranian perspective
Background: Studies show that 90% of an organization’s knowledge is embedded and synthesized in its employees’ minds. Thus, when employees leave the organization or their positions change, their valuable knowledge, skills, and experiences are lost, however, if used properly, tacit knowledge can be a source of innovation and competitive advantage in an organization. This study aimed at exploring the methods for sharing and utilizing tacit knowledge in health organizations.
Methods: In this study, qualitative approach was adopted to explore ways of utilizing tacit knowledge in health organizations. Tacit knowledge experts, who had published at least one relevant article, conducted 17 individual and 2 group interviews. Purposeful sampling was used to select the participants. Methods for sharing and utilizing tacit knowledge were explored by holding in-depth semi-structured interviews. Data were analyzed using thematic analysis.
Results: The results were summarized into 5 categories and 18 themes. The categories included ‘identification of different dimensions of organizational knowledge’, ‘prerequisites of tacit knowledge utilization’, ‘defining the process of tacit knowledge utilization’, ‘converting tacit to explicit knowledge’, and ‘converting tacit to tacit knowledge’. Participants believed that the process of converting tacit to explicit knowledge was a cyclical process that included the understanding the existing situation and detecting knowledge entry points, identifying knowledge items and harvesting them, assessment, codification, and standardization, entry into knowledge repository, and updating.
Conclusion: Our results revealed that health organizations need the prerequisites of tacit knowledge sharing to acquire the capacity to utilize this kind of knowledge. Because the themes extracted in this study are rarely used in health organizations, the results will be helpful in guiding the development of knowledge utilization strategies and planning in these organizations.
Knowledge utilization, Tacit knowledge, Health organizations
678
685
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2250-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/13
1394/10/23
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/26
1396/4/5
Ensiyeh
Jamshidi
Community-based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
ensiyeh_jamshidi@yahoo.com
00319475328460042149
00319475328460042149
No
Sima
Nedjat
Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
nejat_s@farabi.tums.ac.ir
00319475328460042150
00319475328460042150
Yes
Saharnaz
Nedjat
Epidemiology and Biostatistics Department, School of Public Health, Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
saharnaznedjat@gmail.com
00319475328460042151
00319475328460042151
No
Sima
Nikooee
Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
s.nikooee@yahoo.com
00319475328460042152
00319475328460042152
No
Narges
Rostamigooran
Secretariat of Supreme Council of Health and Food Security, MOH & ME
rostamigooran@yahoo.com
00319475328460042153
00319475328460042153
No
Reza
Majdzadeh
School of Public Health and Knowledge Utilization Research Center, Tehran University of Medical Sciences, Head of Iran’s National Institute of Health Research, Tehran, Iran
rezamajd@tums.ac.ir
00319475328460042154
00319475328460042154
No
en
Life satisfaction as the main factor behind the elderly`s health knowledge utilization: A qualitative study in an Iranian context
Background: The elderly population’s health has become a priority as their numbers are on the rise and they are increasingly becoming vulnerable to physical and mental diseases. Studies show that an elderly person’s health depends on his/her utilization of health knowledge in daily life. Hence, here we investigated the contributing factors of knowledge utilization in the elderly population.
Methods: A qualitative study was conducted through conventional content analysis. Semi-structured in-depth interviews were held with 29 elderly individuals from Tehran. A focus group discussion was conducted (eight elderly individuals), and an expert panel was held with nine experts to complement the results.
Results: Upon data analysis, four categories and seven subcategories were extracted. The main categories included provision of basic needs, maintaining dignity, life satisfaction, and negative feelings toward self and others. The concept of ‘life satisfaction’ held a pivotal role in relation to the other categories.
Conclusion: Life satisfaction was the main category in the utilization of health knowledge among the elderly. Aging should be foreseen and forethought to increase life satisfaction. The followings can be effective in increasing life satisfaction in the elderly: Promoting positive-thinking, placing greater emphasis on spiritualism in life, employment of the elderly, and promoting the culture and tradition of respecting the elderly.
Knowledge utilization, Life satisfaction, Old people, Elderly, Iran
671
677
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2250-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/27
1394/7/5
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/22
1395/6/1
Sima
Nedjat
Department of Aging, University of Social Welfare and Rehabilitation, Knowledge Utilization Research Center, Tehran University of Medical sciences, Tehran, Iran
nejat_s@farabi.tums.ac.ir
00319475328460042155
00319475328460042155
No
Robab
Sahaf
Iranian Research Center on Aging, Department of Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
robabsahaf@gmail.com
00319475328460042156
0000000287474932
Yes
Hamid Reza
Khankeh
Department of Health in Emergency and Disaster and Nursing, University of Social Welfare and Rehabilitation, Tehran, Iran, Department of Clinical Science and Educa-tion, Karolinska institute, Stockholm, Sweden
hamid.khankeh@KI.SE
00319475328460042157
00319475328460042157
No
Reza
Fadayevatan
Iranian Research Center on Aging, Department of Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
reza@fadayevatan.co.uk
00319475328460042158
00319475328460042158
No
Reza
Majdzadeh
Department of Epidemiology and Biostatistics, School of Public Health and Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran
rezamajd@tums.ac.ir
00319475328460042159
00319475328460042159
No
Masoud
Karimlou
Department of Epidemiology and Biostatistics, Faculty of Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
mkarimlo@yahoo.com
00319475328460042160
00319475328460042160
No
en
Factors affecting the clinical education of rehabilitation students in Iran: A systematic review
Background: Clinical education is one of the main parts in medical education, and rehabilitation sciences are not exception. Through clinical education programs, students gain required qualifications to enter professional life. Several factors impact on students' clinical education, and identifying these factors could help in the improvement of clinical education and could improve knowledge transferring to clinical practice especially in rehabilitation sciences in Iran. The purpose of present review study is identifying the factors potentially affecting the clinical education of rehabilitation students in Iran.
Methods: A systematic review study conducted based on the evidence-based method on published articles from 2000 to 2017. The search process was carried out on MEDLINE, CINAHL, PsycINFO, and EMBASE databases.
Results: A total of 167 papers were selected. Given identical findings and considering eligibility criteria, 12 articles in the fields of clinical education, clinical competence, professional ethics education, and clinical reasoning were ultimately chosen.
Conclusion: The results indicate that many factors might influence the clinical education of rehabilitation science students. Environmental factors (including ministry policies, educational curriculums, clinical education environments, and educational facilities/equipment) and individual factors (the knowledge and skills of students and characteristics of clinical trainers) were identified as the most influential factors in clinical education.
Education, Rehabilitation, Clinical competence, Professional practice, Students
663
670
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4058-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/11
1396/11/22
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/8
1397/2/18
Marzieh
Pashmdarfard
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
mpashmdarfard@gmail.com
00319475328460042127
00319475328460042127
No
Narges
shafaroodi
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
narges7@yahoo.com
00319475328460042128
00319475328460042128
Yes
en
Molecular prevalence of parvovirus B19 among HIV1-infected patients in Iran
Background: Different outcomes of parvovirus B19 (B19V) infection in immunocompromised patients, including HIV1-infected persons, may be life-threatening. Considering the hematologic disorders associated with B19V infection, this study aimed to investigate the prevalence of B19V infection among HIV1-infected individuals in Iran.
Methods: Serum samples from 100 HIV1-infected patients were analyzed for B19 viral DNA using real-time PCR assay. COBAS TaqMan HIV-1 test was performed for quantitative measurements of HIV-1 RNA in the patients’ sera.
Results: Real-time PCR analysis revealed that 10 out of 100 cases (10%) were positive for B19V infection. Across various age groups, the B19V infection was more prevalent among patients within the age range of 21-40 years. Higher prevalence of B19V infection was observed among HIV1-infected patients with a viral load of higher than 400 copies/mL.
Conclusion: Despite limitations, this study may set the stage for further evaluations with larger sample sizes to elucidate the potential role of B19V in hematologic disorders, which may result in exacerbation of the disease in HIV1-infected patients. Moreover, as it has been shown that B19V infection can be treated using intravenous immunoglobulin (IVIG) therapy, available treatments may help improve the quality of life in HIV-infected persons.
Parvovirus B19, HIV-1, Anemia, AIDS
659
662
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2447-5&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/15
1397/1/26
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/12
1397/3/22
Seyed Jalal
Kiani
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
jalalkiani1@yahoo.com
00319475328460042119
00319475328460042119
No
Davod
Javanmard
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
djavanmard@hotmail.com
00319475328460042120
00319475328460042120
No
Hadi
Ghaffari
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
drhadighaffari@gmail.com
00319475328460042121
00319475328460042121
No
Ahmad
Tavakoli
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
ahmad.tavakoli66@gmail.com
00319475328460042122
00319475328460042122
No
Helya Sadat
Mortazavi
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
heliamortazavi.13@gmail.com
00319475328460042123
00319475328460042123
No
Farah
Bokharaei-Salim
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
bokharaeifarah@gmail.com
00319475328460042124
00319475328460042124
No
Zahra
Bangaleh
Core Laboratory, Iran University of Medical Sciences, Tehran, Iran
zbangaleh1@gmail.com
00319475328460042125
00319475328460042125
No
Seyed Hamidreza
Monavari
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
monavari.hr@iums.ac.ir
00319475328460042126
00319475328460042126
Yes
en
Comparison of intraperitoneal bupivacaine, acetazolamide, and placebo on pain relief after laparoscopic cholecystectomy surgery: A clinical trial
Background: Given the importance of patients’ pain after laparoscopic surgeries, this study was conducted to compare the effectiveness of intraperitoneal bupivacaine, acetazolamide, and placebo on pain relief after laparoscopic cholecystectomy surgery.
Methods: Patients admitted to Rasool Akram hospital with physical status I or II, based on the American Society of Anesthesiologists (ASA) system, who were candidates for laparoscopic cholecystectomy surgery due to gallstones, were included in this study. Patients were divided into 3 groups (each group containing 20 patients) using block randomization with foursome blocks. Group 1 received bupivacaine, group 2 acetazolamide, and group 3 intravenous saline as placebo. After surgery, pain score was assessed by visual analogue scale, and shoulder pain and analgesic doses were also measured. The mentioned parameters were assessed at 1, 4, 8, 12, and 24 hours after surgery.
Results: In this study, 60 patients were included in 3 groups. The mean pain recorded (VAS) at 1, 4, and 8 hours after surgery was not significantly different between acetazolamide and bupivacaine groups, but their score was significantly lower than the placebo group (p<0.05). However, the score recorded at 12 and 24 hours after surgery was not significantly different between the 3 groups (p>0.05). Mean of pain reliever (acetaminophen) injected to the patients when needed was not significantly different among the 3 intervention groups (p<0.05). The highest prevalence of shoulder pain (70%) belonged to the placebo group and the lowest (25%) to acetazolamide (p<0.05). Mean heart rate, systolic blood pressure, diastolic blood pressure, and the respiratory rate were not significantly different among intervention groups in 1, 4, 8, 12, and 24 hours after surgery (p>0.05).
Conclusion: According to the results, acetazolamide and bupivacaine injection reduced pain in early hours after laparoscopy. However, pain intensity was not different between intervention groups and the control group after 12 hours, so re-prescription seems to be appropriate at this time. Acetazolamide injection significantly reduces shoulder pains after surgery.
Laparoscopy, Cholecystectomy, Pain, Acetazolamide, Bupivacaine
653
658
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2029-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/1
1395/10/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/4
1397/5/13
Poupak
Rahimzadeh
Pain Research Center, Iran University of Medical Sciences, Tehran, Iran
poupak_rah@hotmail.com
00319475328460042206
00319475328460042206
No
Seyed Hamid Reza
Faiz
Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
hrfaiz@hotmail.com
00319475328460042207
00319475328460042207
No
Mostafa
Hoseini
Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
md_mastafa_h@yahoo.com
00319475328460042208
00319475328460042208
No
Seyed Hamzeh
Mousavie
Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
s.hamzah.mousavie@gmail.com
00319475328460042209
00319475328460042209
No
Farnad
Imani
Pain Research Center, Iran University of Medical Sciences, Tehran, Iran
farimani@tums.ac.ir
00319475328460042210
00319475328460042210
No
Ali Reza
Negahi
Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
arnegahi@gmail.com
00319475328460042211
00319475328460042211
Yes
en
The Prevalence and risk factors of osteoporosis among the elderly in Hamadan province: A cross sectional study
Background: Osteoporosis is the most common metabolic bone disease and is a public health issue, particularly among the elderly, across the world. Given the significance of the disease in causing disability and, in particular, its dangers in old age, we aimed to examine osteoporosis and its determinant factors among the elderly.
Methods: We conducted a cross sectional study in the province of Hamadan from September 2015 to March 2016 on all the elderly men and women covered by ‘Integrated and Comprehensive Elderly Care Program’. The data required for this study was collected through an aging health care checklist. To estimate the adjusted association of potential risk factors and other confounding variables of osteoporosis, multiple logistic regression was used at a significance level of 5%.
Results: In this cross sectional study, 1779 elderly men and women aged 6o years and over were studied. The prevalence of osteoporosis was 7.99% (95%CI:7.79-8.18), which was higher among women than in men (8.08% vs. 7.83%). The factors that raised the probability of osteoporosis were as follow: aging (OR= 1.05, 95% CI: 1.02-1.07, p<0.001), low education (OR=1.96, 95% CI:1.02-3.84, p=0.04), living in urban areas (OR=2.82, 95% CI:1.93-4.11, p<0.001), smoking (OR=2.39, 95% CI:1.42-4.04, p<0.001), and family history of osteoporosis (OR=1.95, 95% CI:1.07-3.54, p=0.03).
Conclusion: Based on our results, aging, low education level, living in urban areas, being a cigarette smoker, and having a family history of osteoporosis were all predicting factors for osteoporosis among the elderly.
Osteoporosis, Elderly, Prevalence, Iran, Hamadan
648
652
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3467-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/28
1396/3/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/18
1397/3/28
Parvin
Cheraghi
Department of Genterology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran, & Department of Health Education and Promotion, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
parvin.cheraghi@umsha.ac.ir
00319475328460042067
00319475328460042067
No
Zahra
Cheraghi
Department of Epidemiology, Non-communicable Disease Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
cheraghiz@ymail.com
00319475328460042068
00319475328460042068
Yes
Shiva
Bozorgmehr
Health Vice-Chancellors, Hamadan University of Medical Sciences, Hamadan, Iran
ShivaBozorgmehr@yahoo.com
00319475328460042069
00319475328460042069
No
en
The behavior of basic health insurance Organizations after the implementation of Relative Value of Health Services book in Iran: A qualitative study
Background: Since approximately 45% of basic health insurance (BHI) resources are spent and distributed based on the Relative Value of Health Services (RVHS) book, therefore, any revision in this book will most probably affect the behavior of health insurance organizations. The present study was prospected to determine the effect of revising RVHS on behavior of BHI funds as the main providers of treatment resources.
Methods: This is a qualitative study in which data were analyzed using content analysis method. Semi-structured interviews were used to gather the required data. 27 interviewees were chosen using purposive sampling method. Finally, MAXQDA software was used to analyze and code the data.
Results: According to the results, revision of RVHS influenced the behavior of health insurance organizations. The most important changes in the behavior of health insurance funds involved the following: formation of a committee for cost management and handling the insurance documents, creating a uniform coding system for health services, redesigning the handling process of documents, increased share of insurance funds from health expenditures, with 300 new services added to basic package and revising the package according to the new version of the book. Furthermore, the rest of the changes included in the global payment method based on the new book, delay in paying claims, increased deductions based on the payment of expensive services on treatment protocols, holding periodic training courses, and teaching the new book as well as the procedures for handling the documents.
Conclusion: With regard to the revision of RVHS and considering the incremental approach in revision of relative values, the increased claims of health services delivery centers and delay in payment of these claims were the most important changes in the behavior of health insurance funds. Health policy makers can overcome such issues and provide proper financial conditions through reduction of conversion factor and mobilization of resources. Such policies will open the space for best management of the behaviors affected by revision of relative values.
Relative value unit, Payment system, Physician fees, Behavior, Basic health insurance
641
647
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3735-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/5
1396/7/13
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/11
1396/8/20
Mani
Yousefvand
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Mani.yousef@gmail.com
00319475328460042063
00319475328460042063
No
Alireza
Olyaeemanesh
Department of Payment and Financing of Health System, National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran
arolyaee@gmail.com
00319475328460042064
00319475328460042064
Yes
Mohammad
Arab
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
arabmoha@tums.ac.ir
00319475328460042065
00319475328460042065
No
Ebrahim
Jafaripooyan
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
jaafaripooyan@tums.ac.ir
00319475328460042066
00319475328460042066
No
en
Pattern of body mass index, chronic diseases, and physical component of quality of life in a population in North of Iran: A latent class analysis
Background: Due to the rise of non-communicable diseases (NCDs) and lifestyle changes, this study aimed at determining the subclasses of Iranian adults based on body mass index, some NCDs, and status of physical component of quality of life.
Methods: A total of 5207 participants of Amol cohort study were studied in this study. Latent class analysis (LCA) was used to determine the best model with the minimum AIC or BIC.
Results: We decided that the 6 latent classes model was the best model. The first class described 35.1% of the participants and was characterized by individuals with no disease status. The sixth class described 0.7% of the individuals and was characterized by individuals exhibiting high probability of body mass index (BMI) equal or more than 25, kidney inadequacy, hypertension, and moderate physical component of quality of life status.
Conclusion: This study showed the pattern of body mass index, chronic diseases, and physical component of quality of life. Our findings demonstrated that some risk factors and non-communicable diseases tend to accumulate in some classes, especially classes 5 and 6, and thus the risk of developing these diseases rises along with increase in their clustering abilities. These results point out the critical importance of designing specific preventive interventional programs for these stratums of individuals.
Non-communicable diseases, Body mass index, Quality of life, Latent class analysis, Amol
635
640
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1510-4&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/27
1395/9/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/8
1396/7/16
Ali
Gholami
Department of Public Health, School of Public Health, Neyshabur University of Medical Sciences, Neyshabur, Iran
aagholami80@yahoo.com
00319475328460042052
00319475328460042052
No
Farhad
Zamani
Gastrointestinal & Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
zamanif@yahoo.com
00319475328460042053
00319475328460042053
No
Elham
Zandian
Non-Communicable Diseases Research Center, Endocrine and Metabolic Research Institute, Tehran University of Medical Sciences, Tehran, Iran
00319475328460042054
00319475328460042054
No
Masoudreza
Sohrabi
Gastrointestinal & Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
sohrabi_r@yahoo.com
00319475328460042055
00319475328460042055
No
Farhad
Moradpour
Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
farhadepid@yahoo.com
00319475328460042056
00319475328460042056
No
Mansooreh
Maadi
Gastrointestinal & Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
00319475328460042057
00319475328460042057
No
Maryam
Khazaee-Pool
Department of Health Education and Promotion, School of Health, Zanjan University of Medical Sciences, Zanjan, Iran
khazaee_m@yahoo.com
00319475328460042058
00319475328460042058
No
Abbas
Abbasi-Ghahramanloo
Health Management Research Center, Baqiyatallah University of Medical Sciences & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
Abbasi.abbas49@yahoo.com
00319475328460042059
00319475328460042059
Yes
en
Comparison of biophysical, biomechanical and ultrasonographic properties of skin in chronic dermatitis, psoriasis and lichen planus
Background: Skin biometrology is a useful method for evaluation of inflammatory skin disorders such as dermatitis, psoriasis, and lichen planus. The current study tries to compare the biophysical features of skin in dermatitis, psoriasis, and lichen planus.
Methods: By a convenient sampling method, 22 mild to moderate chronic dermatitis, 26 psoriasis, and 21 lichen planus patients were recruited in the study. Stratum corneum (S.C.) hydration, Transepidermal water loss (TEWL), pH, erythema, melanin, sebum, friction, elasticity parameters (R0, R2, and R5), skin temperature, skin thickness, and echo-density of epidermis and dermis were measured on the lesional (selected active lesion), uninvolved perilesional, and uninvolved symmetrical skin. The average of perilesional and symmetrical uninvolved parameters was used as control, while the percentage change of each parameter [(lesion – control / control) ×100] was calculated, and compared among three diseases by ANOVA test using SPSS software version 18. The significance level was set at α=0.05.
Results: Comparison of percentage changes showed that the changes in TEWL, friction index, sebum content, R2 (gross elasticity), R5 (net elasticity), skin temperature, dermal thickness, and epidermal density are not significantly different among three skin diseases. But there were significant differences in three diseases considering the decrease in S.C. hydration (p<0.001), R0 (opposed to firmness) (p<0.001), and dermal density (p<0.001) compared to control skin. Moreover, the increase in skin pH (p<0.001), melanin content (p=0.048), erythema (p=0.023), and epidermal thickness (p <0.001) significantly differed among these diseases.
Conclusion: Dermatitis, psoriasis and lichen planus lesions had specific biophysical changes. It may be helpful in their differential diagnosis.
Biophysical properties, Dermatitis, Lichen planus, Psoriasis, Ultrasonographic properties
630
634
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3847-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/14
1396/8/23
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/16
1397/4/25
Taraneh
Yazdanparast
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences & Telemedicine Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
drtaraneh@yahoo.com
00319475328460042032
00319475328460042032
No
Kamran
Yazdani
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
kyazdani48@yahoo.com
00319475328460042033
00319475328460042033
No
Philippe
Humbert
Centre d’Etudeset de Recherchesur le Tégument (CERT), INSERM UMR1098, SFR FED 4234 IBCT, University of Franche-Comté, Besançon, France
philippe.humbert@univ-fcomte.fr
00319475328460042034
00319475328460042034
No
Alireza
Khatami
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
alirezakhatami1970@yahoo.com
00319475328460042035
00319475328460042035
No
Saman
Ahmad Nasrollahi
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
samannasrol@gmail.com
00319475328460042036
00319475328460042036
No
Hournaz
Hassanzadeh
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
hasanzadeh.hoornaz92@gmail.com
00319475328460042037
00319475328460042037
No
Amir Houshang
Ehsani
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
ehsanih@tums.ac.ir
00319475328460042038
00319475328460042038
No
Leila
Izadi Firouzabadi
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
lilaizadi@yahoo.com
00319475328460042039
00319475328460042039
No
Alireza
Firooz
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences & Clinical Trial Center, Tehran University of Medical Science, Tehran, Iran
alifiruz@yahoo.com
00319475328460042040
00319475328460042040
Yes
en
Impaired nonverbal working memory in high-functioning autism spectrum disorder
Background: Past studies have documented working memory impairment in participants with high-functioning Autism Spectrum Disorders (IQ>70), but inconsistent findings have been reported. One possibility is the existence of verbal responses in the evaluation of working memory performance. The aim of the current study is to examine the working memory performance and its correlation with a prominent deficit in participants with high-functioning Autism Spectrum Disorders by non-verbal working memory tasks compared with typically developing samples.
Methods: The current study is a cross-sectional, comparative study. The working memory performance of the 30 participants with high-functioning Autism Spectrum Disorders (7-16 years) and 30 typically developing was compared by working memory subtests of the Leiter International Performance Scale-Revised in Tehran, Iran. Two groups were matched for age and gender. ANOVA, ANCOVA, repeated measures ANOVA and Pearson’s correlation coefficient were used to analyze the data statistically. The significance value was set at p<0.05.
Results: The results showed that if the effect of FSIQ (full-scale intelligence quotient) were controlled individuals with high-functioning Autism Spectrum Disorders exhibited significant impairment in the Reverse Memory subtest (p=0.001). Also, unpredictably Forward Memory (r=0.38, p=0.03) and Reverse Memory tasks (r=0.38, p=0.03) displayed a significant positive correlation with the Social interaction subscale of the Gilliam Autism Rating Scale (Second Edition).
Conclusion: It seems that nonverbal working memory is impaired in persons with high-functioning Autism Spectrum Disorders. Results of the current study revealed that factors like complexity and cognitive load of tasks may influence working memory performance in individuals with high-functioning Autism Spectrum Disorders.
Autism spectrum disorder, Executive function, Working memory
623
629
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4456-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/12
1397/5/21
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/9
1397/6/18
Atusa
Rabiee
Department of Speech and Language Pathology, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
rabiee.a@tak.iums.ac.ir
00319475328460041986
00319475328460041986
No
Behnoosh
Vasaghi-Gharamaleki
Department of Basic Sciences, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
vasaghi.b@iums.ac.ir
00319475328460041987
00319475328460041987
Yes
Sayyed Ali
Samadi
Institute of Nursing and Health Research, University of Ulster, Northern Ireland, UK
s.samadi@ulster.ac.uk
00319475328460041988
00319475328460041988
No
Younes
Amiri-Shavaki
Department of Speech and Language Pathology, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
Amiriyoon@Yahoo.com
00319475328460041989
00319475328460041989
No
Javad
Alaghband-rad
Department of Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
rad@dal.cd
00319475328460041990
00319475328460041990
No
Saba
Seyedind
Department of Speech and Language Pathology, School of Rehabilitation Sciences, Tehran University of Medical Sciences, Tehran, Iran
s.seyedin86@gmail.com
00319475328460041991
00319475328460041991
No
Soode
Hosseini
Department of Psychology, School of Education and Psychology, Alzahra University, Tehran, Iran
Hoseini.soodeh@gmail.com
00319475328460041992
00319475328460041992
No
en
Social studies in health: A must for today
This debate article highlights the major issues that should be considered in social studies in health, which could guide the policymakers to target the root causes of diseases and to better evaluate the impact of previous health interventions at community level. This is a prerequisite for a prosperous health system, and there is an urgent need for reliable and timely evidence for intervention on all social issues that could affect health.
Social studies, Social determinants of health, Health, Policymaking
618
622
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3826-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/10
1396/8/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/16
1397/6/25
Kamran
Bagheri Lankarani
Health Policy Research Center, Institute of Health, School of Medicine, Shiraz Uni-versity of Medical Sciences, Shiraz, Iran
kblankarani@yahoo.com
00319475328460041984
00319475328460041984
No
Sulmaz
Ghahramani
Health Policy Research Center, Institute of Health, School of Medicine, Shiraz Uni-versity of Medical Sciences, Shiraz, Iran
suli.ghahraman@gmail.com
00319475328460041985
00319475328460041985
Yes
en
Psychometric properties of the Persian version of the nutritional form for the elderly (NUFFE) in nursing home residents
Background: The Nutritional Form for the Elderly (NUFFE) is a newly developed tool. This study aimed to carry out a psychometric evaluation of the Persian version of NUFFE (NUFFE-P) among nursing home residents.
Methods: Nursing home participant’s aged ≥ 60 years (n=97) were enrolled. The inclusion criteria were residency for at least 6 months in the nursing home, and ability to communicate. Exclusion criteria included cognitive impairment, having depressed mood, severe hearing loss, problems in upper and lower extremities also, history of hospital admission during 6 months before enrollment. Anthropometric measures, laboratory tests, three-day food intake, NUFFE-P version, Mini Nutritional Assessment (MNA), Barthel Index (BI) and Geriatric Depression Scale (GDS-15) were assessed. The relationship between the NUFFE-P and MNA scores was considered as concurrent validity.
Results: The Cronbach’s alpha coefficient of NUFFE-P tool was 0.76. The intraclass correlation coefficient for the total score between two raters obtained 0.98 (CI 0.97-0.99). The correlation coefficient between the NUFFE-P and the MNA scores was -0.75 (p<0.01). Four factors were extracted for the NUFFE-P in an exploratory factor analyses. Sensitivity 69.8% and 100% and specificity 75.7% and 85.6% were achieved to detect elderly at medium risk (cutoff=6), and at high risk of under-nutrition (cutoff=11) respectively.
Conclusion: The NUFFE-P has sufficient psychometric properties in nutritional status screening among the Iranian elderly nursing homes residents.
Elderly, Nutrition assessment, Sensitivity, Specificity
610
617
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3775-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/17
1396/7/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/20
1397/2/30
Farshad
Sharifi
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Farshad.Sharifi@gmail.com
00319475328460041974
00319475328460041974
No
Mojde
Mirarefin
Division of Public and Behavioral Health, Nevada Department of Health and Human Services, Carson City, USA
mojde.mirarefin@gmail.com
00319475328460041975
00319475328460041975
No
Mahtab
Alizadeh-Khoei
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute & Geriatric & Gerontology Department, Medical school, Tehran University of Medical Sciences, Tehran, Iran
alizadeh-m@sina.tums.ac.ir
00319475328460041976
00319475328460041976
Yes
Neda
Nazari
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences & Kahrizak Charity Foundation Nursing Home, Tehran, Iran
neda_nazari77@yahoo.com
00319475328460041977
00319475328460041977
No
Baharak
Najafi
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
najafi_bahar@yahoo.com
00319475328460041978
00319475328460041978
No
Hossien
Fakhrzadeh
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
fakhrzad@tums.ac.ir
00319475328460041979
00319475328460041979
No
Seyed Masoud
Arzaghi
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
dr.arzaghi@gmail.com
00319475328460041980
00319475328460041980
No
Ulrika
Söderhamn
Center of Caring Research – Southern Norway, University of Agder, Kristiansand, Norway
ulrika.soderhamn@uia.no
00319475328460041981
00319475328460041981
No
Fahimeh
Taati
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
fahimetaati@gmail.com
00319475328460041982
00319475328460041982
No
Neda
Mehrdad
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
nmehrdad@tums.ac.ir
00319475328460041983
00319475328460041983
No
en
Role of obesity in gestational hypertension in primigravidae women: A case control study in Shadegan, Iran
Background: Gestational hypertension is a serious problem among pregnant women in Shadegan. This study was conducted to estimate the prevalence and risk factors of gestational hypertension in these women.
Methods: In this study, the prevalence of gestational hypertension was estimated. Then, a case-control study was performed on 310 pregnant women with gestational hypertension and 930 healthy pregnant women in 2014. Multiple logistic regression was used to explore the possible risk factors. The analysis was repeated in a subgroup of primigravidae women to identify the risk factors that led to gestational hypertension.
Results: The prevalence of gestational hypertension among pregnant women in Shadegan was 9.6%. Moreover, multiple logistic regression of all pregnant women showed that obese pregnant women were 1.79 times (OR = 1.79; 95%CI = 1.19-2.71; p<0.005) more likely to have gestational hypertension. Overweight and obese primigravidae women were 2.13 (OR = 2.1; 95%CI = 1.031-4.34; p<0.041) and 4.8 (OR = 2.4; 95%CI = 1.13-5.16; p<0.022) times more likely to have gestational hypertension than women with normal BMI, respectively. Age, education, history of gestational hypertension, and type of residential area of the primigravidae women were also significant factors.
Conclusion: BMI is the most important risk factor for gestational hypertension. More focus needs to be laid on this issue to raise awareness on the preservation of proper BMI before pregnancy, which can help decrease gestational hypertension.
Gestational hypertension, Pregnancy, Risk factor, Shadegan, Iran
605
609
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3659-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/31
1396/6/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/27
1396/12/8
Leila
Moftakhar
Department of Epidemiology, School of Health, Iran University of Medical Scienc-es, Tehran, Iran
00319475328460042070
00319475328460042070
No
Masoud
Solaymani-Dodaran
Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran
solaymani.m@iums.ac.ir
00319475328460042071
00319475328460042071
Yes
Bahman
Cheraghian
Research Center for Infectious Diseases of Digestive System, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Cheraghian2000@yahoo.com
00319475328460042072
00319475328460042072
No
en
Prevalence of stunting in Iranian children under five years of age: Systematic review and meta-analysis
Background: Children in all countries, especially in developing countries, constitute a vulnerable group. Therefore, attention to their health issues is very important. The aim of this study was to determine the prevalence of stunting in Iranian children under-five years.
Methods: All original studies were searched by complex search syntax from international databases including Medline (PubMed), Web of sciences, Google scholar, Scopus, CINHAL and the Iranian databases consist of SID (Scientific Information Database, www.sid.ir), Irandoc (Iranian Research Institute for Information Science and Technology, Irandoc.ac.ir), Iranmedex (www.iranmedex.com), and Magiran (www.magiran.com) from January 1989 to August 2017. Two independent reviewers identified relevant studies in several steps. We employed a random effect model to generate a pooled prevalence. The reported prevalence is presented as percent and 95% confidence interval (CI). Sources of heterogeneity among the studies were determined using subgroup analysis and meta-regression.
Results: Finally, 16 studies from different settings remained for meta-analysis in order to have a pooled prevalence estimate, which prevalence of total stunting was 12% (95%CI: 10–14). Subgroup analysis for gender showed that the prevalence of stunting in both boys and girls children were equal to 10% (95%CI: 8–11) and 9% (CI 95% 8–10), respectively. Also pooled prevalence of stunting in southern provinces are higher than other provinces.
Conclusion: The prevalence of stunting in some regions of Iran is higher than others. Although, in recent years much effort has been made to address deprivation such as economical, nutritional and social supporting, improvement of the quality of life, there are still nutritional problems in these areas of Iran.
Prevalence, Stunting, Children under 5 years, Iran
598
604
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1741-11&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/23
1396/11/3
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/25
1397/6/3
Kamyar
Mansori
School of Public Health, Dezful University of Medical Sciences, Dezful & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
kamyarmansori@gmail.com
00319475328460041902
00319475328460041902
No
Fatemeh
Khosravi Shadmani
Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
khosravishadman@gmail.com
00319475328460041903
00319475328460041903
No
Hossein
Mirzaei
National Institute of Health Research, Tehran University of Medical Science, Tehran, Iran
hosseinmirzaei64@yahoo.com
00319475328460041904
00319475328460041904
No
Roya
Vesal Azad
School of Health, Iran University of Medical Sciences, Tehran, Iran
royavesal@yahoo.com
00319475328460041905
00319475328460041905
No
Sorour
Khateri
6. Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
sorur.khateri@yahoo.com
00319475328460041906
00319475328460041906
No
Shiva
Mansouri Hanis
Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran
kamyarmansori@gmail.com
00319475328460041907
00319475328460041907
No
Yousef
Moradi
Department of Epidemiology & Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
Moradi.y@tak.iums.ac.ir
00319475328460041908
00319475328460041908
Yes
en
Strategies for reducing expenditures in Iran's health transformation plan: A qualitative study
Background: Iranian health system underwent a series of reforms entitled Health Transformation Plan (HTP) in 2014. The plan started with packages that have imposed financial burden and increased expenditure in the health system. This study aimed to identify strategies and solutions to reduce expenditures in HTP in Iran.
Methods: To conduct this qualitative study, the researchers held 15 semi-structured interviews with prominent experts in the research arena in 2018. Content analysis was used to analyze the data using MAXQDA 10 software.
Results: Data collection yielded 9 main topics, including purchase and provision medicine, prescription, purchase and use of equipment, diagnostic medical services, referral system, human resources, physical space, payment system, and modifying and increasing base salaries.
Conclusion: In Iran’s health system, some aspects of HTP wasted resources, eg, the waste of resources in the service delivery system; thus, policymakers should consider proper strategies to control the costs based on the nature of their implementation.
Cost control, Health transformation plan, Qualitative study, Iran
591
597
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4680-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/10
1397/8/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/23
1397/10/2
keivan
Rahmany
Health Management and Economics Research center (HMERC), Isfahan University of Medical Sciences, Isfahan, Iran
keivan_rahmany@yahoo.com
00319475328460042987
00319475328460042987
No
Maryam
Barati
Student Research Committee, School of Management and Medical Informatics, Isfahan University of Medical Sciences, Isfahan, Iran
Mbarati92@ymail.com
00319475328460042988
00319475328460042988
No
Masoud
Ferdosi
Health Management and Economics Research center (HMERC), Isfahan University of Medical Sciences, Isfahan, Iran
Masood Ferdosi ferdosi1348@yahoo.com
00319475328460042989
00319475328460042989
No
Amir
Rakhshan
Department of Foreign Languages, Tehran University of Medical Sciences, Tehran, Iran
arakhshan@sina.tums.ac.ir
00319475328460042990
00319475328460042990
No
Ali
Nemati
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
ali_nemati96@yahoo.com
00319475328460042991
00319475328460042991
Yes
en
Application of the short form of quality of life instrument version 2 in a large population of Tehran
Background: Quality of life (QoL) is now considered as a key indicator in health studies. Therefore, this study was conducted to evaluate QoL in the general population of Tehran (capital of Iran) using SF-12v2 questionnaire and determine some factors associated with it.
Methods: This was part of a large population-based cross sectional study conducted in Tehran, Iran, in 2011. Participants were selected from all districts of Tehran using multistage cluster random sampling method. Data were collected using the Iranian version of the SF-12v2 questionnaire. Linear regression model was used to assess the independent effect of surveyed variables of the study population on their QoL. P< 0.05 was considered statistically significant.
Results: Overall, 30 809 individuals over the age of 20 from 22 urban districts were included in this study and evaluated by SF-12v2 questionnaire. The mean age of the study population was 44.5±15.9, and most of them were female (19 967 (64.8%)). The total mean score of SF-12v2 was 60.4 and the lowest and highest mean scores were observed in GH (46.9±26.5) and MH subscales (64.1±24.7), respectively. It was also observed that District 3 of Tehran had the highest mean score (65.2±18.7) in the total QoL and District 12 had the lowest mean score (56.6±18.7), respectively. The results of multiple linear regression model showed that sex, age, education, household size, presence of chronic disease in family, having insurance, smoking, and marital status were significantly related to most subscales and two summary components of QoL.
Conclusion: The results of this study showed that the surveyed population of Tehran had a relatively moderate QoL, but it changed from district to district. It was also observed that age and education of the study population were important variables in relation to QoL.
Quality of life, QoL, Short form instrument, SF-12v2, Iran
583
590
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1510-5&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/15
1395/9/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/3
1396/5/12
Ali
Gholami
Department of Public Health, School of Public Health, Neyshabur University of Medical Sciences, Neyshabur & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
aagholami80@yahoo.com
00319475328460042976
00319475328460042976
Yes
Shabnam
Nadjafi
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran Universi-ty of Medical Sciences, Tehran, Iran
sh-nadjafi@razi.tums.ac.ir
00319475328460042977
00319475328460042977
No
Farhad
Moradpour
Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
fahadepid@yahoo.com
00319475328460042978
00319475328460042978
No
Zahra
Moosavi Jhromi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
zahramusavi_j@yahoo.com
00319475328460042979
00319475328460042979
No
Ali
Montazeri
Iranian Institute for Health Sciences Research, Tehran, Iran
montazeri@acecr.ac.ir
00319475328460042980
00319475328460042980
No
Mohamad-Reza
Vaez-Mahdavi
Department of Physiology, Shahed University, Tehran, Iran
vaezmahdavi@shahed.ac.ir
00319475328460042981
00319475328460042981
No
Ali Asghar
Haeri Mehrizi
Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
haeri.stat@gmail.com
00319475328460042982
00319475328460042982
No
Abbas
Abbasi-Ghahramanloo
Health Management Research Center, Baqiyatallah University of Medical Sciences & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
abbasi.abbas49@yahoo.com
00319475328460042983
00319475328460042983
No
Sare
Hatamian
Department of Epidemiology, School of Public Health & Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
hatamians@yahoo.com
00319475328460042984
00319475328460042984
No
Masoudreza
Sohrabi
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran Universi-ty of Medical Sciences, Tehran, Iran
sohrab_r@yahoo.com
00319475328460042985
00319475328460042985
No
Mohsen
Asadi-Lari
Department of Epidemiology, School of Public Health & Oncopathology Research Centre, Iran University of Medical Sciences, Tehran, Iran
mohsen.asadi@yahoo.com
00319475328460042986
00319475328460042986
No
en
Iran towards universal health coverage: The role of human resources for health
Summary:
Given the key role of adequate, skilled, well-trained, and motivated Human Resources for Health (HRH) in achieving Universal Health Coverage (UHC), this manuscript investigates the current situation of Iran HRH after the implementation of the recent Health Transformation Plan (HTP) in accordance with UHC analytical framework and by using four domains of availability, accessibility, acceptability and quality. We conclude that, Conflicts of interest and multiple interventions from different sectors have controversial and sometimes negative effects on the health workforce. In order to achieve the objectives of UHC from the perspective of human resources, Iran needs unified governance and comprehensive planning in this criterion. Also the effects of health system interventions on health workforce before implementation should be assessing.
Universal health coverage, Human resources for health, Health transition plan, Health workforce
578
582
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3115-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/29
1397/6/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/29
1397/8/7
Elham
Ehsani-Chimeh
National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran
ehsanielham@yahoo.com
00319475328460040978
00319475328460040978
Yes
Haniye Sadat
Sajadi
National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran
hsajjadi@tums.ac.ir
00319475328460040979
00319475328460040979
No
Reza
Majdzadeh
Knowledge Utilization Research Center, Community-Based Participatory-Research Center, and School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
reza.majdzadeh@gmail.com
00319475328460040980
00319475328460040980
No
en
Comparison of conduit and autograft efficiency in repairing femoral nerve injury in New Zealand rabbits
Background: Peripheral nerve injuries may affect all age groups and exert devastating impacts on the professional and personal life of the patients. The investigation of nerve regeneration and use of biomaterials and synthetic materials have resulted in advancements in the treatment of peripheral nerve injuries and lesions. Nerve conduits can be used to adjoin the digital sensory nerve spaces of less than 3 cm, especially when the direct tension-free repair of peripheral nerve lesions is not possible. The present study was conducted to evaluate the use of nerve conduits by functional and nonfunctional parameters (i.e. histological study).
Methods: This experimental study was conducted on 30 male rabbits. After cutting or crushing the right femoral nerve of the rabbits, they were divided into 3 groups: group 1, with right femoral nerve cut; group 2, with right femoral nerve crushed; and group 3, with right femoral nerve cut using a conduit. The 3 groups were evaluated after 1, 8, and 16 weeks for functional parameters (i.e. walking track analysis). In addition, they were subjected to nonfunctional examination (i.e. histological study) after 16 weeks, then, the results were compared.
Results: The 3 groups showed no statistically significant differences in motor recovery in the eighth and 16th weeks (p>0.05). Based on the histological study, group 3 with an end-to-end nerve cutting using a conduit, showed a significantly higher axon count compared to groups 2 and 3 (p<0.05).
Conclusion: End-to-end anastomosis using conduit led to axon growth; moreover, comparable functional recovery was observed with end-to-end neurorrhaphy in a rabbit model. Given that the diameter of the nerves and muscles, which might be neurotized in humans, and is much bigger and not comparable to that of the rabbits, it is highly recommended to conduct studies on animals with the larger size, such as primates, to facilitate the generalization of the results to humans.
Conduit, Femoral nerve, Nerve anastomosis, Motor recovery, Histologic study
574
577
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3661-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/30
1396/7/8
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/9
1397/1/20
Seyed Mehdi
Moosavizadeh
Department of Plastic Surgery, 15 Khordad Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Moosavizadeh2015@sbmu.ac.ir
00319475328460041815
00319475328460041815
No
Hamidreza
Alizadeh Otaghvar
Trauma and Injury Research Center, Iran University of Medical Sciences , Tehran, Iran
drhralizade@yahoo.com
00319475328460041816
00319475328460041816
Yes
Mohammad
Baghae
Shahid Beheshti University of Medical Sciences, Trauma and Injury Research Center, Tehran, Iran
00319475328460041817
00319475328460041817
No
Arefeh
Zavari
Iran University of Medical Sciences, Tehran, Iran.
zavari.hd@gmail.com
00319475328460041818
00319475328460041818
No
Hamid
Mohyeddin
Department of Clinical Sciences, Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran
00319475328460041819
00319475328460041819
No
Hamidreza
Fattahiyan
Department of Clinical Sciences, Faculty of Specialized Veterinary Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
00319475328460041820
00319475328460041820
No
Behnood
Farazmand
Iran University of Medical Sciences, Tehran, Iran
00319475328460041821
00319475328460041821
No
Seyed Mohammad Ali
Moosavizadeh
Student of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
00319475328460041822
00319475328460041822
No
en
Sesame seeds essential oil and Sesamol modulate the pro-inflammatory function of macrophages and dendritic cells and promote Th2 response
Background: Herbal medicine is becoming progressively accepted treatment for management of different diseases worldwide. Recognition of the active ingredients and mechanisms of herbal medicine against the immune system and related anomalies is highly favorable. This experimental study aimed to investigate the effects of Sesame (Sesamum indicum L.) essential oil and sesamol as effective components on mouse splenocytes subsets, macrophages and dendritic cells (DCs).
Methods: Effective components of sesame were extracted and used to treat splenocytes, PHA (5μg/ml) and LPS (10 μg/ml) stimulated splenocytes, macrophages and DCs in different concentration (0.01–100 μg/ml). The cell proliferation/viability was measured using the MTT assay and nitrite levels were measured by the diazotization method. Moreover, TNF-α and IL-1β cytokines concentration were assayed by ELISA. Treated DCs also analysed for maturation marker levels and cytokine production.
Results: Analysis of the results indicated that sesame components suppress PHA-stimulated splenocytes with no effect on LPS-stimulated subsets. Furthermore, the sesame ingredients reduced the release of IFN-γ and increased secretion of IL-4 from lymphocytes. Macrophages viability was not affected and production of NO, TNF-α, and IL-1β were inhibited using sesame essential oil and sesamol. DCs phenotype skewed to immature and release of TNF-α and IL-1β were abrogated form DCs.
Conclusion: These results indicate that sesame essential oil and its effective component as sesamol may capable of suppressing the response of cellular immunity with the domination of Th2 responses and also could modulate macrophages and the dendritic cells pro-inflammatory functions.
Sesame, Sesamol, Splenocyte, Macrophage, Nitric oxide, Dendritic cells
566
573
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3017-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/2
1396/5/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/30
1396/11/10
Samaneh
Khorrami
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious disease, Iran University of Medical Sciences, Tehran, Iran
khorrami.s@gmail.com
00319475328460041138
00319475328460041138
Yes
Saeed
Daneshmandi
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
daneshmandi2006@yahoo.com
00319475328460041139
00319475328460041139
No
Ghasem
Mosayebi
Molecular and Medicine Research Center & Traditional and Complementary Medicine Research Center (TCMRC), Arak University of Medical Sciences, Arak, Iran
gmosayebi@yahoo.com
00319475328460041140
00319475328460041140
No
en
Association of homeobox B13 (HOXB13) gene variants with prostate cancer risk in an Iranian population
Background: Prostate cancer is a complex condition in which both genetic and environmental factors concomitantly contribute to the tumor initiation and progression. Recently, HOXB13 has been proposed as a susceptibility gene for prostate cancer.
Objective: The present study was conducted to determine the existence of potential variations in HOXB13 gene in Iranian men with prostate cancer (PCa) compared to benign prostatic hyperplasia (BPH) cases.
Methods: HOXB13 genetic status was screened in 51 samples, including 21 blood and tissue of PCa cases, and compared to 30 cases affected by BPH using PCR/sequencing. Then, the existence of potential association was investigated between genomic DNA alterations in blood and tissue PCa specimens.
Results: Analysis of BPH tissues showed single nucleotide variations c.366C > T (rs) or c.513T > C (rs9900627) in exon 1, but not in exon 2. Evaluation of PCa tissues revealed 2 cases with both synonymous c.366C > T and c.513T > C variants and 2 cases with the synonymous c.366C > T variant in exon 1. The variants c.366C > T and c.513T > C, simultaneously or separately, were found in blood samples of PCa patients. The novel variant c.127A > G in exon 2 was detected in 1 PCa blood sample. Our analysis indicated a significant reciprocal correlation between HOXB13 mutation in the tissue and blood samples of PCa cases (p= 0.02).
Conclusion: The variants in exon 2 of HOXB13 may influence the risk of prostate cancer. Also, evaluation of HOXB13 mutation may be considered as a novel marker for screening PCa. Further investigations are warranted to evaluate the clinical significance of HOXB13 in Iranian population.
Prostate cancer, HOXB13, Benign prostatic hyperplasia, Variant, Iran
561
565
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2343-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/19
1396/9/28
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/19
1397/2/29
Raheleh
Roudi
Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
Raheleroudi@gmail.com
00319475328460041746
00319475328460041746
Yes
Hosein
Nemati
Department of Genetics, Subdiscipline of Biology, Payame Noor University, Tehran, Iran
iranigen@gmail.com
00319475328460041747
00319475328460041747
No
Mahsa
Moghadam Rastegar
Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
mmoghadam76@yahoo.com
00319475328460041748
00319475328460041748
No
Mehdi
Sotoudeh
Urology and Nephrology Research Center & Department of Urology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mehdi_sotoudeh@yahoo.com
00319475328460041749
00319475328460041749
No
Behzad
Narouie
Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran
b_narouie@yahoo.com
00319475328460041750
00319475328460041750
No
Azadeh
Shojaei
Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
a_shojaei2007@yahoo.com
00319475328460041751
00319475328460041751
No
en
Exploring the concept of scholarship of teaching and learning (SoTL): Concept analysis
Background: Researchers have contributed to the definition of SoTL; however, the literature is not conclusive on its definitions and attributes. Therefore, this study was an attempt to precisely define SoTL by its attributes, antecedents and consequences.
Methods: The Walker and Avant (2011) concept analysis method was used.
Results: The 9 emerged attributes are: Committed engagement in action, Critique-based, Disciplinary, Context-oriented, Critical enquiry process, Continuous deep reflection, Dynamic process, Shared publicly, and Learning focused.
Conclusion: This study helps promote understanding and application of SoTL.
Concept analysis, Scholarship of teaching and learning, SoTL, Walker and avant methodology
553
560
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-761-4&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/29
1396/11/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/7
1397/2/17
Fakhrossadat
Mirhosseini
Department of Medical Education, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, & Department of Anesthesia, Faculty of Para Medicine, Kashan University of Medical Sciences, Kashan, Iran
f_mirhoseiny@yahoo.com
00319475328460041741
00319475328460041741
No
Neda
Mehrdad
Metabolism and Endocrinology Research Institute, Tehran University of Medical Sciences, Tehran, Iran
nmehrdad@tums.ac.ir
00319475328460041742
00319475328460041742
No
Shoaleh
Bigdeli
Center for Educational Research in Medical Sciences (CERMS) & Department of Medical Education, Faculty of Medi-cine, Iran University of Medical Sciences, Tehran, Iran
sbigdeli@alumni.sfu.ca
00319475328460041743
00319475328460041743
Yes
Hamid
Peyravi
Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
hamidpeyravi@yahoo.com
00319475328460041744
00319475328460041744
No
Homeira
Khoddam
Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran
homeira_khoddam@yahoo.com
00319475328460041745
00319475328460041745
No
en
Depressive symptoms among metabolically healthy and unhealthy overweight/obese individuals: a comparative study
Background: Although a growing body of evidence suggests an association between obesity and depressive disorder, the association remains inconclusive. Metabolically healthy obese (MHO) phenotype, defined by favorable lipid profile, and normal insulin sensitivity, blood pressure, may be considered as a possible explanation for these inconsistencies. Accordingly, this study aimed to compare depression score among metabolic unhealthy obese (MUO) and age- and sex-matched healthy controls.
Methods: In this comparative study including 157 Iranian adults, we assigned participants into three groups (non-obese metabolic healthy group, MHO and MUO) according to the BMI cutoff and MetS criteria. Depressive symptoms were assessed by Beck Depression Inventory. Analysis was done using SPSS version 14.0. All variables are expressed as means ± SD. One-way ANOVA and Multiple linear regression were used for data analysis.
Results: After adjustment for sex, marital status and educational level, MUO participants had significantly higher Beck depression score (P= 0.036) compared to MHO and non-obese metabolic healthy groups. After adjustment for demographic variables, there was a significant association between waist circumference (β = 0.142, p=0.023), BMI (β= 0.347, p= 0.037), FBS (β= 0.096, p< 0.001), and the number of MetS components (β= 1.71, p= 0.002) with depression score.
Conclusion: MHO was a benign phenotype in relation to depression.
Depressive symptom, MetS, Obesity
549
552
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2083-4&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/5
1396/6/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/6
1396/10/16
Somaye
Yosaee
School of Public Health, Iran University of Medical Sciences, Tehran & School of Health, Larestan University of Medical Sciences, Larestan, Iran
s_yousai2006@yahoo.com
00319475328460041196
00319475328460041196
No
Kurosh
Djafarian
School of Nutrition Sciences, Tehran University of Medical Sciences, Tehran, Iran
kdjafarian@tums.ac.ir
00319475328460041197
00319475328460041197
No
Alireza
Esteghamati
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
esteghamati@tums.ac.ir
00319475328460041198
00319475328460041198
No
Abbas
Motevalian
School of Public Health, Iran University of Medical Sciences, Tehran, Iran
amotevalian@yahoo.com
00319475328460041199
00319475328460041199
No
Farzad
Shidfar
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, & School of Public Health, Iran University of Medical Sciences, Tehran, Iran
farzadshidfar@yahoo.com
00319475328460041200
00319475328460041200
No
Mehdi
Tehrani-Doost
Department of Psychiatry School of Medicine, Roozbeh Psychiatry Hospital Tehran University of Medical Sciences, Tehran, Iran
tehranid@sina.tums.ac.ir
00319475328460041201
0002-9134-7178, Esteghamati A, 0000-0001-5114-3982
No
Shima
Jazayeri
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, & School of Public Health, Iran University of Medical Sciences, Tehran, Iran
sh_jaz@yahoo.com
00319475328460041202
00319475328460041202
Yes
en
Levels of total IgA and IgA subclasses in the serum of chronic rhinosinusitis patients
Background: Different inflammatory mechanisms take part in the immunopathogenesis of chronic rhinosinusitis (CRS). Immunoglobulin (Ig) A is the first-line defense in the airway tracts and other mucosal sites, but little is reported regarding its serum level in CRS patients. The purpose of current study is to determine the serum levels of total IgA, and its subclasses (IgA1, and IgA2) in CRS with nasal polyps (CRSwNP), CRS without nasal polyps (CRSsNP), and control groups.
Methods: In this case-control study the serum levels of total IgA and IgA subclasses were determined by Nephelometry and ELISA methods, respectively. The difference of the median concentrations was analyzed with the Kruskal-Wallis test. Collected data were analyzed using SPSS and presented by GraphPad Prism software.
Results: A total of 10 CRSwNP patient, 10 CRSsNP patients and 10 healthy controls participated in our study. The mean age of the groups were 38.2±12.6, 25.6±10.54, and 30.1±9.5, respectively. The concentrations of total IgA were 156(120-165), 165 (149-173), and 172 (152.8-184.3) mg/dl, respectively. The concentrations of IgA1 were 107 (77.9-169.9), 156.1(112.8-175.6), and 130.4 (118.8-175.2) mg/dl, respectively. The concentrations of IgA2 were 26.11 (18.41-38.11), 26.96 (15.48-38.39), and 23.2 (18.42-31.78) mg/dl, respectively. There was no significant difference in total IgA (p=0.120), IgA1 (p=0.397) and IgA2 (p=0.925) serum levels among three groups.
Conclusion: Our study showed there is no difference in total IgA and IgA subclasses in the serum of CRS patients in comparison to healthy controls.
Chronic Rhinosinusitis, Nasal polyps, CRSsNP, CRSwNP, Serum IgA, Isotype switching
545
548
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3673-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/25
1396/12/6
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/16
1397/4/25
Hossein
Aazami
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
hossein.aazami@gmail.com
00319475328460040901
00319475328460040901
Yes
Farhad
Seif
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
farhad.seif@outlook.com
00319475328460040902
00319475328460040902
No
Babak
Ghalehbaghi
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
ghalehbaghi@gmail.com
00319475328460040903
00319475328460040903
No
Alireza
Mohebbi
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
mohebbi.ar@iums.ac.ir
00319475328460040904
00319475328460040904
No
Aslan
Ahmadi
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
dr.aslan_ahmadi@yahoo.com
00319475328460040905
00319475328460040905
No
Pegah
Babaheidarian
Pathology Department, Rasoul Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran
pegah.heidarian@yahoo.com
00319475328460040906
00319475328460040906
No
Kobra Zinat
Entezami
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
entezamirahimi@gmail.com
00319475328460040907
00319475328460040907
No
Majid
Khoshmirsafa
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
mj.khoshmirsafa@hotmail.com
00319475328460040908
00319475328460040908
No
Sahand
Ghalehbaghi
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
00319475328460040909
00319475328460040909
No
Reza
Falak
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
rezafalak@yahoo.com
00319475328460040910
00319475328460040910
No
en
Iranian drug use survey in workplaces: A study protocol
Background: Addiction is a serious concern in workplaces, as it can lead to accidents, absenteeism, and loss of productivity, neglect, delay, arguing, unhappiness, production cuts, and irregular working pattern. This national survey was conducted to assess the prevalence and pattern of drug use among employees of industrial environments in Iran.
Methods: In this cross sectional study, the sample size was determined to be 13489 using multistage cluster sampling method during November 2013 and November 2014. Data were collected by trained interviewers using a structured questionnaire developed by the research team. Urine drug test was done for participants using laboratory rapid kits. A total of 13 286 questionnaires were completed with remarkable responsiveness such that only 1.2% of them were excluded due to defects in urine drug tests, and the rest were analyzed after the review.
Results: The response rate to the questionnaires was 98.4% and 13 128 individuals took the urinary drug test. Many participants who had positive urine test did not express drug use and positive tests were more than self-reported cases. Compared to information about the pattern of drug use, data on the estimated prevalence of drug use was more reliable.
Conclusion: This study presents the protocol of a well-designed national survey, including sampling procedure, appropriate instrument and test, field work, and discussion on the strengths and limitations of the study, and thus its results can be used effectively by policymakers.
Drug use, Survey, Workplace, Addiction
537
544
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1829-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/10
1395/11/22
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/9
1397/4/18
Behzad
Damari
Tehran University of Medical Sciences, Neuroscience Institute, Governance and Health Department, Tehran, Iran
bdamari@gmail.com
00319475328460040891
00319475328460040891
No
Hossein
Almadani
Department of Prevention of Social Pathologies, Ministry of Co-operation, Work and Social Welfare, Tehran, Iran
h.almadani@gmail.com
00319475328460040892
00319475328460040892
No
Mahin
Ahmadi Pishkuhi
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran
mahin.ahmadipishkuhi@gmail.com
00319475328460040893
00319475328460040893
Yes
other
Time for key decisions: The increasing need for evidence-informed decision-making
tough decisions, decision-making, evidence-informed
535
536
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-821-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/20
1397/8/29
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/20
1397/8/29
Reza
Majdzadeh
Knowledge Utilization Research Center, Community-Based Participatory-Research Center and School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
rezamajd@tums.ac.ir
00319475328460043255
00319475328460043255
Yes
en
Raphe nuclei echogenicity changes in obsessive-compulsive disorder
Background: Dysregulation of serotonin system is hypothesized to play the main role in the etiology of obsessive-compulsive disorder (OCD). Transcranial sonography (TCS) is a helpful noninvasive and low-cost tool for the assessment of subcortical brain architectures, mainly basal nuclei, cerebellar central structures, and midbrain. In this study, an ultrasound assessment was performed for a sample of the patients with OCD and healthy control group to evaluate echogenicity of midbrain raphe nuclei (RN).
Methods: A total of 35 patients with OCD and 35 healthy controls of similar age and sex entered the study. Semi-structured clinical interview was performed according to the DSM IV-TR criteria to verify OCD. Echogenicity of the midbrain RN was assessed by an experienced neurologist applying TCS. The echogenicity of the 2 groups was compared using chi- square test. SPSS software (version 18, PASW) was used for statistical analysis and p-value of less than 0.05 was considered significant.
Results: In this study, 15 OCD patients (42.9%) and 11 (31.4%) controls showed decreased echogenicity of midbrain RN. Also, the results of the chi-square test showed that the midbrain RN echogenicity was not significantly lower in patients with OCD compared to the control group (p= 0.322).
Conclusion: Although decreased midbrain RN echogenicity is a characteristic of patients with major depression, it was not shown in OCD patients in this study, which can be explained by the involvement of RN projections rather that RN serotoninergic neurons.
Transcranial sonography, Obsessive-compulsive disorder, Raphe nuclei, Echogenicity
531
534
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-624-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/23
1396/7/1
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/2
1397/4/11
Nahid
Mohammadzadea
Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
nahid.mohammadzade@yahoo.com
00319475328460040870
00319475328460040870
No
Mohammad Reza
Shalbafan
Mental Health Research Center, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
drmrsh@gmail.com
00319475328460040871
00319475328460040871
No
Vahid
Shariat
Mental Health Research Center, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
vahid.shariat@gmail.com
00319475328460040872
00319475328460040872
No
Babak
Zamani
Department of Neurology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran
zamba3@yahoo.com
00319475328460040873
00319475328460040873
No
Behnam
Shariati
Department of Psychiatry, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
behnamshariatimd@gmail.com
00319475328460040874
00319475328460040874
No
Fateme
Omrani
Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
omrani.fatemeh86@gmail.com
00319475328460040875
00319475328460040875
No
Mohammad
Rohani
Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
mohammadroohani@gmail.com
00319475328460040876
00319475328460040876
Yes
en
Electrosurgery and clinical applications of electrosurgical devices in gynecologic procedures
Background: Electrosurgery is widely used in reproductive related surgeries and technological advancements to improve efficacy and reduce potential complications. However, some reports have indicated lack of sufficient knowledge and training about basic principles and technical aspects of electrosurgery among obstetricians and gynecologists.
Methods: In this paper we present a summary on basic concepts and principles of electrosurgery and review the recent evidence on the use of electrosurgical devices in gynecologic procedures including endometrial ablation, gynecologic malignancies, loop electrode excision procedure (LEEP), and infertility.
Result: Considering the extensive use of these technologies in reproductive related surgeries, procedures including laparoscopy, hysteroscopy, and loop procedures further highlights the importance of more detailed training in this field. Gynecologists must learn the basics in more detail and update their knowledge on the growing body of evidence regarding the advancements of these technologies to reduce potential complications and select the most cost-effective treatment options for each patient.
Conclusion: Try to understanding the underlying biophysical principles and more in-depth familiarity with various electrosurgical devices could lead to less complications and optimize evidence-based gynecological practice.
Electrosurgery, Gynecologic procedures
525
530
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1694-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/12
1396/6/21
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/22
1397/6/31
Soheila
Aminimoghaddam
Department of Gynecology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
dr_aminimoghaddam@yahoo.com
00319475328460040867
00319475328460040867
No
Rozhin
Pahlevani
School of Medicine, International Campus (IC), Iran Medical University of Medical Sciences, Tehran, Iran
Rozhin_p92@yahoo.com
00319475328460040868
00319475328460040868
Yes
Maryam
Kazemi
School of Medicine, International Campus (IC), Iran Medical University of Medical Sciences, Tehran, Iran
maryamkazemi991@gmail.com
00319475328460040869
00319475328460040869
No
en
The effectiveness of PMT program on parent-child relationship in parents with ADHD children: A randomized trial
Background: Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral disorder in children that creates problems in parents-children relationships. Improving familial and social interactions of these children needs mental and social interventions, and parents’ management training (PMT) program is one of these interventions. The present study aimed at determining the effectiveness of PMT program on parent-child relationship of parents with ADHD children.
Methods: Through an experimental research, 40 parents with ADHD children were selected based on purposeful sampling. A total of 20 parents were randomly placed in intervention group and received 8 sessions of intervention course (60 minutes per session) and the other 20 parents were grouped in the control group and received no training intervention. Research tools included a researcher-designed demographics questionnaire and Parker’s Bonding Instrument (PBI). Data were collected at pretest, posttest, and follow- up stages and analyzed using descriptive and covariance analysis.
Results: The results revealed that PMT program was significantly effective in reducing excessive support and increasing parent care index in parents with ADHD children (p<0.05).
Conclusion: The results of the present study supported the effectiveness of PMT program on parent-child relationship of the parents with ADHD children.
Parents management training program, Parents, Parent-child relationship, Mental health, Psychology, ADHD
519
524
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3119-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/15
1395/9/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/12
1396/3/22
Zahra
Maddah
Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
maddah_z550@yahoo.com
00319475328460041735
00319475328460041735
No
Mahdieh
Ghalenoee
Psychiatric Nursing Department, School of Nursing and Midwifery, Shahid Beheshti University of Medical Science, Tehran, Iran
ghalenoee5.m@gmail.com
00319475328460041736
00319475328460041736
Yes
Jamileh
Mohtashami
Psychiatric Nursing Department, School of Nursing and Midwifery, Shahid Beheshti University of Medical Science, Tehran, Iran
jmohtashami@yahoo.com
00319475328460041737
00319475328460041737
No
Mohammad Amin
Pour Hoseingholi
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastro-enterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
amin_phg@yahoo.com
00319475328460041738
00319475328460041738
No
Roghayeh
Esmaieli
Geriatric Nursing Department, School of Nursing and Midwifery, Shahid Beheshti University of Medical Science, Tehran, Iran
r.esmaieli@sbmu.ac.ir
00319475328460041739
00319475328460041739
No
Vahid
Naseri-Salahshour
School of Nursing and Midwifery, Arak University of Medical Science, Arak, Iran
vahidnaseri1994@yahoo.com
00319475328460041740
00319475328460041740
No
en
Incidence, patterns and associated factors for occupational injuries among agricultural workers in a developing country
Background: Injuries are common among agricultural workers, and a large section of the population is employed in agriculture worldwide. We aimed to determine the incidence, patterns and associated risk factors of occupational injuries among the agricultural workers in a developing country.
Methods: A cross-sectional study in Hyderabad, Pakistan was conducted from December 2012 to February 2013. Information was collected about incidence, pattern and associated risk factors of occupational injuries from 472 agricultural workers. Injury incidence and patterns for place, severity, type, agent, parts of body affected and work activity were calculated. Analysis was performed using SPSS version 19.0. Multivariate logistic regression was performed to calculate the adjusted odds ratio (OR) with 95% confidence interval, to identify the putative risk factors for occupational injuries.
Results: Incidence of occupational injuries was 35.0 per 100 per year (95% CI: 28.9 - 42.7). Cuts (70%) and hand tools (71%) were the most common type and agent for injury, respectively. Majority of injuries occurred during harvesting (55%). Increasing age [AOR 1.03 (95% CI: 1.01 - 1.05)], income <6000PKR/month [AOR 2.27 (95% CI: 1.08 - 4.76)] and driving tractor [AOR 2.58 (95% CI: 1.25 -5.33)] increase the risk for injuries.
Conclusion: There was a high burden of injuries among the agricultural workers in Pakistan. Large-scale studies are required to further characterize the risk of injuries and develop preventive strategies to protect agricultural workers.
Agriculture, Developing country, Incidence, Occupational injuries, Pakistan
512
518
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4297-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/10
1397/3/20
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/1
1397/5/10
Unaib
Rabbani
Saudi Board Family Medicine, Buraidah, Qassim, Saudi Arabia
rabbaniunaib@gmail.com
00319475328460040859
00319475328460040859
Yes
Zafar
Fatmi
Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan
zafar.fatmi@aku.edu
00319475328460040860
00319475328460040860
No
en
Investigating of variations in BRCA1 gene in Iranian families with breast cancer
Background: Breast cancer is one of the most common cancers among Iranian women whose relationship with mutation status in BRCA1 is previously approved. Therefore, screening of the most mutated exons in BRCA1 in hereditary breast cancer patients provides beneficial information about the main disease-causing reason.
Methods: A total of 14 Iranian hereditary breast cancer patients participated in this case series study. DNA was extracted from patients’ blood samples for PCR assay. The quality of PCR products was determined using horizontal electrophoresis. Then, sequencing and analysis of the sequencing results were performed to investigate variation status in the sequences.
Results: Five variants in 4 patients were found, including 1 pathogenic variant in exon 16 (H1686Q, NM_007294.3:c.5058T>A) and 4 novel intronic variants of uncertain significance (NC_000017.11:41228314G>T, NC_000017.11:41228309C>T, NC_000017.11:41228317G>T, and NC_000017.11:41203042G>A) in BRCA1. This study was the first to report 1 rare pathogenic variant in BRCA1 (H1686Q, NM_007294.3: c.5058T>A) in an Iranian family as the main disease-causing reason. Another interesting finding was non-existence of variations in almost all globally-reported and mutated exons in BRCA1.
Conclusion: Investigation of these exons in BRCA1 showed the uniqueness of mutation pattern in Iranian breast cancer patients compared to other world regions. Due to the existence of other BRCA1 exons and also other predisposing genes in breast cancer, the main cause of cancer development in other participants might have been put in those exons and genes. We concluded that the most mutated exons in BRCA1 in Iranian population may not be the same as those found in other parts of the world.
Hereditary breast cancer, BRCA1 gene, Variation
507
511
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4150-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/30
1397/1/10
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/5
1397/6/14
Amir
Mehrgou
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
amirmehrgo@yahoo.com
00319475328460040856
00319475328460040856
No
Mansoureh
Akouchekian
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mackouch@yahoo.com, akouchekian.m@iums.ac.ir
00319475328460040857
00319475328460040857
Yes
Simin
Hemati
Department of Oncology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
hematti@med.mui.ac.ir
00319475328460040858
00319475328460040858
No
en
Dkk-3 as a potential biomarker for diagnosis and prognosis of colorectal cancer
Background: The Dickkopf 3 (Dkk-3) protein is a member of the Dkk family known as Wnt signaling inhibitor. The level of DKk-3 changes in a wide range of cancers, such as colorectal cancer, lung cancer, prostate cancer, and bladder cancer, is proposed as a biomarker for diagnosis and prognosis of many cancers. The present study was conducted to evaluate the serum level of Dkk-3 as a cancer biomarker and to determine their prognostic value in colorectal cancer (CRC) patients and healthy matched controls.
Methods: A total of 30 colorectal cancer patients at different stages of the disease and healthy matched controls with no history of inflammatory and autoimmune disease or cancer were enrolled in the study. The level of Dkk-3 was assessed serologically using enzyme-linked immunosorbent assay (ELISA) method, moreover, relevance of these markers with patients’ clinicopathological features was subsequently assessed. Means comparison and ROC curves analysis were done using SPSS software. P-value ˂0.05 was considered significant in all the tests.
Results: In this study, it was revealed that serum level of Dkk-3 was significantly (p<0.001) lower in patients compared to the healthy controls. Statistical analysis showed that serum level of Dkk-3 has 78% specificity and 77% sensitivity (AUC= 0.782, 95% CI) for diagnosis of colorectal cancer.
Conclusion: Dkk-3 protein can be considered as a potential biomarker for diagnosis and possibly the prognosis of colorectal cancer.
Dkk-3, Colorectal cancer, Biomarker
502
506
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3107-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/3
1396/4/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/22
1396/11/2
Elahe
Safari
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran
safari.e@iums.ac.ir
00319475328460041840
00319475328460041840
No
Ghasem
Mosayebi
Molecular and Medicine Research Center, & Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
Gmosayebi@yahoo.com
00319475328460041841
00319475328460041841
No
Samaneh
Khorrami
Department of Immunology, School of Medicine & Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran
khorami.s@iums.ac.ir
00319475328460041842
00319475328460041842
Yes
en
A novel method for fuzzy diagnostic system design
Background: In recent years, liver disorders have been continuously increased. Proper performance of data mining techniques in decision-making and forecasting caused to use them commonly in designing of automatic medical diagnostic systems. The main aim of this paper is to introduce a classifier for diagnosis of liver disease that not only has high precision but also is understandable and has been created without expert knowledge.
Methods: In regards to this purpose, fuzzy association rules have been extracted from dataset according to fuzzy membership functions which determined by fuzzy C-means clustering method; while each time, extracting fuzzy association rules, one of the five quality measures including confidence, coverage, reliability, comprehensibility and interestingness is used and five fuzzy rule-bases extracted based on them. Then, five fuzzy inference systems are designed on the basis of obtained rule-bases and evaluated in order to choose the best model in terms of diagnostic accuracy.
Results: The proposed diagnostic method was examined using data set of Indian liver patients available at UCI repository. Results showed that among considered quality measures, interestingness, reliability and truth outperformed respectively, and yielded precision, sensitivity, specificity and accuracy of more than 90%.
Conclusion: In this paper, a classification method was developed to predict liver disease which in addition to high classification accuracy, it has been created without expert knowledge and provided an understandable explanation of data. This method is convenient, user friendly, efficient and requires no expertise.
Fuzzy association rule mining, Membership function extraction, Liver disease, Fuzzy diagnostic system, Rule quality measures
495
501
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3193-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/16
1395/10/27
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/29
1396/9/8
Mostafa
Langarizadeh
Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
langarizadeh2001@yahoo.com
00319475328460040227
00319475328460040227
No
Azam
Orooji
Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
orooji.a@tak.iums.ac.ir
00319475328460040228
00319475328460040228
Yes
en
Mapping diabetes research in Middle Eastern countries during 2007-2013: A scientometric analysis
Background: Scientometric studies are highly important, as they provide information about scientific products worldwide and empower scientists to compare research activities in different regions. The present study was conducted to map scientific research in diabetes mellitus using scientometric analysis in Middle Eastern countries during 2003- 2007.
Methods: This was an analytical study with a scientometric approach. The study population was formed by the indexed scientific results of diabetes mellitus in the Web of Science database during 2007-2013. Data were analyzed using Excel, and HistCite to map the scientific texts.
Results: A total of 6532 records were retrieved from 3926 institutions. These records belonged to 19 323 authors and were published in 1420 journals.
The Journal of Diabetes Care, with 3928 citations, had the most global citation score (GCS). The Journal of Diabetes Research and Clinical Practice, with 185 citations, achieved the first degree of local citation score (LCS). Most of the scientific documents produced in the Middle East belonged to Turkey (31.91%) and Iran (21.7%). Seven scientific clusters based on LCS, and 5 based on GCS existed in the scientific mapping. Topical clusters based on global and local indices showed that the prevalence of diabetes, hyperglycemia, and pregnancy outcomes, diabetic risk factors, diabetic complications and their new treatments, and glucose monitoring in Type 1 diabetes were the fields being addressed in the main articles of the clusters.
Conclusion: Scientific production and local and global citations in diabetes research in Iran (21.7% of diabetes research in the Middle East) have elevated the country to a prominent position. Top ranking countries in diabetic research were Turkey, Iran, and Israel, respectively. Moreover, this paper quantified the studies that were done on different aspects of diabetes. The results of this study can be used by health care providers to employ the best multidisciplinary approach for managing diabetes and its complications. Also, the results can help the policy-makers and governments to determine the priorities for budget allocation based on the burden of diseases. Establishing a regional diabetes network in the Middle East can be beneficial and lead to scientific collaboration and an increase in scientific production in this field.
Scientific research, Diabetes mellitus, Middle East, Scientometric
486
494
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2651-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/3
1395/2/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/14
1395/10/25
Zahra
Emami
Department of Knowledge & Information Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
zemami64@gmail.com
00319475328460042202
00319475328460042202
No
Nadjla
Hariri
Department of Knowledge & Information Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
nadjlahariri@gmail.com
00319475328460042203
00319475328460042203
Yes
Mohammad Ebrahim
Khamseh
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
khamseh.m@iums.ac.ir
00319475328460042204
00319475328460042204
No
Fatemeh
Nooshinfard
Department of Knowledge & Information Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
nooshinfar2000@yahoo.com
00319475328460042205
00319475328460042205
No
en
Prevalence of vitamin D deficiency in healthy Iranian children: A systematic review and meta-analysis
Background: Vitamin D deficiency is related to rickets in children, and it can increase the risk of osteoporosis in adulthood. The aim of our study was to estimate the prevalence of vitamin D deficiency among healthy Iranian children and adolescents. Vitamin D levels less than 20ng/ml and between 20 and 30ng/ml was considered as vitamin D deficiency and insufficiency, respectively.
Methods: Relevant observational studies evaluating the prevalence of vitamin D deficiency through 1 January 1990 to 28 Dec 2016, were searched in several electronic databases including Iran-Medex, Scientific Information Database (SID), Irandoc, PubMed and NLM Gateway (for MEDLINE), Web of Science, and Scopus with no restriction on language. Only full-text articles were used for data extraction and synthesis after considering the inclusion/exclusion criteria.
Results: 11 studies included; the data of four studies of Iranian newborns were withdrawn because of their high heterogeneity. The prevalence of vitamin D deficiency in Iranian boys and girls were 35% (CI 95% 34–37) and 61% (CI 95% 60–63), respectively. The prevalence of vitamin D insufficiency in Iranian children and adolescents was 31% (CI 95% 30–31).
Conclusion: It seems that the prevalence of vitamin D deficiency is very high among Iranian children and adolescents. The present findings could provide practical information for healthcare decision makers.
Vitamin D deficiency, Insufficiency, Prevalence, Children, Iran
480
485
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1741-13&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/16
1396/11/27
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/21
1397/5/30
Maryam
Jazayeri
Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
maryamjazayeri@yahoo.com
00319475328460040211
00319475328460040211
No
Yousef
Moradi
Department of Epidemiology, School of Public Health, Iran University of Medical Science, Tehran, Iran
Yousefmoradi211@yahoo.com
00319475328460040212
00319475328460040212
No
Arezoo
Rasti
Department of Basic Sciences, Medical-Surgical Nursing, School of Nursing and Mid-wifery, Tehran University of Medical Sciences, Tehran, Iran
rastirf@yahoo.com
00319475328460040213
00319475328460040213
No
Manouchehr
Nakhjavani
Endocrinology and Metabolism Research Center, Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
nakhjavanim@tums.ac.ir
00319475328460040214
00319475328460040214
No
Mahboobeh
Kamali
Central library and Archive Center, Iran University of Medical Sciences, Tehran, Iran
kamali.m@iums.ac.ir
00319475328460040215
00319475328460040215
No
Hamid Reza
Baradaran
Endocrinology Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran & Ageing Clinical & Experimental Research Team, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK
baradaran.hr@iums.ac.ir
00319475328460040216
00319475328460040216
Yes
en
National action plan of the Islamic Republic of Iran for combating antimicrobial resistance during 2016 – 2021
Background: Antimicrobial resistance (AMR) is one of the most important threats to health worldwide. Therefore, the World Health Organization (WHO) have invited countries around the world to work together to inhibit AMR, and all the member states are expected to prepare a national plan for tackling AMR by 2017. This project was aimed to prepare the National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance (NAP-IRIAMR) during 2016 to 2021.
Methods: In this article, the literature and available documents were reviewed to identify key stakeholders. Moreover, interviews, brain storming sessions, and meetings with key stakeholders were held to determine NAP-IRIAMR objectives, strategies, policies, and indicators for monitoring and evaluation. To reach consensus and make a conclusion, participants’ views and comments were analyzed using Delphi method and expert panel.
Results: In this national action plan for combating AMR, 13 key stakeholders were identified and 5 objectives were set: (1) raising public awareness and increasing trainings on AMR, (2) continuous monitoring of AMR, (3) preventing the spread of microorganisms resistant to antimicrobials, (4) promoting the rational use of antimicrobials, (5) promoting research and development in the field of AMR.
Conclusion: The NAP-IRIAMR was prepared for the years 2016- 2021. Intersectoral cooperation is needed to combat AMR. It is expected that implementing the NAP-IRIAMR and reaching the determined goals will help overcome the problems related to AMR.
Antimicrobial resistance, Antimicrobial, Infectious disease, National Action Plan, Iran
475
479
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2534-4&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/3
1396/9/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/16
1397/2/26
Ghobad
Moradi
Social Determinants of Health Research Center, Research Institute for Health Devel-opment, Kurdistan University of Medical Sciences, Sanandaj, Iran.
moradi_gh@yahoo.com
00319475328460078216
00319475328460078216
No
Mohammad Mehdi
Gouya
Centre for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
mgouya57@gmail.com
00319475328460078217
00319475328460078217
No
Babak
Eshrati
Centre for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
eshratib@sina.tums.ac.ir
00319475328460078218
00319475328460078218
No
Minoo
Mohraz
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
minoomohraz@gmail.com
00319475328460078219
00319475328460078219
No
Leila
Molaei
Department of Epidemiology, Iran University of Medical Sciences, Tehran, Iran.
leilamolaei_epi@yahoo.com
00319475328460078220
00319475328460078220
No
Bakhtiar
Piroozi
Social Determinants of Health Research Center, Research Institute for Health Devel-opment, Kurdistan University of Medical Sciences, Sanandaj, Iran.
bpiroozi@gmail.com
00319475328460078221
00319475328460078221
Yes
en
A preliminary study: The effect of ergonomic latex pillow on pain and disability in patients with cervical spondylosis
Background: Cervical pillows are considered to be part of the therapeutic strategy in cervical spondylosis, but there is little or no convincing scientific evidence on the effectiveness of these pillows in relieving pain and disability in these patients. Hence, this study investigated the effects of ergonomic latex pillow in conjunction with routine physiotherapy versus routine physiotherapy alone on disability and pain intensity in patients with cervical spondylosis.
Methods: 22 patients with cervical spondylosis in a single-blinded pilot study with a pre/post-test design were randomly assigned to experimental and control groups. Both groups received 12 sessions of physiotherapy for four weeks. In the experimental group, participants were given an ergonomic latex pillow to sleep it for four weeks. Participants in the control group slept on their own usual pillow. All the participants filled out the Neck Disability Index questionnaire, and scored their neck pain intensity on the Numerical Pain Rating Scale before and after the intervention. Changes of variables (pain and disability) within and between groups were compared by Paired T-test and the Independent Sample T-test, respectively via SPSS v.20 (p<0.05).
Results: Numerical Pain Rating Scale and Neck Disability Index scores were decreased statistically significant within groups. In the experimental group, neck disability scores were significantly lower than those in the control group (p=0.038). However, pain intensity scores were not significantly different between groups.
Conclusion: Ergonomic latex pillows can significantly decrease disability related to neck pain in patients with cervical spondylosis after four weeks.
Cervical spondylosis, Pillow, Neck pain, Disability
470
474
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3574-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/20
1396/4/29
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/21
1396/11/1
Fatemeh
Fazli
Department of Orthotics and Prosthetics, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
fatemehfazli89@gmail.com
00319475328460039875
00319475328460039875
No
Behshid
Farahmand
Department of Orthotics and Prosthetics, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
farahmand.b@iums.ac.ir
00319475328460039876
00319475328460039876
Yes
Fatemeh
Azadinia
Department of Orthotics and Prosthetics, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
azadinia.fatemeh@yahoo.com
00319475328460039877
00319475328460039877
No
Ali
Amiri
Department of Physiotherapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
amiri.alipt10@yahoo.com
00319475328460039878
00319475328460039878
No
en
Anti-inflammatory effects of the Portulaca oleracea hydroalcholic extract on human peripheral blood mononuclear cells
Background: Portulaca oleracea, known as Purslane, is an annual growing herb with wide distribution around the world and traditionally used to manage several diseases. Different therapeutic properties as an anti-fever agent as well as anti-inflammatory and analgesic effects have been attributed to P. oleracea. The aim of this study was to investigate the effects of P. oleracea aerial extract on production of pro- and anti-inflammatory cytokines by human peripheral blood mononuclear cells (PBMCs).
Methods: Aerial parts of P. oleracea (stems and leaves) were collected and extracted by percolation using methanol. The optimal and non-cytotoxic dose of hydro-alcoholic extract for cell culture analysis was determined by MTT assay. To assess the anti-inflammatory effects of P. oleracea, PBMCs obtained from 12 normal volunteers were cultured in RPMI complete medium and co-treated with E. coli lipopolysaccharide (LPS) and P. oleracea hydro-alcoholic extract. Following 18-hour incubation, culture supernatants were harvested for measurement of secreted TNF-α, IL-6 and IL-10 by ELISA. Statistical analyses were performed using the SPSS v.20, and data analyzed by Kolmogorov-Smirnov, Mann-Whitney U, Kruskal-Wallis and post Hoc tests. P-values<0.05 were considered significant.
Results: The optimal non-cytotoxic concentration of P. oleracea aerial extract was defined as 100 μg/ml based on MTT viability assay. P. oleracea hydro-alcoholic extract significantly decreased the concentration of both pro-inflammatory cytokines TNF-α and IL-6 in LPS-stimulated PBMCs (p<0.001 and p<0.001, respectively). However, the concentration of IL-10 as an anti-inflammatory cytokine, did not show any statistically significant change (p=0.390).
Conclusion: Our findings highlighted the potential anti-inflammatory properties of P. oleracea in herbal medicine. Future analysis on different constituents of total extract may confirm its therapeutic effects as a promising anti-inflammatory compound.
Portulaca oleracea, Anti-inflammatory agent, Tumor necrosis factor-alpha, Interleukin-6, Interleukin-10
464
469
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3397-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/23
1396/2/3
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/9
1396/8/18
Esmaeil
Allahmoradi
Student Research Committee, & Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
s.allahmoradi69@gmail.com
00319475328460039839
00319475328460039839
No
Saeid
Taghiloo
Student Research Committee, & Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
saeid.taghiloo@yahoo.com
00319475328460039840
00319475328460039840
No
Versa
Omrani-Nava
Student Research Committee, & Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
versa.peace@gmail.com
00319475328460039841
00319475328460039841
No
Saeideh
Sadat Shobeiri
Student Research Committee, & Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
saeideshobeiri@gmail.com
00319475328460039842
00319475328460039842
No
Mohsen
Tehrani
Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
drmtehrani@gmail.com
00319475328460039843
00319475328460039843
No
Mohammad Ali
Ebrahimzadeh
Student Research Committee, & Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Zadeh20@yahoo.com
00319475328460039844
00319475328460039844
No
Hossein
Asgarian-Omran
Department of Immunology, School of Medicine, & Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
asgarianhossein@yahoo.com
00319475328460039845
00319475328460039845
Yes
en
Translation, cross-cultural adaptation and factor analysis of the Persian version of ankle instability instrument
Background: Ankle Instability Instrument (AII) is a questionnaire for determination of ankle stability status. The aim of this study is to cross-culturally translate and investigate the reliability and validity of AII in a sample of Persian-speaking Iranians, suffering from ankle sprain.
Methods: One hundred twenty persons with a history of ankle sprain were recruited in the study. All participants completed the Persian version of Ankle Instability Instrument, Cumberland Ankle Instability Tool (CAIT), Foot and Ankle Ability Measure (FAAM) and Foot and Ankle Outcome Score (FAOS) at the baseline. Out of them, 60 randomly selected subjects completed the questionnaires once more, one week later. Face validity, Test–retest reliability, internal consistency, standard error of measurement, minimal metric detectable change, spearman’s correlation coefficient and confirmatory factor analysis of AII measured. We used Lisrel v 8.80 software with significant level of p<0.05.
Results: Persian version of AII is clear and unambiguous and its qualitative face validity was confirmed in the pilot study on the 20 subjects with a lateral ankle sprain. The interclass correlation coefficient, Cronbach’s alpha, standard error of measurement and minimal metric detectable change were 0.93, 0.87, 0.81 and 2.25 (95% confidence interval, 0.85-0.96). The Spearman correlations coefficients between AII, and CAIT, FAAM and FAOS measures were 0.91, 0.71 and 0.69 respectively. The original three factor structure of AII was replicated based on the confirmatory factor analysis. Which showed an adequate fit of the model to the data and goodness-of-various fit indices.
Conclusion: The Ankle Instability Instrument Persian Version (AII-PV) is a reliable and valid measure for assessing the ankle stability status.
Ankle sprain, Instability, Psychometric, Questionnaire, Persian, Confirmatory factor analysis
459
463
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3867-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/28
1396/9/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/17
1396/10/27
Somayeh
Mohamadi
Department of Physiotherapy, Iran University of Medical Sciences, Tehran, Iran.
mohammadi.so@tak.iums.ac.ir
00319475328460039833
00319475328460039833
No
Ismail
Ebrahimi
Department of Physiotherapy, Iran University of Medical Sciences, Tehran, Iran.
ebrahimitakamjani.e@iums.ac.ir
00319475328460039834
00319475328460039834
Yes
Mehdi
Dadgoo
Department of Physiotherapy, Iran University of Medical Sciences, Tehran, Iran.
Dadgoo.m@iums.ac.ir
00319475328460039835
00319475328460039835
No
Mahyar
Salavati
Department of Physiotherapy, University of Social Welfare and Rehabilitation Scienc-es, Tehran, Iran.
mahyarsalavati@gmail.com
00319475328460039836
00319475328460039836
No
Ahmad
Saeedi
Department of Statistical Research and Information Technology, Institute for Research and Planning in Higher Education, Tehran, Iran.
a_saidee@yahoo.com
00319475328460039837
00319475328460039837
No
Bijan
Valiollahi
Department of Orthopedic Surgery, Iran University of Medical Sciences, Tehran, Iran.
Bijan.valiollahi@gmail.com
00319475328460039838
00319475328460039838
No
en
Is ultrasound-measured abdominal fat thickness a reliable method for predicting metabolic diseases in obese and overweight women?
Background: Central fat deposition seems to be a risk factor for developing metabolic and cardiovascular diseases in overweight and obese individuals. Ultrasound is an accurate and non-invasive tool for measuring abdominal fat thickness and can precisely separate subcutaneous from visceral fat. This study was conducted to apply ultrasonography as a simple and reliable method to measure subcutaneous and visceral abdominal fat thickness and evaluate the relationship between this measured abdominal fat thickness and metabolic risk factors.
Methods: A total of 80 overweight and obese women were included in this study. Anthropometric indices and abdominal fat thickness were measured using ultrasound. The association between abdominal fat thickness and metabolic risk factors with anthropometric indices was assessed using correlation coefficient.
Results: The mean (± SD) of subcutaneous and visceral fat thickness was 2.71±0.92 and 5.46±1.88, respectively. There was a relationship between waist circumference and visceral and subcutaneous fat thickness. Also, there was a relationship between ultrasound–measured visceral fat thickness and fasting blood glucose and triglyceride.
Conclusion: Ultrasonography is a simple and reliable method to measure abdominal fat thickness as an important predictor of metabolic diseases.
Ultrasonography, Obesity, Visceral fat, Metabolic disease
453
458
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-455-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/17
1395/3/28
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/29
1396/6/7
Hooman
Angoorani
Department of Sports and Exercise Medicine, Hazrat Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
hoomanangoorani@yahoo.com
00319475328460039846
00319475328460039846
No
Zeinab
Karimi
Department of Sports and Exercise Medicine, Hazrat Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Dr.zeinabk@yahDr.zeinabk@yahoo.com
00319475328460039847
00319475328460039847
No
Farokh
Naderi
Department of Radiology, Hazrat Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Dr.naderi@yahoo.com
00319475328460039848
00319475328460039848
No
Ali
Mazaherinezhad
Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
mazaherinezhad@gmail.com
00319475328460039849
00319475328460039849
Yes
en
Interaction between stewardship and social health insurances: A comparative and document analysis
Background: Social health insurances provide protection to access affordable coverage of services and stewardships of health system need to intervene to fulfill these objectives. This study conducted to assess interaction between stewardship and social health insurances.
Methods: This qualitative study conducted in two phases as comparative study and document analysis in 2018. Comparative study employed to identify the dimensions and requirements of interaction between stewardship of health systems and social health insurances in countries around the world. In document analysis, all evidence about Iran health financing reviewed. Data extraction forms were used to gather data.
Results: There were less interaction between stewardship and social health insurances in revenue collection and risk pooling. Advisory role of stewardship and proposals to coverage of uninsured people and performing risk analysis were some examples of such interaction. In Iran’s health system, where stewardship plays a magnificent role in service provision, the basis of interactions are contracts, payment systems and timeline of payments.
Conclusion: Mechanisms of interaction in Iran is not clear or does not work properly. Thus, nonstructural merging of social health insurances needs to redefine these mechanisms.
Stewardship, Health system, Social health insurances, Interaction, Iran
446
452
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-4164-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/8
1397/1/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/1
1397/7/9
Aslan
Nazari
Department of Health Services Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.
anazari_1983@yahoo.com
00319475328460039807
00319475328460039807
No
Iravan
Masoudi Asl
Department of Health Services Management, School of Health Management and Information Sciences, Iran university of medical sciences, Tehran, Iran.
masoudi_1352@yahoo.com
00319475328460039808
00319475328460039808
Yes
Masoud
Abolhallaje
Budgeting and Performance Monitoring Center, Ministry of Health and Medical Education, Tehran, Iran.
mohme2003@gmail.com
00319475328460039809
00319475328460039809
No
Amir Ashkan
Nasiripour
Department of Health Services Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.
nasiripour@srbiau.ac.ir
00319475328460039810
00319475328460039810
No
Mohammad Javad
Kabir
Health Management & Social Development Research Center, Gorgan University of Medical Sciences, Gorgan, Iran.
kabirmj63@yahoo.com
00319475328460039811
00319475328460039811
No
en
The association of hospital emergency admissions due to respiratory-cardiovascular diseases and acute myocardial infarction with air pollution in Tehran during 2005-2014
Background: Air pollution is one of the main reasons for disease and emergency hospitalizations. Therefore, air pollution control and hospital preparedness are of paramount importance. This study was conducted to determine the association of air pollutant levels with the rate of hospital emergency admissions due to respiratory and cardiovascular diseases and acute myocardial infarction in Tehran during the last decade.
Methods: This was a cross sectional study. At first, information on hourly concentration of air pollutants was gathered from Tehran Environmental Protection Agency and Air Quality Control Company. Raw data and meteorological parameters were used in Excel format to prepare an input file. The number of emergency hospital admissions due to pollutant exposure was assessed using the AirQ2.2.3 model.
Results: Results of this study revealed that there were 54 352 cases of emergency hospitalizations due to respiratory diseases in a relative risk of 1.0048 [1.0008-1.0112] and 20 990 cases of emergency hospitalizations due to cardiovascular diseases in a relative risk of 1.009[1.006-1.013] during 2005-2014. In addition, 3478 patients were admitted to the emergency department because of acute myocardial infarction with RR of 1.0026 [1.0026-1.0101].
Conclusion: This study demonstrated that a high percentage of hospital emergency admissions was because of respiratory and cardiovascular diseases. Moreover, it was found that acute myocardial infarction could be due to the high level of air pollution and could increase admissions to the emergency department. Therefore, appropriate measures are needed to reduce air pollution and increase hospital preparedness.
Air pollution, Emergency, Respiratory diseases, Cardiovascular diseases
440
445
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3260-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/7
1395/11/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/8
1396/7/16
Majid
Kermani
Research Center for Environmental Health Technology, Iran University of Medical Sciences, Tehran, Iran.
Majidkermani@ yahoo.com
00319475328460039596
00319475328460039596
No
Mohsen
Dowlati
Research Center for Environmental Health Technology, & . Health in Disasters and Emergencies Department, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
mohsendowlati.69@gmail.com
00319475328460039597
00319475328460039597
Yes
Ahmad
Jonidi Jafari
Research Center for Environmental Health Technology, & Environmental Health Engineering Department, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
ahmad_jonidi@ yahoo.com
00319475328460039598
00319475328460039598
No
Roshanak
Rezaei Kalantary
Research Center for Environmental Health Technology, & Environmental Health Engineering Department, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
00319475328460039599
00319475328460039599
No
en
Development and psychometrics of script concordance test (SCT) in midwifery
Background: Clinical reasoning plays an important role in the accurate diagnosis and treatment of diseases. Script Concordance test (SCT) is one of the tools that assess clinical reasoning skill. This study was conducted to determine the reliability and concurrent and predictive validity of SCT in assessing final lessons and gynecology exams of undergraduate midwifery students.
Methods: At first, 20 clinical scenarios followed by 3 questions were designed by 2 experienced midwives. Then, after examining the content validity, 15 scenarios were selected. The test was used for 55 midwifery students. The correlation of SCT results with grade point average (GPA) was measured. To evaluate the concurrent validity of SCT, the correlation between SCT scores and the final exam of the gynecology course was measured. To measure predictive validity, the correlation of SCT scores with comprehensive exams of midwifery was calculated. Data were analyzed using SPSS software. Descriptive statistics, Pearson correlation, and coefficient Cronbach's alpha were used for analysis. The test’s item difficulty level (IDL) and item discriminative index (IDI) were determined using Whitney and Sabers’ method.
Results: The internal reliability of the test (calculated using Cronbach’s alpha coefficient) was 0.74. All questions were positively correlated with the total score. The highest correlation coefficient was related to GPA and comprehensive test with the score of 0.91. The correlation coefficient between SCT and the final test (concurrent validity) was 0.654, and the correlation coefficient between SCT and comprehensive test (predictive validity) was 0.721. The range of item discriminative index and item difficulty level in this exam was 0.39-0.59 and 0.32-0.66, respectively.
Conclusion: SCT shows a relatively high internal validity and can predict the success rate of students in the comprehensive exams of midwifery. Also, it showed a high concurrent validity in the final test of gynecology course. This test could be a good alternative for formative and summative tests of clinical courses.
Clinical decision-making, Problem-solving, Assessment, Educational, Clinical competence, Clinical skill, Midwifery, Psychometrics
434
439
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3863-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/20
1396/8/29
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/21
1396/12/2
Somayeh
Delavari
Department of Medical Education, School of Medicine, & Center for Educational Research in Medical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
delavariso@gmail.com
00319475328460039600
00319475328460039600
No
Mitra
Amini
Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
mitraamini51@yahoo.com
00319475328460039601
00319475328460039601
No
Zohreh
Sohrabi
Center for Educational Research in Medical Sciences, School of Medicine, & Department of Medical Education, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
zo_sohrabi@yahoo.com
00319475328460039602
00319475328460039602
Yes
Hamidreza
Koohestani
Department of Medical Education, Saveh University of Medical Sciences, Saveh, Iran.
koohestani709@gmail.com
00319475328460039603
00319475328460039603
No
Sajad
Delavari
Health Human Resources Research Center, School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
sajadd@gmail.com
00319475328460039604
00319475328460039604
No
Rita
Rezaee
Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
rezaeerita@yahoo.com
00319475328460039605
00319475328460039605
No
Elaheh
Mohammadi
Department of Medical Education, School of Medicine, Tehran University of Medi-cal Sciences, Tehran, Iran.
mohamadiel@yahoo.com
00319475328460039606
00319475328460039606
No
Anne
Demeester
Ecole Supérieure du Professorat et de I’éducation (ESPE), Aix-Marseille Université, EA4671 ADEF, 13 284 Marseille cedex07.
anne.demeester@univ-amu.fr
00319475328460039607
00319475328460039607
No
Bernard
Charlin
Centre de pédagogie appliquée aux sciences de la santé (CPASS), Université de Montréal, Montreal, QC, Canada.
bernard.charlin@umontreal.ca
00319475328460039608
00319475328460039608
No
Masoomeh
Kheirkhah
Department of Midwifery and Reproductive Health, Nursing Care Research Center School of Nursing and Midwifery, & Center for Educational Research in Medical Sciences, School of Medicine, Iran University of Medical Scien
00319475328460039609
00319475328460039609
No
en
Effect of cawthorne and cooksey exercises on balance and quality of life of 60 to 80 year- old individuals in Shiraz: A randomized clinical trial
Background: One of the vulnerable populations of any community are the elderly, who are exposed to poor balance, falls, injuries, reduced quality of life (QoL) and independency, and early death. Considering the importance of balance in independently performing activities of daily living (ADL) and its impact on QoL, in this study, we aimed at investigating the effect of Cawthorne and Cooksey exercises (CCE) on QoL and balance of 60 to 80 year-old individuals in Shiraz, Iran.
Methods: This clinical trial study was conducted on forty 80 to 60-year-old individuals of Jahandideghan retirement center in Shiraz (20 in the intervention and 20 in the control groups) in 2014. The intervention group did CCE in three 60- minute sessions a week for 2 months. The balance status of the participants was assessed with Berg balance test, and their QoL was also examined using SF36 Quality of Life Questionnaire before the intervention and at 2 months post intervention. Data were analyzed by independent t test in SPSS software Version 19.
Results: The results of the study revealed that the difference was significant in the balance change scores between the 2 groups (p<0.001, effect size = 0.78). Change differences in the QoL scores were significant between the 2 groups as well (p<0.001, effect size = 0.39).
Conclusion: CCT improved QoL and balance of 60 to 80 year- old Shirazians, so considering the low cost, easy implementation, and considerable impact of the exercises, CCT could be used to prevent and treat balance disorders of the elderly.
Balance, Cawthorne and Cooksey exercises, Quality of life, The elderly
429
433
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2044-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/24
1395/9/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/1
1396/5/10
Abolghasem
Fallahzadeh Abarghuei
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
Msc.fallahzadeh@gmail.com
00319475328460039581
00319475328460039581
No
Mahsa
Fadavi-Ghaffari
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
mahsafadavi91@yahoo.com
00319475328460039582
00319475328460039582
Yes
Safoura
Tousi
School of Rehabilitation Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
safouratousi@yahoo.com
00319475328460039583
00319475328460039583
No
Malek
Amini
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
Malekamini8@gmail.com
00319475328460039584
00319475328460039584
No
Ali Reza
Salehi
Shiraz University of Medical Sciences, Shiraz, Iran.
salehialireza45@yahoo.com
00319475328460039585
00319475328460039585
No
en
Association of Helicobacter pylori and Coronary heart disease in Iran: A meta-analysis
Background: Several studies in the recent decade have supported a relationship between different types of infections and CHD (Coronary Heart Disease); however, such a relationship is not definitely proven. Helicobacter pylori is one of the most common infections in human. The role of inflammation in the pathogens of CAD (Coronary Artery Disease) has been widely discussed; although, the mechanism is not clearly known yet.
Methods: In this systematic review and meta-analysis all case-control articles on the relationship between Helicobacter pylori and CHD published from 31st June 2000 to 31st June 2016 indexed in Scopus, PubMed, Google Scholar, Science Direct, and Iranian databases Magiran, Iran Medex, Irandoc, and SID were included. The articles were searched using the following keywords in Farsi and English. The extracted data was imported into Microsoft Excel and analyzed in Stata 12.
Results: Thirty case-control studies conducted in different regions of Iran (15 provinces) have been published from 2001 to 2015 included in this study. A general estimate of OR (Odds Ratio) for the association of Helicobacter pylori and heart diseases in Iran was 2.351 (95 CI: (1.715, 3.221)).
Conclusion: According to the observed association between Helicobacter pylori and heart diseases in the resent study, most of the hosts of the bacterium are afflicted with the infection in their childhood. Therefore, personal hygiene promotion and preventive programs for Iranian children may have a considerable role in reducing the risk of the infection and cardiovascular diseases, consequently.
Coronary heart disease, Helicobacter pylori, Iran, Meta-analysis
420
428
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3181-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/14
1395/10/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/5
1396/7/13
Yousef
Rahmani
Clinical Research Development Center, Imam Ali and Taleghani Hospital, Kermanshah University of Medical Sciences. Kermanshah, Iran.
00319475328460039519
00319475328460039519
No
Sareh
Mohammadi
Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kerman-shah, Iran.
00319475328460039520
00319475328460039520
No
Hossein
Karim
Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kerman-shah, Iran.
00319475328460039521
00319475328460039521
No
Mahin
Rezazadeh
Clinical Research Development Center, Imam Ali and Taleghani Hospital, Kermanshah University of Medical Sciences. Kermanshah, Iran.
00319475328460039522
00319475328460039522
No
Mehran
Babanejad
Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kerman-shah, Iran.
00319475328460039523
00319475328460039523
No
Afshar
Shahmohammadi
Clinical Research Development Center, Imam Ali and Taleghani Hospital, Kermanshah University of Medical Sciences. Kermanshah, Iran.
afsharshahmohammadi@yahoo.com
00319475328460039524
00319475328460039524
Yes
Alireza
Rai
Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kerman-shah, Iran.
00319475328460039525
00319475328460039525
No
en
Growth velocity of children and its affective factors in northwestern Iran: A longitudinal study using marginal models
Background: Child growth is an important health indicator in human’s lifespan. Evaluating growth variations in infants and children is highly important. This study was conducted to evaluate the risk factors of child growth retardation and determine childhood growth velocity in Zanjan province, Iran.
Methods: This longitudinal study was conducted on 7892 children aged 0 to 2 years in Zanjan province in 2013. The sampling method was multi-stage cluster sampling. To determine the growth velocity, 2- pointed model was used. We applied the marginal models of generalized equation estimators (GEE). The related curves were obtained using LOWESS method, and data were analyzed using R Version 2.14.1.
Results: In this study, 3879 (49%) of the participants were female, and the mean age of mothers was 27.1±5.4 years. Growth velocity had a significant association with gender, mother’s residency, multiple pregnancies, gestational age, and exclusive breastfeeding (p<0.001). A significant association was observed between gender and weight growth velocity (p<0.001). Moreover, exclusive breastfeeding had a significant association with weight growth velocity (p<0.001).
Conclusion: Growth velocity in girls was slightly higher than in boys, however, no considerable difference was found between height growth velocity of girls and boys. The findings of this study also indicated that each month increase in exclusive breastfeeding leads to less growth velocity in children. So, exclusive breastfeeding is strongly recommended to prevent childhood obesity.
Growth, Marginal model, Growth velocity, Weight
414
419
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3399-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/27
1396/2/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/7
1396/10/17
Ramazan
Fallah
Department of Biostatistics & Epidemiology, Faculty of Medical Sciences, Zanjan University of Medical Sciences, Zanjan & Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
ramazanfallah@yahoo.com
00319475328460039704
00319475328460039704
No
Anoshirvan
Kazemnejad
Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
kazem_an@modares.ac.ir
00319475328460039705
00319475328460039705
Yes
Alireza
Shoghli
Department of Social Medicine, Faculty of Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran.
shoghli@yahoo.com
00319475328460039706
00319475328460039706
No
Nasim
Vahabi
Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
nasim.vahabi@modares.ac.ir
00319475328460039707
00319475328460039707
No
en
Cutaneous Leishmaniasis in Erbil Governorate: Clinical manifestations and disease course
Background: Cutaneous leishmaniasis (CL) is an infectious disease of zoonotic characteristic; its etiological agent is a protozoan of Leishmania species. This infectious agent is transmitted to humans through a secondary vector, which is infected sand-fly. According to WHO report, Iraq is a country where cutaneous leishmaniasis is an emerging disease, especially, its rural areas are labeled to be the source of the infection and endemicity. Course of the disease and treatment is highly defined by the subtype of cutaneous leishmaniasis and its species.
Methods: Data were collected from cutaneous leishmaniasis registry database of Erbil Dermatology Teaching Center in city of Erbil from August 2016 to August 2017. The collected data were descriptively analyzed for the clinical manifestations and the course of disease in the outbreak of this disease in Erbil governorate.
Results: A total of 124 patients were enrolled in this study. Among them, 93 (75%) were male and 31 (25%) were female. Their age ranged from 2 years to 73 years, with the mean age of 30.7±11.3. The majority of the patients were members of army forces. The total number of the lesions was 325. The number of lesions being ulcerated at the time of presentation was 179 (55%) and non-ulcerated lesions 146 (45%). Time needed for improvement ranged from 1.5 to 4.8 months. Recovery time of cutaneous leishmaniasis lesions from time of onset to the remission ranged from 1.3 to 14.3 months.
Conclusion: The complete recovery time of the CL lesions was longer than what has been mentioned previously in Iraq. Ulceration of the lesions depends on the diameter of the lesions, as increased diameter increases the possibility of the ulceration. The possibility of lesion ulceration increases with an increase in the diameter of the lesions. Considering the observations in different clinical patterns and course of this disease, further studies should be conducted to identify CL species.
Cutaneous leishmaniasis, Clinical manifestation, Ulceration
411
413
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3950-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/25
1396/10/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/3
1397/3/13
Dindar
Qurtas
College of Medicine Hawler Medical University, Erbil Dermatology Teaching Center, Erbil, Iraq.
dindar.qurtas@med.hmu.edu.krd
00319475328460039514
00319475328460039514
Yes
en
Ageing and inpatient hospital expenditures: A study of steepening
Background: Considering the health economics aspect, the effect of population aging on the growth of medical expenditures is of great importance. Thus, the aim of this study was to investigate the growth rate of inpatient hospital expenditures (IHE) of older age groups compared to younger age groups or testing of steepening hypothesis.
Methods: In this descriptive-analytic study, monthly IHE data of insured patients from April 2011 to March 2014 was collected from Iran Health Insurance Organization database. The sample consisted of 297,145 patients who were selected using stratified random sampling among the patients insured by different health insurance funds. Using the Age-cut method, patients were classified into two main age groups: older than 60 and under 60 years old. The average IHE of the two groups and the growth rate of their expenditures were estimated. At the 95% significance level, the difference in average growth rate of IHE was tested between the two age groups using t-statistic in Stata (version 13.0) software.
Results: The findings of this study revealed that per capita IHE for the older and younger groups was $469 and $399, respectively. The monthly average growth rate of IHE for the older (60-90 yrs.) and younger groups (30-59 yrs.) was 2.43% and 2.38%, respectively. The difference between the monthly average growth rate of the older and younger groups was not statistically significant (t = - 0.0332; P value = 0.9736).
Conclusion: Our study results rejected the steepening hypothesis. The monthly average growth rates of IHE in both older and younger age groups have risen to a similar extent over the period of 36 months. Further research should focus on the inpatient hospital expenditures of younger age groups to explain the causes of their increased expenditures.
Ageing, Inpatient hospital expenditures, Steepening hypothesis
406
410
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1759-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/8
1396/11/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/28
1397/5/6
Vahid
Alipour
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
vahid.alipoor1360@yahoo.com
00319475328460039439
00319475328460039439
No
Abolghasem
Pourreza
. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
abolghasempp@yahoo.com
00319475328460039440
00319475328460039440
Yes
Majid
Koosheshi
Department of Demography, Social Science Faculty, Tehran University, Tehran, Iran.
koosheshi@ut.ac.ir
00319475328460039441
00319475328460039441
No
Hassan
Heydari
Department of Economic Sciences, School of Management and Economics, Tarbiat Modares University.
hassan.heydarii@modares.ac.ir
00319475328460039442
00319475328460039442
No
Sara
Emamgholipour Sefiddashti
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
s.emamgholipour@tums.ac.ir
00319475328460039443
00319475328460039443
No
Abbas
Rahimi Foroushani
Department of Epidemiology and Biostatistics, School of Public Health, Tehran Univer-sity of Medical Sciences, Tehran, Iran.
rahimifor@tums.ac.ir
00319475328460039444
00319475328460039444
No
en
Identifying the pattern of unhealthy dietary habits among an Iranian population: A latent class analysis
Background: An unhealthy diet is one of the most important risk factors for chronic diseases. The goal of this study was to use the latent class analysis (LCA) modeling to define unhealthy diet habits among an Iranian population.
Methods: This cross-sectional study was conducted within the framework of Amol (North of Iran) cohort health study (Phase 1). The participants aged 10 to 90 years. All participants provided written informed consent. Latent class analysis was used to classify the participants of the study. All analyses were conducted by PROC LCA in SAS 9.2 software. Significance level was set at 0.05.
Results: The mean age of the participants was 42.58±17.23 years. Four classes of individuals with different diet habits were identified using LCA modeling: class 1: individuals with healthy diet patterns (92.6%); class 2: individuals with slightly unhealthy diet habits (6.3%); class 3: individuals with relatively unhealthy diet habits (0.8%); and class 4: individuals with unhealthy diet habits (0.2%). Being female and alcohol consumption increased the odds of membership in latent classes 2,3, and 4 compared to class 1. Physical activity decreased the odds of membership in classes 3 and 4 compared to class 1.
Conclusion: Overall, almost more than 7.4% of all participants had some degree of unhealthy dietary habits, and some variables acted as risk factors for membership in risky classes. Therefore, focusing on these variables may help design and execute effective preventive interventions in groups with unhealthy dietary habits.
Unhealthy diets, Latent class analysis, Diet pattern
400
405
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2239-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/1
1395/12/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/22
1397/2/2
Ali
Gholami
Department of Public Health, School of Public Health, Neyshabur University of Medi-cal Sciences, Neyshabur, & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
aagholami80@yahoo.com
00319475328460039257
00319475328460039257
No
Msoudreza
Sohrabi
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
sohrab_r@yahoo.com
00319475328460039258
00319475328460039258
No
Abbas
Abbasi-Ghahramanloo
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
abbasi.abbas49@yahoo.com
00319475328460039259
00319475328460039259
No
Farhad
Moradpour
Health Management Research Center, Baqiyatallah University of Medical Sciences, & Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
farhadmepid@yahoo.com
00319475328460039260
00319475328460039260
No
Saeid
Safiri
Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, Iran.
saeidsafiri@gmail.com
00319475328460039261
00319475328460039261
No
Mansooreh
Maadi
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
abbasi.abbas49@gmail.com
00319475328460039262
00319475328460039262
No
Maryam
Khazaee-Pool
Department of Health Education and Promotion, School of Health, Zanjan University of Medical Sciences, Zanjan, Iran.
khazaie_m@yahoo.com
00319475328460039263
00319475328460039263
No
Farhad
Zamani
Department of Epidemiology and Biostatistics, School of Public Health, Tehran Univer-sity of Medical Sciences, Tehran, Iran.
epidemiology.msc@gmail.com
00319475328460039264
00319475328460039264
Yes
en
Citalopram and group psychotherapy in breast cancer patients: A randomized clinical trial
Background: Depression is a common psychiatric disorder in breast cancer patients. This study was designed to evaluate the clinical efficacy of group psychotherapy on breast cancer patients with depressive disorder who took citalopram.
Methods: This clinical trial was conducted on 40 breast cancer patients with depressive disorder. The control group received citalopram 20-40 mg/ day for 12 weeks and the intervention group participated in 8 sessions of group psychotherapy in addition to the same dose of citalopram. At the baseline and 3, 6, and 12 weeks after treatment, patients were followed- up. Treatment outcomes and quality of life were compared between the 2 groups.
Results: Overall, the depression score of Hospital Anxiety and Depression Scale (HADS) at baseline with the mean of 11.6±1.6 was signed in the range of clinical depression and after intervention it declined to 8.8±3.6 (in the 3rd week), 7.1±3.9 (6th week), and 5.9±4.5 (12th week). Furthermore, HADS anxiety score at baseline with the mean of 12.6±2.6 was signed in the range of clinical anxiety and after intervention it declined to 9.1±3.0, 7.3±4.1, and 6.0±4.0, respectively. This improvement was significantly more in the combined therapy intervention group (p<0.001). The mean score of quality of life based on WHO QOL-BREF questionnaire increased by 1.85 fold in the case group, improved from 44.09 to 81.70, while the slight change was observed in the control group (p<0.001). During the treatment, no significant adverse drug event was observed in the 2 groups (p>0.05).
Conclusion: Group psychotherapy has a significant effect on improving depression, anxiety, and quality of life in breast cancer patients.
Breast cancer, Depression, Anxiety, Citalopram, Group psychotherapy
394
399
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3401-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/25
1396/2/5
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/7
1396/10/17
Novin
Nikbakhsh
Cancer Research Center, Babol University of Medical Sciences, Babol, Iran.
novinsu@hotmail.com
00319475328460039250
00319475328460039250
No
Sussan
Moudi
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
sussan.mouodi@gmail.com
00319475328460039251
00319475328460039251
Yes
Sara
Alvarzandi
Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
sarazand87@yahoo.com
00319475328460039252
00319475328460039252
No
Maede
Niazifar
Department of Clinical Psychology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
mae.nzf@gmail.com
00319475328460039253
00319475328460039253
No
Nazila
Farnoush
Department of Surgery, Babol University of Medical Sciences, Babol, Iran.
nazilafarnoush@gmail.com
00319475328460039254
00319475328460039254
No
Ali
Bijani
SDH Research Center, Babol University of Medical Sciences, Babol, Iran.
alibijani@yahoo.com
00319475328460039255
00319475328460039255
No
Marjan
Moudi
Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran.
marjan_mouodi@yahoo.com
00319475328460039256
00319475328460039256
No
en
Costs of hospital-acquired infection for patients hospitalized in intensive care unit of an Iranian referral hospital
Background: Hospital infections have affected millions of people around the world and are considered as one of the most important issues related to patient safety. Therefore, this study was conducted to estimate the extra costs caused by hospital-acquired infections in hospitals.
Methods: This retrospective cohort study was conducted in Tehran province, Iran, in 2017. Medical records of 235 patients hospitalized in one of Tehran hospitals were reviewed for the study. They were divided into case (90 patients) and control (145 patients) groups. Data were analyzed using SPSS and STATA software.
Results: Results revealed no significant relationship between age and gender with the incidence of nosocomial infection (p>0.05). However, the chance of nosocomial infection is most affected by length of hospital stay and costs paid by patients. Moreover, nosocomial infection increases the length of hospital stay up to 25 days. Our results revealed that the mean±SD hospital stay of infected and non-infected patients were 15.8±17.2 and 40.8±19.1 days, respectively. Furthermore, the total cost of patients without any hospital infection was 2451±3098 USD (83 674 480±105 765 500 Rials). On the other hand, the cost for infected patients was 3264±6078 USD (207 497 500±111 430 700 Rials).
Conclusion: Hospital-acquired infections can impose great costs on both patients and the health system. The results of this study indicated the importance of taking specific measures for infection control in hospitals.
Hospital-acquired infection, Hospital costs, Medical records, Iran
388
393
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2305-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/9
1396/9/18
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/15
1396/11/26
Farzad
Soleymani
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
farzadsoleymani75@gmail.com
00319475328460039238
00319475328460039238
No
Hossein
Safari palangi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
hossein.comely@gmail.com
00319475328460039239
00319475328460039239
Yes
Ali
Sarabi Asiabar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
ali.sarabi@gmail.com
00319475328460039240
00319475328460039240
No
Abbasali
Keshtkar
Department of Health Sciences Education Development, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
abkeshtkar@gmail.com
00319475328460039241
00319475328460039241
No
Mohsen
Mohammadi
Kermanshah University of Medical Sciences, Kermanshah, Iran.
mohammadi956@yahoo.com
00319475328460039242
00319475328460039242
No
Ali
Akbari Sari
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
akbarisari1@tums.ac.ir
00319475328460039243
00319475328460039243
No
Ali
Saber
School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
saberali134@gmail.com
00319475328460039244
00319475328460039244
No
en
Spontaneous coiling of the distal tip of the chemotherapy port
For doing systemic chemotherapy, central venous ports are used to access central veins and internal jugular vein. Installing these devices though can be with complications on the side which cause them function limits. In this text a case is presented in which after installing a complete and intact port, some malfunction was detected in the chemotherapy procedure after several months which leads us to port Malposition which is probably caused by the huge soft tissue of patient’s breast. This can be prevented simply by installing the port primarily in the zone with less soft tissue.
Central Venous Catheter Chemotherapy Port, Coiling of the Distal Tip
386
387
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1435-7&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/22
1396/4/31
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/8
1396/7/16
Morteza
khavnin Zadeh
Vascular Access Surgeon, Iran University of Medical Sciences, Hasheminejad Kidney Center, Tehran, Iran.
mkhavanin@yahoo.com
00319475328460039235
00319475328460039235
Yes
Amirhossein
Dehghani Esfahani
Iran University of Medical Sciences, Tehran, Iran.
adesfahani14@gmail.com
00319475328460039236
2855_9257_0001_0000
No
Alireza
Azadeh
Iran University of Medical Sciences, Tehran, Iran.
alirezaaz1995@gmail.com
00319475328460039237
00319475328460039237
No
en
The clinical application of ICF model for occupational therapy in a patient with stroke: A case report
The ICF (the international classification of functioning, disability, and health) is a globally agreed framework and classification to define the spectrum of problems in the functioning of patients. ICF tools were developed based on ICF Core Set (ICF-CS) for the clinical application of ICF and patient management in the rehabilitation process. The current case report aimed at using ICF-based documentation tools in the occupational therapy process in a patient with chronic stroke. The case was a male who had a stroke 6 months prior to the study. The occupational therapy provided to this patient included 5 patient management components (examination, evaluation, prognosis, diagnosis, and intervention) using the ICF-based documentation tool. After one month, improvement in balance and mobility, going up and down the stairs without help, independent upper and lower body dressing achieved. The ICF was clinically applied to the occupational therapy practice in this case report. Because of the close relationship of ICF tools with the concept of occupational therapy, particularly client-centered approach and holistic evaluation of patients, occupational therapists can use ICF in clinical practice to have a more comprehensive view toward patients’ recovery.
381
385
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2044-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/15
1396/10/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/11
1396/12/20
Abolghasem
Fallahzadeh Abarghuei
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
ghasemfallahzade@yahoo.com
00319475328460042590
00319475328460042590
No
Afsoon
Hassani Mehraban
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
Mehraban.a@iums.ac.ir
00319475328460042591
00319475328460042591
Yes
Laleh
Lajevardi
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
laleh23275@yahoo.com
00319475328460042592
00319475328460042592
No
Mahin
Yousefi
Iran University of Medical Sciences, Tehran, Iran
Mahin.Yousefi@yahoo.com
00319475328460042593
00319475328460042593
No
en
Healthy housing: A case study of intersectoral collaboration for better health
Residency areas are primary social factors that directly and indirectly affect health and in synergy with other factors, changes health equity indices.
Qazvin as one of the provinces in the Islamic Republic of Iran has been a pioneer in the provision of an integrated health program with intersectoral collaboration approach and the participation of residents.
In this study required data was gathered in a qualitative method by reviewing documents, group discussions with stakeholders and residents and interviews with key informed individuals. In the beginning, stakeholder’s analysis revealed highly effective organizations and their method of cooperation.
Insufficient access to housing, weak security, insufficient swage system and deficiency of entertainment and park environment are four top urgent issues which are related to housing. Strategic goals for each issue has been designed in a four-year time frame and projects for reaching the goals that are considered in three categories: promotional, facilitator and mandatory.
Cooperation of multiple stakeholders including managers and residents are features of preparing this program. A change of stakeholders’ perspective to health-oriented performance in housing is the added value of this public act.
Housing, Intersectoral collaboration, Social determinant of health
377
380
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-417-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/27
1395/2/8
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/23
1396/6/1
Behzad
Damari
Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran.
bdamari@gmail.com
00319475328460039862
00319475328460039862
No
Kamel
Shadpour
Ministry of Health and Medical Sciences, Tehran, Iran. [Passed away on 2014]
k.shadpour@yahoo.com
00319475328460039863
00319475328460039863
No
Narges
Rostamigooran
Ministry of Health and Medical Sciences, Secretariat of Supreme Council of Health and Food Security, Tehran, Iran.
rostamigooran@yahoo.com
00319475328460039864
00319475328460039864
Yes
en
Measuring positive health of Iranians; Finding from Iran social health survey (ISHS)
Background: Positive health as a “health asset” goes beyond risk factors for diseases and produces longer and healthier life, as well as, better prognosis when illness strikes, against traditional medicine focusing on treating people in negative health to a state that is neutral or free from disease. The aim of present study was to conduct a national survey estimating positive health indicators of Iranians
Methods: This survey was performed on September 2014 in all provinces of Iran with 10500 samples. The psychometrics of employed scale was examined in separate study. To estimate positive health indicators, each question included a series of declarative statements and each respondents answer to questions based on a five-point Likert type scale.
Results: From a total of 10500 respondents, 10244 fulfilled questionnaire (Response rate= 97.5%). About 49% of participants were male. In a scale from 1 to 5, mean of score of life satisfaction, happiness, quality of life, and self-perceived health were 3.45, 3.28, 3.56 and 3.66, respectively. The highest level of positive health indicators was achieved in provinces of Guilan and West Azerbaijan.
Conclusion: The result of the study shows majority of Iranian people assess their perception of health, quality of life, life satisfaction and happiness as ‘moderate’ or ‘good’ (between 66 to 82% of respondents. It would seem that measured positive health indicators in comparison with the rates of past national studies, have been decreased between 3.5 to 4% that should be noticed in social health policy making.
Positive health, Iran, Indicator, Survey, National
371
376
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2819-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/10
1395/4/20
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/27
1396/12/8
Kambiz
Abachizadeh
Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, & Department of community medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Email: k.abachizadeh@sbmu.ac.ir
00319475328460039191
00319475328460039191
No
Soheila
Omidnia
Social Health Office, Health Deputy of Ministry of Health and Medical Education, Tehran, Iran.
ne_soha@yahoo.com
00319475328460039192
00319475328460039192
Yes
Ahmad
Hajebi
Research Center for Addiction & Risky Behaviors (ReCARB), Psychiatric Department, Iran University of Medical Sciences, Tehran, Iran.
hajebi.ahmad@gmail.com
00319475328460039193
00319475328460039193
No
Reza
Shekarriz-Foumani
Department of Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
reza.shekarriz@gmail.com
00319475328460039194
00319475328460039194
No
Maryam
Mohseni
Department of Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
mohseny.maryam0@gmail.com
00319475328460039195
00319475328460039195
No
en
A new method to determine anastomosis angle configuration for arteriovenous fistula maturation
Background: The kidneys of patients with chronic kidney disease (CKD) do not function well enough and those in end-stage renal disease (ESRD) of CKD need hemodialysis (HD) as a common renal replacement therapy (RRT) procedure. HD requires a vascular access (VA), and arteriovenous fistula (AVF) is the common VA choice in the world due to its very few complications. Despite the widespread use of AVFs, some risk factors maximize AVF failure, which is accompanied by complications of the patient such as repeating VA surgeries and hospitalization. Therefore, finding effective factors in the success of surgery is highly important and, thus, this study aimed at measuring the effect of anastomosis angle on the success of AVF surgery.
Methods: This study evaluated the effect of conducted angle in an AVF anastomosis on AVF maturation. The images of 48 created AVFs for CKD patients was provided over a one-year period (from May 2016 to April 2017). Cross-tab analysis was used, and significance level was considered meaningful at p-value≤0.001. A centralized database was designed to integrate data. A method for image processing was developed and geometrical characteristics of the vessels (such as anastomosis angle) and also the diameter of artery and vein were measured via AutoCAD 2017 software and exported to the database along with other data.
Results: The rate of the AVF failure in the studied patients was 8.96%. The anastomosis angle ≤ 30° is preferable from the AVF status point of view because most AVF maturation (or least AVF failure) rates are detected at this range.
Conclusion: This study was performed based on a new approach without the need to measure hemodynamic parameters. Moreover, it signified the important role of anastomosis angle in the function of AVF, showing that the anastomosis angle ≤ 30° is a preferable intraoperative recommendation for AVF surgery.
Vascular access surgery, Hemodialysis, Anastomosis angle, AVF failure, AVF maturation, Surgical process improvement
365
370
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1435-8&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/5
1396/9/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/21
1396/11/1
Mohammad
Rezapour
Department of Information Technology Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.
mrezapour@srbiau.ac.ir
00319475328460039393
00319475328460039393
No
Mohammad Mehdi
Sepehri
Faculty of Industrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran, & Hospital Management Research Center, Iran University of Medical Sciences, Tehran, Iran.
mehdi.sepehri@modares.ac.ir
00319475328460039394
00319475328460039394
No
Morteza
Khavanin Zadeh
Faculty of Medicine, Iran University of Medical Sciences, Hasheminejad Kidney Center (HKC), Tehran, Iran.
khavaninzadeh.m@iums.ac.ir
00319475328460039395
00319475328460039395
Yes
Mahmood
Alborzi
Faculty of IT Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.
mahmood_alborzi@yahoo.com
00319475328460039396
00319475328460039396
No
en
Effect of oral contraceptive pills on rheumatoid arthritis disease activity in women: A randomized clinical trial
Background: Rheumatoid arthritis is one of the most common autoimmune diseases. Because immunological changes can be induced by steroid hormones, it seems that oral contraceptive pills can affect the severity of the disease. In this study, we examined the effect of oral contraceptive pills on rheumatoid arthritis activity in women.
Methods: This blinded randomized clinical control trial was performed in the selected rheumatology centers in Tehran, Iran, in 2011. A total of 100 women with rheumatoid arthritis were included (50 in the intervention and 50 in the control groups), and those in the intervention group took oral contraceptive pills intermittently for 8 weeks. Disease activity was measured at 1 and 9 weeks based on DAS-28, which includes the number of tender joints, number of swollen joints, ESR, and GH. Data were analyzed using SPSS-16, and significance level was set at p≤0.05. This study was registered in IRCT (number: 138904224364N1) and all interventions were done after receiving confirmation from the Ethical Committee of Tehran University of Medical Sciences (Code: 250/ 6441).
Results: After administering oral contraceptive pills to the intervention group, we found significant differences between the 2 groups in disease activity and severity scores (p=0.04). Intervention group showed lower swollen joints score (p=0.02), lower joint tenderness score (p=0.02), and lower general health score (p=0.001) than the control group.
Conclusion: According to the results of this study, oral contraceptive pills can improve rheumatoid arthritis activity and severity. As these pills are used for contraception, women with rheumatoid arthritis can benefit from both effects of these pills.
Oral contraceptive pill, Disease activity, Rheumatoid arthritis, Autoimmune diseases, Contraception
361
364
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3258-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/7
1395/11/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/30
1396/6/8
Leila
Amini
Department of Reproductive Health, School of Nursing & Midwifery, Iran University of Medical Sciences, Tehran, Iran.
le.amini@yahoo.com
00319475328460038967
00319475328460038967
No
Mehri
Kalhor
School of Nursing & Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
mkalhor20@gmail.com
00319475328460038968
00319475328460038968
Yes
Anoushe
Haghighi
Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
haghighi533@yahoo.com
00319475328460038969
00319475328460038969
No
Naiemeh
Seyedfatemi
Nursing Care Research Center (NCRC), Iran University of Medical Sciences, Tehran, Iran.
n-seyedfatemi@tums.ac.ir
00319475328460038970
00319475328460038970
No
Fatemah
Hosseini
Department of Biostatistics, School of Public Health, Iran University of Medical Scienc-es, Tehran, Iran.
hosseini.f@iums.ac..ir
00319475328460038971
00319475328460038971
No
en
Managing acutely aggressive or agitated people in a psychiatric setting: a survey in Lebanon
Background: Violent patients constitute 10% of all psychiatric admissions. Treatment options and clinical practice interventions vary across the globe and no survey of practice in a Middle Eastern setting exists. Surveying treatments in Lebanon will show treatment interventions used in this part of the world and, most importantly, provide the treatment options that could potentially be used for clinical trials pertaining to emergency psychiatry.
Methods: A survey of clinicians’ opinions and practice was conducted between July and August 2017 at the largest psychiatric hospital in Lebanon.
Results: Five of seven experienced psychiatrists provided opinions when interviewed of their preferred intervention when dealing with an emergency psychiatric episode. Whilst this varied in detail, there was a consistent view that there should first be verbal control, then use of medications, and finally physical restrain of the patient. A total of 39 emergency episodes (28 people) occurred in the one month (64% men in their 30s). Bipolar disorder was the most frequent single diagnosis behind the aggression (n=16, 41%; 12 people 43%) but the combined schizophrenia-like illnesses underlay 18 of the 39 episodes (46%; 13/28 people 46%). In clinical life, we found evidence of high family involvement, but little attempts made at initial verbal control in the hospital. All 39 episodes involved administration of pharmacological interventions. Medications were used in 29 of cases (74%) and non-medication interventions used in the remaining 10/39 (26%).
Conclusion: This survey provides some evidence that clinicians’ preferences may not fully reflect clinical practice but also that experienced clinicians are using several clearly effective techniques to manage these very difficult situations. However, as for other parts of the world, treatment in Lebanon has limited or no underpinning by evidence from well-designed, conducted and reported evaluative studies.
Aggression, Agitation, Survey, Psychiatric Hospital, Lebanon, Pharmacotherapy
352
360
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3855-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/16
1396/8/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/24
1396/12/5
Joseph E.
Dib
Division of Psychiatry and Clinical Psychology, School of Medicine, University of Nottingham, Nottingham, UK.
joseph.elie.dib@gmail.com
00319475328460038710
00319475328460038710
Yes
Clive E.
Adams
Institute of Mental Health, University of Nottingham, Nottingham, UK.
Clive.Adams@nottingham.ac.uk
00319475328460038711
00319475328460038711
No
Francois
Kazour
Hôpital Psychiatrique De La Croix, Jal Eddib, Lebanon & Department of Psychology, Holy Spirit University of Kaslik, Kaslik, Lebanon, & INSERM U930, équipe 4 “Troubles affectifs”, Université François-Rabelais de Tours, Parc de Grandmont, 37200 Tours, France & Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Francoiskazour@hotmail.com
00319475328460038712
00319475328460038712
No
Fouad
Tahan
Hôpital Psychiatrique De La Croix, Jal Eddib, Lebanon.
Fouadtahan@gmail.com
00319475328460038713
00319475328460038713
No
Georges
Haddad
Hôpital Psychiatrique De La Croix, Jal Eddib & Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Georgeshaddad.hpc@gmail.com
00319475328460038714
00319475328460038714
No
Chadia
Haddad
Hôpital Psychiatrique De La Croix, Jal Eddib, Lebanon.
Chadia_9@hotmail.com
00319475328460038715
00319475328460038715
No
Souheil
Hallit
Hôpital Psychiatrique De La Croix, Jal Eddib & Faculty of Pharmacy, Lebanese University, Beirut, Lebanon, & Faculty of Pharmacy, Saint-Joseph University, Beirut, Lebanon, & Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Kaslik, Lebanon, & Occupational Health Environment Research Team, U1219 BPH Bordeaux Population Health Research Center Inserm - Université de Bordeaux, Bordeaux, France, & INSPECT-LB: Institut National de Sante Publique, Epidemiologie Clinique et Toxicologie, Faculty of Public Health, Lebanese University, Beirut, Lebanon.
souheilhallit@hotmail.com
00319475328460038716
00319475328460038716
No
en
Service quality in Iranian hospitals: A systematic review and meta-analysis
Background: This study aimed to explore service quality in Iranian hospitals by a systematic review and meta-analysis of the existing literature.
Methods: The literature search in the international (PubMed, Scopus, and the ISI) and Iranian (SID, Iranmedex, and Magiran) scientific databases was conducted to identify studies (published in English and Persian) used the service quality gap (SERVQUAL) model to examine service quality in Iranian hospitals between 2000 and 2016. The databases were searched using a combination of the following keywords: “hospital service quality”, or “healthcare service quality”, and “SERVQUAL model”, or “gap model”, and “Iran”. A random-effects meta-analysis model was used to investigate the quality of hospital care in Iran.
Results: A total of 13 articles with 4,217 patients were included in the study. Results indicate that there are negative gap values between patients' expectations and perceptions in six SERVQUAL dimensions namely. tangibility, reliability, responsiveness, assurance, empathy, and access. The overall mean score of patients’ expectations and perceptions of quality of hospital care in Iran were estimated 4.59 and 3.69, respectively (i.e., quality score gap= -0.9). The highest and lowest quality score gap values were related to the reliability and responsiveness dimensions, correspondingly.
Conclusion: The study found that expectations of patients from hospital care have not been met in Iran. Thus, improving service quality in Iranian hospitals warrants further attention by health professionals, health policy-makers, and hospital managers.
Service quality, Iranian hospitals, SERVQUAL model, Systematic review, Meta-analysis
344
351
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2034-8&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/17
1396/7/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/11
1397/1/22
Satar
Rezaei
Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
satarrezaei@gmail.com
00319475328460038640
00319475328460038640
No
Mohammad
Hajizadeh
School of Health Administration, Faculty of Health, Dalhousie University, Halifax, Canada.
m.hajizadeh@dal.ca
00319475328460038641
00319475328460038641
No
Hamed
Zandian
Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
zandiyan.899@gmail.com
00319475328460038642
00319475328460038642
No
Afshin
Fathi
Department of Pediatrics, Ardabil University of Medical Sciences, Ardabil, Iran.
a.fathi@arums.ac.ir
00319475328460038643
00319475328460038643
No
Bijan
Nouri
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
bijannuri@gmail.com
00319475328460038644
00319475328460038644
Yes
en
Average medical visit time in Iran: A systematic review and meta-analysis
Background: Visit length is an indicator that can be used to assess patients’ satisfaction of the health care services. In recent years, some studies have focused on the mean visit time in Iran. This study aimed at determining the average visit time in Iran by performing a systematic review and meta-analysis.
Methods: In this study, Embase, PubMed/MEDLINE, Scopus, ISI/Web of Science databases, and Google Scholar search engine, as well as Iranian national databases/thesauri, such as MagIran, SID, and Irandoc were used. These databases were searched from their inception until September 2017. The quality of retained studies was assessed using the STROBE checklist. Average visit length was reported using stochastic model with 95% confidence interval (CI). I2 and Q tests were used to assess the heterogeneity of the studies. A sensitivity analysis was conducted to ensure the stability of the results.
Results: After searching the scholarly databases and reviewing the articles based on inclusion and exclusion criteria, 6 studies were finally selected. Based on the random model, the mean visit time was 4.89 minutes in Iran, ranging from 4.66 to 5.12 minutes (p=0.82). The most time visit in specialists belonged to psychiatrists with 9.12 (7.28 to 10.96) minutes (p=0.19) and the lowest belonged to internists with 3.59 (2.24 to 4.95) minutes (p=0.00), respectively.
Conclusion: The average visit time in Iran was estimated to be 4.89 minutes. To increase patients’ satisfaction and provide a better disease treatment and management in Iran, the following suggestions could be helpful: properly distributing physicians across the country, reducing waiting lists, and implementing the use of guidelines to standardize the visit time.
Visit length, Physicians, Specialists, Iran, Systematic review, Meta-analysis
338
343
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2047-7&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/5
1396/8/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/8
1396/9/17
Sanaz
Heydarvand
Bahrami Pediatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
heidarvand_sanaz@yahoo.com
00319475328460038972
00319475328460038972
No
Masoud
Behzadifar
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
masoudbehzadifar@gmail.com
00319475328460038973
00319475328460038973
Yes
Hasan
Abolghasem Gorji
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
saaz2000@yahoo.com
00319475328460038974
00319475328460038974
No
Meysam
Behzadifar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
m_behzadifar67@yahoo.com
00319475328460038975
00319475328460038975
No
Maryam
Darvishnia
Department of Nursing, Islamic Azad University Khorramabad Branch, Khorramabad, Iran.
maryam.darvishnia@gmail.com
00319475328460038976
00319475328460038976
No
Nicola Luigi
Bragazzi
School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
robertobragazzi@gmail.com
00319475328460038977
00319475328460038977
No
en
Association between tooth impaction and odontogenic lesions: A matched case-control study
Background: Impacted tooth is common in dental practice. Dentists usually remove them if they are associated with any pathologic sign or symptom. The challenge is whether to extract the asymptomatic tooth or not. This study was conducted to determine the association between developmental odontogenic cysts and tumors and impacted and unerupted teeth, if left untreated.
Methods: In this matched case-control study, 262 participants were recruited in case and control groups to evaluate the association between the presence of odontogenic cyst and tumors and unerupted and impacted teeth in patient records in the School of Dentistry, Shahid Beheshti University of Medical Sciences during 2000-2002. The controls referred to a dental radiology center for routine OPG. We also recorded the data on age, gender, the involved jaw, and type of lesion. All patients’ records were reviewed by the research director and an oral pathologist separately. The variables that were matched as confounders were age, gender, and the site of the involved jaw.
Results: Results of conditional logistic regression analysis showed that the presence of odontogenic lesions was associated with impacted teeth (OR = 6.9), and not associated with the involved jaw and unerupted teeth.
Conclusion: Impacted teeth could be considered as a potential risk factor for the presence of odontogenic lesions.
Impacted tooth, Unerupted tooth, Odontogenic lesions
334
337
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3522-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/25
1396/4/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/7
1396/10/17
Shervan
Shoaee
Otolaryngology, Head and Neck Surgery Research Center, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences & Elderly Health Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences & Non-communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
shervanoo@yahoo.com
00319475328460038561
00319475328460038561
No
Pegah
Khazaei
Research Center for Caries Prevention (RCCP), Dentistry Research Institute, Tehran University of Medical Sciences & Department of Community Oral Health, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
pegahkhazaee@gmail.com
00319475328460038562
00319475328460038562
No
Fatemeh
Mashhadiabbas
Department of Oral and Maxillofacial Pathology, School of Dentistry, Shahid Beheshti University of Medical Science & Dental Research Center, Research Institute for Dental Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.
fmashhadiabbas@yahoo.com
00319475328460038563
00319475328460038563
No
Masoud
Varshosaz
Department of Oral and Maxillofacial Pathology, School of Dentistry, Shahid Beheshti University of Medical Science, Tehran, Iran.
varshowsaz@hotmail.com
00319475328460038564
00319475328460038564
No
Farshad
Sharifi
Elderly Health Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
farshad.sharifi@gmail.com
00319475328460038565
00319475328460038565
No
Hossein
Hessari
Research Center for Caries Prevention (RCCP), Dentistry Research Institute, Tehran University of Medical Sciences & Department of Community Oral Health, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
h-hessari@tums.ac.ir
00319475328460038566
00319475328460038566
Yes
en
Factors influencing decision making for healthcare services outsourcing: A review and Delphi study
Background: Outsourcing is considered as one of the tools for organizational development and promotion of productivity by managers. In recent years, outsourcing of healthcare services has become significant. The aim of this study was to identify the most important factors influencing the decision making of outsourcing healthcare services.
Methods: This study is a combined study. First, the literature was examined to identify the factors influencing decision making for outsourcing. Then, with the aim of consensus on the most important factors affecting the decision making of outsourcing in health services, the panel of experts and Delphi technique were used. Sampling was purposeful.
Results: In the selected articles, a total of 180 factors were extracted. The members of the panel of experts from these 180 factors selected 29 sub-factors in the form of six main factors: strategy, quality, management, technology, performance feature, and economy, as the most important factors affecting the outsourcing of services. Finally, the results of Delphi showed that 22 sub-factors were more important in outsourcing decision making at healthcare services.
Conclusion: The study showed that the decision making to outsource health services is a complex and multi-criteria decision. Therefore, when deciding to outsource healthcare services, attention should be paid to various factors, such as strategy, quality, management, technology, and economics.
Outsourcing, Health services, Management, Decision making, Quality, Delphi
327
333
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1934-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/2
1396/8/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/28
1396/11/8
Zahra
Kavosi
Health Human Resources Research Center, School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
zhr.kavosi@gmail.com
00319475328460038556
00319475328460038556
No
Hamed
Rahimi
Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of medical sciences, Kerman, Iran.
s.hamedrahimi68@gmail.com
00319475328460038557
00319475328460038557
No
Saeideh
Khanian
School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
khanian_s@yahoo.com
00319475328460038558
00319475328460038558
Yes
Payam
Farhadi
Management Department, Zand higher Education Institute, Shiraz, Iran.
pyamfarhadi88@gmail.com
00319475328460038559
00319475328460038559
No
Erfan
Kharazmi
Health Human Resources Research Center, School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
erfankh2001@yahoo.com
00319475328460038560
00319475328460038560
No
en
Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies
Background: Iran is located in Asian esophageal cancer belt, with age-standardized incidence rate (ASR) of approximately 7 per 100,000 for both men and women. To provide potential solution recommendations for achieving accurate estimations regarding the burden of the disease in Iran, we designed a study to assess the burden of esophageal cancer in Iran during 1995-2015 by collecting data from the Global Burden of Disease studies.
Methods: Data were extracted from the Global Burden of Disease (GBD) during 1995-2015, which were published by the Institute for Health Metrics and Evaluation. For this purpose, disability adjusted life years (DALYs), incidence, and prevalence rate were applied to report burden of esophageal cancer based on gender and age group in Iran during 1995-2015. The Cochran-Armitage and t test were used to assess statistical significance. Stata Version 13 and Excel 2016 were used for data analysis.
Results: During 1995-2015, in total, 304 102 DALYs (179 562 for males vs. 124 540 for females) were attributed to esophageal cancer in Iran. In both genders and all ages, the number of DALYs increased significantly from 45 018 in 1995 to 74 399 in 2015.
Conclusion: Esophageal cancer is still a public health issue in Iran. Most of DALYs were due to years of life lost (YLL), suggesting the need for prevention, early detection, and screening programs. P-value was statistically significant just between male and female groups (p<0.05).
Esophageal cancer, Disability adjusted life years, Iran, Global burden of disease
321
326
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2686-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/15
1396/12/24
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/10
1397/3/20
Hojjat
Rahmani
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
hojjatrahmani@yahoo.com
00319475328460038549
00319475328460038549
No
Ali
Sarabi Asiabar
Health Management and Economics Center, Iran University of Medical Sciences, Tehran, Iran.
sarabi.a@iums.ac.ir
00319475328460038550
00319475328460038550
No
Somayeh
Niakan
Department of Prosthodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
علی
00319475328460038551
00319475328460038551
No
Seyed Yaser
Hashemi
Fasa University of Medical Sciences, Fasa, Iran.
s.yaser.hashemi@gmail.com
00319475328460038552
00319475328460038552
No
Ahmad
Faramarzi
Department of Public Health, School of Health, Urmia University of Medical Sciences, Urmia, Iran.
ahmadfaramarzi97@yahoo.com
00319475328460038553
00319475328460038553
Yes
Sahar
Manuchehri
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
سحر
منوچهری
sahar_manuchehri@yahoo.com
00319475328460038554
00319475328460038554
No
Ghasem
Rajabi Vasokolaei
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran & Scientific Research Center, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
00319475328460038555
00319475328460038555
No
en
The relationship between important reproductive health indices and human development index in Iran
Background: Reviewing the reproductive health indicators (RHIs) provides the possibility of periodic health system performance evaluation to achieve balanced development. This study aimed to determine the trend of ten reproductive health indicators changes during 2002-2011, and examining their relationship with the Human Development Index (HDI).
Methods: In this ecological study the trend of ten reproductive health indicators from five selected provinces of Iran were mapped. Then the relationship of these ten indicators with HDI was investigated using non parametric Spearman's rank correlation coefficient in SPSS v. 20.
Results: There was a statistically significant direct and strong correlation between the percentage of childbirth by a trained person and HDI (r= 0.9, p=0.037).
Conclusion: In our study, it can be expected that the provinces with similar reproductive health indicators, likely have similar HDI.
Reproductive health indices, Human development index, Ecological study
317
320
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2868-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/15
1395/10/26
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/2
1396/10/12
Hamideh
Sabet Rohani
Department of Community Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
hamidehsabetrohani@gmail.com
00319475328460038546
00319475328460038546
Yes
Alireza
Ahmadvand
Global Health Clinical Research Training Fellow, Imperial College London, London, UK, & Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
ahmadvand.ar@gmail.com
00319475328460038547
00319475328460038547
No
Gholamreza
Garmaroudi
Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
garmaroudi@tums.ac.ir
00319475328460038548
00319475328460038548
No
en
Molecular epidemiology; New but impressive
Molecular epidemiology is a subdivision of medical science and epidemiology that emphases on the involvement of potential environmental and genetic risk factors, recognized at the molecular level, to the etiology and avoidance of sickness through populations. This arena has developed from the combination of molecular biology and traditional epidemiological research. Molecular epidemiology can improve our knowledge about the precise pathogenesis of disease through recognizing particular pathways that affect the risk of developing the disease. Furthermore, it tries to find how the collaborations between genetic characteristics and environmental exposures works in disease occurrence.
molecular biology, epidemiology,
312
316
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3607-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/1
1396/5/10
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/3
1396/11/14
Maryam
Honardoost
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
marymail79@gmail.com
00319475328460038333
00319475328460038333
Yes
Azam
Rajabpour
Molecular Medicine Department, Faculty of Medical Science, Qazvin Medical University, Qazvin, Iran.
marymail-58@yahoo.com
00319475328460038334
00319475328460038334
No
Ladan
Vakil
Molecular Medicine Department, Faculty of Medical Science, Qazvin Medical University, Qazvin, Iran.
paya_ka@yahoo.com
00319475328460038335
00319475328460038335
No
en
Application of policy analysis frameworks in tobacco control research: A systematic review of qualitative literature
Background: Tobacco consumption is still considered as the first preventable cause of death in the world. In order to influence tobacco policy process, researchers and policymakers must use frameworks of policy-making to understand the process to provide them insights for influence the process. This systematic review aims to review the application of policy analysis frameworks in the field of tobacco control.
Methods: A systematic search for articles was performed using four databases (Ovid Medline, Scopus, Cochrane Library, and PubMed) up to December 19, 2016. The articles were selected based on inclusion and exclusion criteria. All research studies focusing on tobacco policy and on one or more specified frameworks of policy analysis included in this study. Finally, thematic analysis was used to synthesize the findings.
Results: 17 studies based on eligibility criteria were included in this study. The findings of this study showed that most of the studies were in North America, published in the Health journals, conducted to analyze the national and state policies, focused on analyzing agenda-setting phase. Multiple streams model was the most widely used framework within the literature. Few studies had used advocacy coalition framework. From the three agenda setting frameworks and theories (MSF, PEF, ACF), the ACF framework is the most detailed framework in terms of elements and factors affecting the dynamics of political sub-system the reasons for models selection and suitability for the study was noted only in a small number of studies. The results of this study showed underuse and the incomplete or improper use of policy analysis models and frameworks in the field of tobacco research.
Conclusion: The study showed that a number of theories and frameworks have been used but their use was limited and have significant methodological weaknesses.
Tobacco, Systematic review, Policy analysis
304
311
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2056-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/23
1396/7/1
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/27
1396/8/5
Jalal
Arabloo
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
arabloo_j64@yahoo.com
00319475328460038074
00319475328460038074
No
Sogand
Tourani
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
sogandtourani@yahoo.com
00319475328460038075
00319475328460038075
No
Hamid
Ravaghi
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
ravaghih@gmail.com
00319475328460038076
00319475328460038076
Yes
en
Health education models application by peer group for improving breast cancer screening among Iranian women with a family history of breast cancer: A randomized control trial
Background: Studies have shown that participation of Iranian women with family history of breast cancer in screening service is low. This investigation has evaluated the effectiveness of health models according to peer group in improving clinical breast exam (CBE) among Iranian women with a family history of breast cancer.
Methods: This was a randomized control trial conducted during June and August 2015 in Isfahan. A total of 54 women were assigned into intervention and 53 to control group. Women 20 years or older with an affected relative were included. CBE screening, stage of change screening, knowledge, and belief were considered as outcomes after educational program. Data were analyzed by ANOVA and descriptive statistics by SPSS. Significance level was set at 0.025.
Results: Investigation was completed by 98 women; and we considered 22% as effect size. Three months after the intervention, screening practice was 52% in interventional versus 18% in control group (p<0.001). Knowledge and all health belief subscales scores were significantly affected by time factor and time-group interaction (p<0.001). The effect of group factor was significantly related to knowledge score and perceived sensitivity, benefits, and health motivation subscales. Three months after the intervention, most women in the intermediation group were in the action stage of CBE compared to the controls who continued to be in contemplation stage (p<0.001).
Conclusion: Peer group interventions, which can be organized by health models, have positive effects on CBE in women with positive history of breast cancer.
Breast cancer, Peer group, Health belief model, Transtheoretical model, Family history, Screening
296
303
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3081-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/2
1395/9/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/5
1396/7/13
Fariba
Fathollahi-Dehkordi
Community Medicine Department, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
fathollahi.fariba@yahoo.com
00319475328460038072
00319475328460038072
No
Ziba
Farajzadegan
Community Medicine Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
farajzadegan@med.mui.ac.ir
00319475328460038073
00319475328460038073
Yes
en
Epidemiological study of hospitalized road traffic injuries in Iran 2011
Background: In Iran, Road Traffic Injuries (RTIs) is the second-leading cause of deaths, and the first leading cause of disability-adjusted life year, and has one of the highest rates of death (32.1 per 100 000 population) all over the world. This study’s aim was to investigate the epidemiological pattern and underlying components of hospitalized RTIs in 31 provinces of Iran in 2011.
Methods: This study conducted on all hospitalized RTIs during one-year period (March 21, 2011 to March 21, 2012). Data extracted from a hospital-based traffic injury registration system. According to a national law passed in 2005, all hospital expenses of traffic injuries should be covered by ministry of health based on governmental tariffs. The medical costs of eligible patients will be paid to the hospitals only if the patient data are sent to the above mentioned database. Statistical analysis was performed using SPSS v.16 (SPSS Inc., Chicago, USA), and spatial maps are provided using GIS 10.2. Descriptive statistics and t-test were used to compare means. World (WHO 2000-2025) standard population used to calculate age-adjusted incidence rate. All statistical tests were performed at the 5% level of statistical significance.
Results: There were 322,064 injured cases recorded in the registration system during the study period. The national age-adjusted incidence rate of RTIs was 405 per 100,000 population. The highest incidence rates were in the age group of 15-29 years (643 per 100,000 population), followed by 30-44 year age groups (401 per 100,000 population). The incidence rate in men was 3.36 times more than women. Motorcyclist were the most frequent type of road users (39.2%) who involved in RTIs, followed by passengers (28.9%) and pedestrians (20.0%). Head injuries were among the most affected part of the body which occurred in 27.2% of the patients. The proportion of urban crashes was 60.7%.
Conclusion: The results of this study indicated that the majority of RTI occurred on motorcyclists and head injuries was the most commonly affected body part. Therefore, in order to reduce motorcycle accidents and avoiding head injury among them, stricter law enforcement is urgently needed for helmet use and promotion of safety behaviors among motorcycle riders.
Road traffic injuries, Road user, Head injury
291
295
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3209-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/22
1395/11/3
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/3
1396/5/12
Rasoul
Shavaleh
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
rasoul.shavaleh@gmail.com
00319475328460038059
00319475328460038059
No
Seyed Abbas
Motevalian
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
amotevalian@yahoo.com
00319475328460038060
00319475328460038060
Yes
ان
Nader
Mahdavi
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
nmahdavi24@yahoo.com
00319475328460038061
00319475328460038061
No
Mashyaneh
Haddadi
. Injury Prevention & Safety Promotion Department, Disaster & Emergency Management Center, Ministry of Health & Medical Education, Tehran, Iran.
mashyaneh_hd@yahoo.com
00319475328460038062
00319475328460038062
No
Mahmoud Reza
Mohaghegh
Anesthesia and Critical Care Department, Hasheminejad Kidney Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mahmoudreza.m@yahoo.com
00319475328460038063
00319475328460038063
No
Zahra
Hamedi
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
hamedi.z@gmail.com
00319475328460038064
00319475328460038064
No
en
Downhill walking influence on physical condition and quality of life in patients with COPD: A randomized controlled trial
Background: Chronic Obstructive Pulmonary Disease (COPD), in addition to its respiratory problems, is accompanied by several musculoskeletal consequences. The aim of this study is to investigate the effectiveness of eccentric exercise in the form of downhill walking (DW) on respiratory capacity, physical function and quality of life (QOL) in patients with COPD.
Methods: The randomized controlled trial was carried out during 2014 - 2015 in Hazrat-e-Rasool Hospital in Tehran, Iran. The study design was as an assessor blind RCT on 32 patients with COPD that randomly assigned to the eccentric training (ET) and control (CON) groups. Patients in ET group received a 12-week DW exercise on the treadmill while the patients in the control group were only treated by COPD conventional medications and walked on paved surfaces. Functional tests, FEV1, FEV1 to FVC and St. George’s Respiratory Questionnaire (SGRQ) were used to assess the subject’s physical status and QOL pre and post-intervention.
Results: The FEV1 (p=0.008), FEV1/FVC (p=0.002), six-minute walk test (p=0.029), timed up & go test (p=0.023), SGRQ symptom (p=0.022), SGRQ activity (p=0.007), SGRQ impact (p=0.033) and total score of SGRQ (p=0.013) improved significantly in the ET group compare to the CON group.
Conclusion: DW could have positive influence on physical status and QOL of patients with COPD.
Chronic obstructive pulmonary disease (COPD), Eccentric training, Downhill walking, Quality of life (QOL), Physical function, RCT
283
290
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-853-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/31
1396/3/10
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/25
1397/1/5
Azar
Moezy
Department of Sports Medicine, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.
azarmoezy@yahoo.com
00319475328460038047
00319475328460038047
Yes
Azadeh
Erfani
Iran University of Medical Sciences, Tehran, Iran.
azadeh_erf@hotmail.com
00319475328460038048
00319475328460038048
No
Ali
Mazaherinezhad
Department of Sports Medicine, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.
mazaherinezhad@gmail.com
00319475328460038049
00319475328460038049
No
Seyed Ali
Javad Mousavi
Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
moosavi.j@iums.ac.ir
00319475328460038050
00319475328460038050
No
en
Prevalence of nosocomial infections in Iran: A systematic review and meta-analysis
Background: Nosocomial infections represent a serious public health concern worldwide, and, especially, in developing countries where, due to financial constraints, it is difficult to control infections. This study aimed to review and assess the prevalence of nosocomial infections in Iran.
Methods: Different databases were searched between January 2000 and December 2017. To determine the pooled prevalence, the stochastic DerSimonian-Laird model was used, computing the effect size with its 95% confidence interval. To examine the heterogeneity among studies, the I2 test were conducted. The reporting of observational studies in epidemiology (STROBE) checklist was used to assess the methodological quality of observational studies. To further investigate the source of heterogeneity, meta-regression analyses stratified by publication year, sample size and duration of hospitalization in the hospital were carried out.
Results: 52 studies were included. Based on the random-effects model, the overall prevalence of nosocomial infection in Iran was 4.5% [95% CI: 3.5 to 5.7] with a high, statistically significant heterogeneity (I2=99.82%). A sensitivity analysis was performed to ensure the stability results. After removing each study, results did not change. A cumulative meta-analysis of the included studies was performed based on year of publication and the results did not change. In the present study, a high rate of infections caused by Klebsiella pneumoniae (urinary tract, respiratory tract, and bloodstream infections) was found.
Conclusion: Preventing and reducing hospital infections can significantly impact on reducing mortality and health-related costs. Implementing ad hoc programs, such as training healthcare staff on admission to the hospital, may play an important role in reducing infections spreading.
Nosocomial infections, Prevalence, Iran, Systematic review, Meta-analysis, Hospital
273
282
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2047-9&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/8
1396/11/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/16
1397/2/26
Ahmad
Ghashghaee
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Ghaemmohamadi.m@gmail.com
00319475328460039095
00319475328460039095
No
Masoud
Behzadifar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
masoudbehzadifar@gmail.com
00319475328460039096
00319475328460039096
Yes
Samad
Azari
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
samadazari1010@gmail.com
00319475328460039097
00319475328460039097
No
Zeynab
Farhadi
Babol University of Medical Sciences, Babol, Iran.
farhadi_zeynab@yahoo.com
00319475328460039098
00319475328460039098
No
Nicola Luigi
Bragazzi
School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
robertobragazzi@gmail.com
00319475328460039099
00319475328460039099
No
Meysam
Behzadifar
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran & Department of Epidemiology, Faculty of Health & Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.
m_behzadifar67@yahoo.com
00319475328460039100
00319475328460039100
No
Sahar Sadat
Saeedi Shahri
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
s.s.saeedi75@gmail.com
00319475328460039101
00319475328460039101
No
Mozhgan
Sadat Ghaemmohamadi
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Ghaemmohamadi.m@gmail.com
00319475328460039102
00319475328460039102
No
Faezeh
Ebadi
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
ebadi.faezeh@yahoo.com
00319475328460039103
00319475328460039103
No
Roghayeh
Mohammadibakhsh
Department of Health Services Management, School of Health Management and In-formation Sciences, Iran University of Medical Sciences, Tehran, Iran.
r.mohammadib@yahoo.com
00319475328460039104
00319475328460039104
No
Hesam
Seyedin
Department of Health Services Management, School of Health Management and In-formation Sciences, Iran University of Medical Sciences, Tehran, Iran.
h.seyedin@gmail.com
00319475328460039105
00319475328460039105
No
Mahya
Razi Moghadam
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
00319475328460039106
00319475328460039106
No
en
Absence of FLT3 mutations in Iranian adult T-cell leukemia/lymphoma patients
Background: Adult T cell leukemia lymphoma (ATLL) is a rare disease, significantly linked to the infection by the human T-cell lymphotropic virus 1(HTLV-1). ATLL is typically preceded by decades of clinical latency during which infected cells accumulate selectable traits leading to a malignant transformation. Amongst all the HTLV-1 infected carriers only about 3-5% will develop ATLL. Despite the intensive attempt to improve the overall survival, ATLL remains one of worse prognosis among the hematologic malignancies. FMS like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutations are mutations which are frequent among leukemic patients. We aimed to investigate the frequency of FLT3 mutation status in patients with acute type of ATLL which has not been studied yet.
Methods: In this case control study 38 patients with acute type of ATLL were retrospectively analyzed between February 2015 and February 2017. Forty HTLV-1 positive patients were also used as control cases. Genomic DNA was extracted according to phenol-chloroform protocol and two restriction fragment length polymorphism (RFLP) PCR reactions were set up to detect FLT3/ ITD and FLT3/TKD mutations. Differences between variables were evaluated by the chi-square test and t test for categorical and continuous variables, respectively. SPSS software v. 15 was used for statistical analysis. All P values were two sided and values less than 0.05 were considered to be significant.
Results: No FLT3 mutations were detected in acute type of ATLL patients. So far, not many studies have shown the frequency of FLT3 mutation in ATLL patients
Conclusion: Therefore, we conclude that although FLT3 mutations are rather unusual in the acute type of ATLL patients, but other alternative mechanisms associated with ATLL remain to be further investigated. This study was a novel project regarding the analysis of FLT3 mutation in the field of ATLL research.
Adult T cell leukemia, Human T-cell lymphotropic virus 1, Iran
268
272
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3582-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/23
1396/5/1
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/9
1396/8/18
Hossein
Ayatollahi
Department of Hematology and Blood Bank, Faculty of Medicine, Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ayatollahih@mums.ac.ir
00319475328460043035
00319475328460043035
No
Mohammadhadi
Sadeghian
Department of Hematology and Blood Bank, Faculty of Medicine, Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
sadeghianmh@mums.ac.ir
00319475328460043036
00319475328460043036
No
Mohammadmahdi
Kooshyar
Department of Internal Medicine, Faculty of Medicine, Ghaem Medical Center, Mashhad university of Medical sciences, Mashhad, Iran.
kooshyarh@mums.ac.ir
00319475328460043037
00319475328460043037
No
Abass
Shirdel
Department of Internal Medicine, Faculty of Medicine, Ghaem Medical Center, Mashhad university of Medical sciences, Mashhad, Iran.
shirdela@mums.ac.ir
00319475328460043038
00319475328460043038
No
Hossein
Rahimi
Department of Internal Medicine, Faculty of Medicine, Ghaem Medical Center, Mashhad university of Medical sciences, Mashhad, Iran.
rahimih@mums.ac.ir
00319475328460043039
00319475328460043039
No
Amirhossein
Jafarian
Department of Pathology, Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
jafarianah@mums.ac.ir
00319475328460043040
00319475328460043040
No
Saeedeh
Ghazaey Zidanloo
Cancer Molecular Pathology Research Center, Ghaem Medical Center Mashhad University of Medical Sciences, Mashhad, Iran.
Ghazaeys@kub.ac.ir
00319475328460043041
00319475328460043041
No
Narges
Soltani
Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
soltanin2@mums.ac.ir
00319475328460043042
00319475328460043042
No
Fatemeh
Shams
Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
shams8869@yahoo.com
00319475328460043043
00319475328460043043
No
Neda
Motamedi Rad
Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
neda_neli@yahoo.com
00319475328460043044
00319475328460043044
No
Sepideh
Shakeri
Cancer Molecular Pathology Research Center, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ssh.shakeri@gmail.com
00319475328460043045
00319475328460043045
Yes
en
A Successful implementation of an idea to a nationally approved plan: Analyzing Iran's National Health Roadmap using the Kingdon model of policymaking
Introduction: Hospital beds, human resources, and medical equipment are the costliest elements in the health system and play an essential role at the time of treatment. In this paper, different phases of the NEDA 2026 project and its methodological approach were presented and its formulation process was analysed using the Kingdon model of policymaking.
Methods: Iran Health Roadmap (NEDA 2026) project started in March 2016 and ended in March 2017. The main components of this project were hospital beds, clinical human resources, specialist personnel, capital medical equipment, laboratory facilities, emergency services, and service delivery model. Kingdon model of policymaking was used to evaluate NEDA 2026 development and implementation. In this study, all activities to accomplish each step in the Kingdon model was described.
Results: The followings were done to accomplish the goals of each step: collecting experts’ viewpoint (problem identification and definition), systematic review of the literature, analysis of previous experiences, stakeholder analysis, economic analysis, and feasibility study (solution appropriateness analysis), three-round Delphi survey (policy survey and scrutinization), and intersectoral and interasectoral agreement (policy legislation).
Conclusion: In the provision of an efficient health service, various components affect each other and the desired outcome, so they need to be considered as parts of an integrated system in developing a roadmap for the health system. Thus, this study demonstrated the cooperation process at different levels of Iran’s health system to formulate a roadmap to provide the necessary resources for the health sector for the next 10 years and to ensure its feasibility using the Kingdon policy framework.
Policy making, National Roadmap, Health system, Iran
262
267
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1615-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/7
1396/12/16
Hassan
Hashemi
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
hhashemi@norc.ac.ir
00319475328460038210
00319475328460038210
No
Ali Akbar
Haghdoost
Modeling in Health Research Center, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
ahaghdoost@gmail.com
00319475328460038211
00319475328460038211
No
Mohammad
Haji-Aghajani
Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
00319475328460038212
00319475328460038212
No
Ghasem
Janbabaee
Department of Hematology-Oncology, Gastrointestinal Cancer Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
00319475328460038213
00319475328460038213
No
Ali
Maher
Department of Health Policy, School of Medical Education, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
00319475328460038214
00319475328460038214
No
Somayeh
Noori Hekmat
Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038215
00319475328460038215
No
Amir M.
Javadi
Executive director, Iranian healthcare information Observatory, Researcher of Noor Ophthalmology Research Center, Tehran, Iran.
00319475328460038216
00319475328460038216
Yes
Rohaneh
Rahimisadegh
Research Center for Health Services Management, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038217
00319475328460038217
No
Samira
Emadi
Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038218
00319475328460038218
No
Mahamad Reza
Rajabalipour
Supervisor of Public Health Department in School of Public Health in Bam University of Medical Sciences, Bam, Iran.
00319475328460038219
00319475328460038219
No
Hajar
Haghighi
Research Center for Health Services Management, Future Studies Research Center in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038220
00319475328460038220
No
Reza
Dehnavieh
Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038221
00319475328460038221
No
Masoud
Ferdosi
Health Management and Economics Research Center (HMERC), Isfahan University of Medical Sciences, Isfahan, Iran.
00319475328460038222
00319475328460038222
No
Gholamreza
Khademi
Assistant Director of Medical Accident and Emergency Management Center, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038223
00319475328460038223
No
Mohammad Hossein
Mehralhasani
Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038224
00319475328460038224
No
Asma
Sabermahani
Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038225
00319475328460038225
No
Kaveh Nouhi
Bezanjani
Master of Public Administration, Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038226
00319475328460038226
No
Abedin
Iranpour
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038227
00319475328460038227
No
Hamidreza
Rashidi Nejad
Research Center for Modeling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038228
00319475328460038228
No
Fatemeh Moeen
Samadani
Department of Statistics, Deputy of Curative Affaire, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038229
00319475328460038229
No
Maryam
Maki
Department of Environmental Health, School of public Health, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460038230
00319475328460038230
No
Behzad
Kalantari
MD, Department of Planning, Deputy of Curative Affaire, MOHME, Tehran, Iran.
00319475328460038231
00319475328460038231
No
Nahid
Farrokhyar
Department of Planning, Deputy of Curative Affaire, MOHME, Tehran, Iran.
00319475328460038232
00319475328460038232
No
Hamed
Rouhanizadeh
Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran.
00319475328460038233
00319475328460038233
No
Monireh
Falakbaz
Department of Statistics, Deputy of Curative Affaire, Guilan University of Medical Sciences, Rasht, Iran.
00319475328460038234
00319475328460038234
No
Hamid
Allahyari
Golestan University of Medical Sciences, Gorgan, Iran.
00319475328460038235
00319475328460038235
No
Mohammad Taghi
Fathalian
Management of Diseases, Diagnosis & Treatment Center, Semnan University of Medical Sciences, Semnan, Iran.
00319475328460038236
00319475328460038236
No
Ali Reza
Khajehmirzaei
MD, vice-chancellery of treatment, Shahroud University of Medical Sciences, Shahroud, Iran.
00319475328460038237
00319475328460038237
No
Ali
Jannati
Iranian Center of Excellence in Health Management (IceHM), School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.
00319475328460038238
00319475328460038238
No
Javad
Derakhshani
Health Information Officer, Tabriz University of Medical Sciences, Tabriz, Iran.
00319475328460038239
00319475328460038239
No
Ali
Rezapour
Human Resources. Head of Hospital Administration and Clinical Services Excellence. Ardabil University of Medical Sciences, Ardabil, Iran.
00319475328460038240
00319475328460038240
No
Jamal
Eftekhari
Department of clinical affairs, Urmia university of medical sciences, Urmia, Iran.
00319475328460038241
00319475328460038241
No
Parisa
Khaterneshanian fam
Head of hospital administration and clinical services excellence. Treatment dept. Faculty of medical sciences and health services, Maragheh. Maragheh, Iran.
00319475328460038242
00319475328460038242
No
Mahmoud
Kazemi
Department of Statistics, Deputy of Curative Affaire, Kermanshah University of Medical Sciences, Kermanshah, Iran.
00319475328460038243
00319475328460038243
No
Mohsen
Mohammadi
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
00319475328460038244
00319475328460038244
No
Payam
Rastbin
Department of Statistics, Deputy of Curative Affaire, medical university of Kurdestan, Iran.
00319475328460038245
00319475328460038245
No
Bahareh
Pirhayati
Expert Statistics, Unit of Statistics, Ilam University of Medical Science, Ilam, Iran.
00319475328460038246
00319475328460038246
No
Elahe
Souri
Deputy of Curative Affaire, Hamadan University of Medical Science, Hamadan, Iran.
00319475328460038247
00319475328460038247
No
Amin
Torabipour
Department of Health Services Management, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
00319475328460038248
00319475328460038248
No
Mohammad
Keshvari
Department of Health Services Management, School of Medical Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
00319475328460038249
00319475328460038249
No
en
Direct observation of procedural skills (DOPS) evaluation method: Systematic review of evidence
Background: Evaluation is one of the most important aspects of medical education. Thus, new methods of effective evaluation are required in this area, and direct observation of procedural skills (DOPS) is one of these methods. This study was conducted to systematically review the evidence involved in this type of assessment to allow the effective use of this method.
Methods: Data were collected searching such keywords as evaluation, assessment, medical education, and direct observation of procedural skills (DOPS) on Google Scholar, PubMed, Science Direct, SID, Medlib and Google and by searching unpublished sources (Gray literature) and selected references (reference of reference).
Results: Of 236 papers, 28 were studied. Satisfaction with DOPS method was found to be moderate. The major strengths of this evaluation method are as follow: providing feedback to the participants and promoting independence and practical skills during assessment. However, stressful evaluation, time limitation for participants, and bias between assessors are the main drawbacks of this method. Positive impact of DOPS method on improving student performance has been noted in most studies. The results showed that the validity and reliability of DOPS are relatively acceptable. Performance of participants using DOPS was relatively satisfactory. However, not providing necessary trainings on how to take DOPS test, not providing essential feedback to participants, and insufficient time for the test are the major drawbacks of the DOPS tests.
Conclusion: According to the results of this study, DOPS tests can be applied as a valuable and effective evaluation method in medical education. However, more attention should be paid to the quality of these tests.
Evaluation, Medical education, Directly observed procedural skills
254
261
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3217-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/23
1395/11/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/26
1397/3/5
Masoumeh
Erfani Khanghahi
Department of Educational Management, Faculty of Management and Accounting, Yadegar-e-Imam Khomeini (RAH), Shahre Rey Branch, Islamic Azad University, Tehran, Iran.
afsaneerfani@gmail.com
00319475328460037634
00319475328460037634
Yes
Farbod
Ebadi Fard Azar
Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran.
dr_febadi@yahoo.com
00319475328460037635
00319475328460037635
No
en
Surgical treatment outcome of giant cell tumor of distal ulna: En bloc resection vs. curettage and bone graft
Background: Giant cell tumor (GCT) of the bone is a benign neoplasm with local aggressive behavior. Distal ulna is a very rare place for GCT. Published studies have mainly focused on case reports, and thus there is no consistent treatment strategy for this tumor at this location. This retrospective study was conducted to evaluate the oncological and functional results of 2 different surgical treatment methods for GCT in distal ulna.
Methods: In this study, 9 patients with GCT of distal ulna were followed after surgical treatment of GCT of distal ulna. Of the patients, 2 had local recurrence after surgery in other hospitals and 7 had primarily been admitted to our hospital. Four patients, all with grade 2 Enneking and Campanacci’s classification, were treated by extended curettage and bone grafting, while 5 patients with grade 3 were managed by distal ulnar resection. Minimum follow-up time was 24 months.
Results: Patients with grade 3 GCT of distal ulna, who had extended curettage, had a local recurrence up to one year after surgery. Local recurrence was never seen in those with grade 3 disease with resection or in those with grade 2 disease with extended curettage as the treatment of GCT in this location.
Conclusion: Based on our study, which is the largest cohort of GCT of distal ulna, extended curettage, and en bloc resection can be suggested as valuable methods of treatment for grades 2 and 3 tumors, respectively.
Giant cell tumor, Ulna, Extended curettage, En bloc resection, Benign aggressive
249
253
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-281-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/11
1396/3/21
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/10
1396/8/19
Khodamorad
Jamshidi
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
jamshidi.k.j@gmail.com
00319475328460037557
00319475328460037557
No
Mehrdad
Bahrabadi
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
Mehrdad.bahrabadi@gmail.com
00319475328460037558
00319475328460037558
Yes
Abolfazl
Bagherifard
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
bagherifd@gmail.com
00319475328460037559
00319475328460037559
No
Mehdi
Mohamadpour
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
mehdi.668491@gmail.com
00319475328460037560
00319475328460037560
No
en
Case series of papillectomy by endoscopic retrograde cholangiopancreatography (ERCP)
Ampullary neoplasms are one of the causes of obstructive jaundice. Endoscopic retrograde cholangiopancreatography (ERCP) is useful procedure for diagnosing and tissue sampling of ampullary neoplasms. Ampullectomy by resecting entire ampulla provides whole lesion for pathologic evaluation and also is appropriate for real pathologic staging for further management decision but ampullectomy considered as a heroic endoscopic procedure. We share our experience in this field and explain our results.
Ampullary neoplasm, Endoscopic retrograde cholangiopancreatography
246
248
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3919-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/15
1396/9/24
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/28
1397/2/8
Nader
Roshan
GI Ward, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
naderroshan@yahoo.com
00319475328460037554
00319475328460037554
No
Seyed Farshad
Allameh
GI Ward, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
allamehfarshad@gmail.com
00319475328460037555
00319475328460037555
Yes
Omid
Eslami
GI Ward, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
o_eslami@yahoo.com
00319475328460037556
00319475328460037556
No
en
Highlighting a valuable dimension in health care librarianship: A systematic review
Background: Educational role is one of the most important roles of librarians, which has taken on wider dimensions. A review of the literature on the training programs provided by librarians revealed an evolution of the ideas and trends in this area. This systematic review aimed at providing a clear image of the available educational programs, their target groups, and the way they are performed.
Methods: This systematic review was done to identify different aspects of the educational role of medical librarians. It was conducted on the studies published in PubMed database during 2005 and 2015. All the studies that described the educational activities of medical librarians were considered for inclusion. All the studies were evaluated by 2 researchers using a checklist, which was developed as an assessment tool. Variables that were considered were as follow: skills taught by librarians, target group, providing training on information resource, teaching method, and session location. After data extraction process and appraisal, the mentioned variables were classified into main categories.
Results: A total of 24 studies met the inclusion criteria. The training skills taught by librarians were classified into 3 main groups: information literacy, evidence-based practice, and health literacy. The target groups were library users, patients, and health professionals. Group training was provided, and if necessary, personal training was also offered. Recently, synchronous online training has also been added to the training methods. Most of the training programs are held in classrooms.
Conclusion: By categorizing different aspects of training programs, this study aimed at providing a basis for designing a framework to identify the tasks of educational librarians in health sciences.
Librarians, Education, Information literacy, Evidence-based practice, Health literacy
239
245
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3504-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/16
1396/3/26
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/6
1396/5/15
Reza
Safdari
Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
rsafdari@tums.ac.ir
00319475328460037551
00319475328460037551
No
Hamideh
Ehtesham
Birjand University of Medical Sciences, Birjand, Iran. & Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
h-ehtesham@razi.tums.ac.ir
00319475328460037552
00319475328460037552
Yes
Leila
Bahadori
Central Library, Iran University of Medical Sciences, Tehran, Iran.
leila.bahadori@yahoo.com
00319475328460037553
00319475328460037553
No
en
Trends in surveillance data of influenza virus in Tehran before decreasing dispatch of Iranian Hajj pilgrims to Mecca
Background: Respiratory infections, especially viral infections, are the most prevalent infection affecting Hajj pilgrims. Commonly 3 major human influenza viruses (A/H1N1, A/H3N2, and B) are responsible for these morbidities. The present study was conducted to develop a statistical report on human influenza in Hajj pilgrims.
Methods: Nasal and throat samples were collected from 232 returning Iranian pilgrims in hospitals of IUMS. All samples were kept in the refrigerator at 4 °C and stored at −70 °C until RNA extraction. RNA extraction was performed by QIAamp viral RNAmini kits (QIAGEN, Hilden, Germany) and influenza viruses were detected by TaqMan RT-PCR.
Results: Participants included 115 (49.5%) male and 117 (50.5%) female patients, with the age range of 10 to 93 years (mean: 53 years). The pandemic and seasonal influenza A (H1N1) virus were detected in 2 (0.8%) and 20 (8.6%) pilgrims, respectively, and also influenza B was identified in 1 person (0.4%).
Conclusions: Since the probability of an influenza pandemic has been anticipated for the coming years, it seems necessary to plan a continuous monitoring of large gatherings like Hajj and conduct statistical studies in the region. Moreover, material surveillance in humans needs to be boosted. Therefore, results of influenza research can be important for developing WHO reports.
Influenza, Hajj, Pilgrim, Iran
235
238
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3535-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/3
1396/4/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/26
1396/7/4
Maryam
Esghaei
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
maryam.esghaei@gmail.com
00319475328460043107
00319475328460043107
No
Mohsen
Moghoofei
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mohsenmoghoofei@yahoo.com
00319475328460043108
00319475328460043108
No
Mohsen
Keshavarz
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mohsen373@rocketmail.com
00319475328460043109
00319475328460043109
No
Hossein
Keyvani
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
keyvanlab@yahoo.com
00319475328460043110
00319475328460043110
Yes
Farah
Bokharaei-Salim
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & HIV Laboratory of National Center, Vice Chancellor for Health, Iran University of Medical Sciences, Tehran, Iran.
bokharaeifarah@gmail.com
00319475328460043111
00319475328460043111
No
Mohamad
Farahmand
Department of Virology, Faculty of Public Health, Tehran University of Medical Scienc-es, Tehran, Iran.
farahmandm@outlook.com
00319475328460043112
00319475328460043112
No
Seyed Hamidreza
Monavari
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
hrmonavari@yahoo.com
00319475328460043113
00319475328460043113
No
en
The relationship between emotional intelligence and critical thinking skills in Iranian nursing students
Background: Critical thinking skills are one of the most important competencies in successful clinical performance of nursing students. Emotional intelligence is also one of the concepts related to critical thinking and can play an important role in the ability to think. Thus, this study was conducted to investigate the relationship between emotional intelligence and critical thinking in nursing students.
Methods: This was a quantitative, descriptive–correlative Study. Participants were nursing students in different levels. To collect data, California Critical Thinking Test (form B) and Bar-On Emotional Intelligence Questionnaire were used. Then, data were analyzed with descriptive and inferential statistics using SPSS 16 software.
Results: Pearson correlation test showed no significant correlation between the total score of critical thinking skills and each of its components with the total score of emotional intelligence and its component, except for empathy (p=0.001), in nursing students.
Conclusion: The findings revealed a significant relationship between empathy and critical thinking skills in nursing students. Using these elements as teaching techniques for nursing education courses can be very helpful in developing good nurse-patient relationships and improving patient care.
Critical Thinking, Emotional Intelligence, Nursing Students, Iran
231
234
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3191-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/16
1395/10/27
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/28
1396/12/9
Marzieh
Hasanpour
School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
m-hasanpour@sina.tums.ac.ir
00319475328460037541
00319475328460037541
No
Maryam
Bagheri
Student Research Committee, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
maryambagheri83@yahoo.com
00319475328460037542
00319475328460037542
No
Fatemeh
Ghaedi Heidari
Student Research Committee, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
fatemeh.ghaedi@gmail.com
00319475328460037543
00319475328460037543
Yes
en
Iran’s Health System Transformation Plan: A SWOT analysis
Background: Societies are characterized by evolving health needs, which become more challenging throughout time, to which health system should respond. As such, a constant monitoring and a periodic review and reformation of healthcare systems are of fundamental importance to increase the efficiency and effectiveness of healthcare services delivery, equity, and sustainable funding. The establishment of President Rouhani’s government in Iran, on May 5, 2014, the settlement of the new Ministry of Health and Medical Education administration (MoHME) and the need for change in the provision of healthcare services has led to the “Health System Transformation Plan” (HSTP). The aim of the current investigation was to critically evaluate the health transformation plan in Iran.
Methods: Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis enables to identify and assess the strengths and weaknesses within an organization or program, as well as the threats and opportunities outside the given organization or program. To identify SWOT of the HSTP in Iran, all articles concerning this program published in scholarly databases as well as in the gray literature were systematically searched. Subsequently, all factors identified at the first round were thematically classified into four categories and for reaching consensus on this classification, the list of points and factors was sent to 40 experts – policy- and decision-makers, professors and academicians, health department workers, health activists, journalists.
Results: Thirty-four subjects expressed comments on classification. Incorporating their suggestions, the SWOT analysis of Iran’s HSTP was revised, finalized and then performed.
Conclusion: HSTP in Iran, like many of the initiatives that have been recently introduced and not fully implemented, have various challenges, difficulties and pitfalls that health policymakers need to pay attention to. Interacting with criticisms, taking into account public opinion and strengthening the plan can make the project more effective, and it can be anticipated that in the future, better conditions in the health sector will be achieved.
Strengths, Weaknesses, Opportunities, Threats, SWOT, Health system transformation plan, Iran
224
230
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2047-6&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/27
1396/7/5
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/19
1396/10/29
Alireza
Olyaeemanesh
National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
arolyaee@gmail.com
00319475328460038990
00319475328460038990
No
Masoud
Behzadifar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
masoudbehzadifard@gmail.com
00319475328460038991
00319475328460038991
Yes
Nasrin
Mousavinejhad
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
masoud59bf@yahoo.com
00319475328460038992
00319475328460038992
No
Meysam
Behzadifar
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran & Department of Epidemiology, Faculty of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.
m_behzadifar67@yahoo.com
00319475328460038993
00319475328460038993
No
Sanaz
Heydarvand
Bahrami Pediatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
heidarvand_sanaz@yahoo.com
00319475328460038994
00319475328460038994
No
Samad
Azari
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
samadazari1010@gmail.com
00319475328460038995
00319475328460038995
No
Mariano
Martini
Postgraduate School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
mariomartini@yahoo.com
00319475328460038996
00319475328460038996
No
Ahad
Bakhtiari
Department of Health Economics and Management, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
ah.bakhtyari@gmail.com
00319475328460038997
00319475328460038997
No
Nicola Luigi
Bragazzi
Department of Health Sciences (DISSAL), Section of History of Medicine and Ethics, University of Genoa, Genoa, Italy.
robertobragazzi@gmail.com
00319475328460038998
00319475328460038998
No
en
Frequency of human Parvovirus B19 among patients with respiratory infection in Iran
Background: Human parvovirus B19 was known as one of the possible cause of mild respiratory tract diseases in previous studies. However, there are some reports of acute obstructive respiratory disease and severe pneumonia. The purpose of current study was to assess the prevalence and clinical features of parvovirus B19 in respiratory infection.
Methods: This study was conducted on 156 patients diagnosed with respiratory infection at the Iran University of Medical Sciences-affiliated hospitals. After extraction of viral DNA from swab samples, detection of parvovirus B19 was performed by real-time PCR assay.
Results: In 156 patient’s samples, parvovirus B19 was found in 8 (5.1 %) cases including 5 males (5.9%) and 3 females (4.1%). The most common clinical symptoms were wheezing (100%), tachypnea (100%), fever (75%) and rhinorrhea/pharyngitis (75%).
Conclusion: This is the first attempt to assess the prevalence of parvovirus B19 infection in Iranian patients with respiratory infection. The low frequency of parvovirus B19 detected in our study does not support the role of this virus in the development of respiratory infection. However, further studies are needed to better evaluate the etiological role of parvovirus B19 in respiratory infection.
Parvovirus B19, Real-time PCR, Respiratory infection, Iran
220
223
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2447-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/4
1395/12/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/4
1396/4/13
Ahmad
Tavakoli
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
ahmad.tavakoli66@gmail.com
00319475328460037525
00319475328460037525
No
Seyed Hamidreza
Monavari
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
hrmonavari@yahoo.com
00319475328460037526
00319475328460037526
Yes
Hamidreza
Mollaei
Department of Microbiology and Virology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
tavakoli@email.com
00319475328460037527
00319475328460037527
No
Farah
Bokharaei-Salim
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
bokharaeifarah@gmail.com
00319475328460037528
00319475328460037528
No
Maryam
Esghaei
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
maryam.esghaei@gmail.com
00319475328460037529
00319475328460037529
No
Hossein
Keyvani
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
keyvanlab@yahoo.com
00319475328460037530
00319475328460037530
No
Hadi
Ghaffari
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
ghaffari1364@yahoo.com
00319475328460037531
00319475328460037531
No
en
A comparison of the earnings of specialist physicians and nurses before and after implementing the Iran’s New Tariffs Book
Background: The fair wage to specialist physicians and nurses can enhance their job motivation, quality of work, job satisfaction level, and improve the delivery of services to patients. The present study aimed to compare the proportion of changes in earnings of specialist physicians and nurses before and after implementing the Iran’s New Tariffs Book and compare their average income with a number of selected countries.
Methods: This descriptive-analytical study was conducted cross-sectional in the hospitals affiliated to Iran University of Medical Sciences (IUMS) in 2016. Six months before and after the announcement and implementation of the Iran’s New Tariffs Book, the relative values of healthcare services were compared. Study population included all specialist physicians and nurses working in the hospitals affiliated to IUMS. Sample size was determined by sampling formula.
Results: The proportion of changes in the income of medical specialists and nurses after establishing the book varied between 8% and 184%. Based on our findings, the highest increases were observed in internal medicine (184%), surgery (160%), gastroenterology (153%), and pediatrics (120%), whereas, the lowest ones belonged to ophthalmology (8%), emergency medicine (11%), neurology (24%) and anesthesia (32%). Nurses’ income was surged by 43%.
Conclusion: Pursuant to the findings, the income belonged to all examined medical specialists and nursing groups has increased after implementing the Iran’s New Tariffs Book. The result suggested that income differences among groups have been broadened after the implementation of the Book. There was a wide and significant difference in specialist physicians’ income vis-à-vis nursing groups’ income before and after establishing the New Book.
Medical tariffs, Specialists, Nurses, Earnings, Iran
214
219
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3682-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/12
1396/6/21
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/27
1396/10/6
Alireza
Mazdaki
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
mazdakiii@yahoo.com
00319475328460037711
00319475328460037711
No
Aziz
Rezapour
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
rezapoor_a57@yahoo.com
00319475328460037712
00319475328460037712
No
Samad
Azari
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
samadazari1010@gmail.com
00319475328460037713
00319475328460037713
Yes
Touraj
Harati Khaliabad
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
toorajharati@gmail.com
00319475328460037714
00319475328460037714
No
Masoud
Behzadifar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
masoudbehzadifar@gmail.com
00319475328460037715
00319475328460037715
No
Mahya
Razi Moghadam
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
00319475328460037716
00319475328460037716
No
Behzad
Raei
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
raeibehzad@gmail.com
00319475328460037717
00319475328460037717
No
Mehdi
Raadabadi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
mehdiraadabadi@gmail.com
00319475328460037718
00319475328460037718
No
en
Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and
cisplatin) regimen in gestational trophoblastic neoplasia
Background: Gestational trophoblastic neoplasia (GTN) originates from placental trophoblast and is a highly chemosensitive and curable gynecologic malignancy. The present study was conducted to evaluate the effectiveness and safety of EMA/EP (etoposide, methotrexate, actinomycin-D, etoposide, and cisplatin) regimen in the treatment of high-risk GTN as well as patients’ outcome.
Methods: Hospital charts of all patients with confirmed diagnosis of high-risk GTN who received EMA/EP regimen treatment during a 12-year period (2001-2012) at the tertiary center of comprehensive women's hospital in Tehran, Iran, were reviewed from 2012 to 2013, retrospectively.
Results: In this study, 25 patients with GTN who were treated with EMA/EP regimen during the study were identified. Complete remission rate in GTN patients with failure of single agent chemotherapy who were treated with EMA/EP regimen, as the first- line treatment, was 100%, while it was 81% in those with primary high-risk GTN. Overall remission rate in high-risk GTN patients treated with EMA/EP regimen was 88%. Anemia (92%) and leucopenia (72%) were the most common adverse effects of EMA/EP chemotherapy regimen. Acute myeloid leukemia (AML) and mortality, as the most severe adverse effects of EMA/EP regimen, were seen only in 1 patient.
Conclusion: According to the results, EMA/EP regimen could induce complete remission in 88% of patients with high-risk GTN. Application of EMA/EP is recommended as the first- line therapy in patients with failure of single agent chemotherapy. However, proper care should be considered to prevent and reduce EMA/EP hematologic toxicity.
EMA/EP regimen, Chemotherapy, Gestational trophoblastic neoplasia
210
213
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-717-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/22
1396/7/30
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/30
1396/11/10
Soheila
Aminimoghaddam
Department of Gynecology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
Aminimoghaddam.s@iums.ac.ir
00319475328460038804
00319475328460038804
Yes
Forough
Nezhadisalami
Department of Gynecology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
forough.salami1396@gmail.com
00319475328460038805
00319475328460038805
No
Shabnam
Anjidani
Iran University of Medical Sciences, Tehran, Iran.
shabnam88anjidani@gmail.com
00319475328460038806
00319475328460038806
No
Saeedeh
Barzin Tond
Department of Gynecology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
saeedeh.barzin@yahoo.com
00319475328460038807
00319475328460038807
No
en
Effects of private and public health expenditure on health outcomes among countries with different health care systems: 2000 and 2014
Background: In the recent decades, most studies have paid more attention to community expenditures in health sector and health outcomes. This study provides econometric evidence linking countries’ health expenditures to 3 health outcomes: (1) infant mortality, (2) under 5 mortality and (3) life expectancy within 4 different health care systems.
Methods: In this study, we used the econometric method to estimate the effect of health expenditure on health status. Panel data were collected and grouped for 25 countries according to the health care system over 15 years (2000-2015). The random effects model was selected over the fixed effects model based on the Hausman test to assess the effect of different factors on the 3 mentioned health outcomes.
Results: A significant relationship was found between health expenditures and health indicators. The effect of private health expenditures on health outcomes in countries with mixed health financing system and traditional sickness fund insurance was higher than public expenditures. Also, after comparing the results between different health care systems, we found that the effect of health expenditure on the health outcome in countries with national health system (NHS) was more than other health care systems.
Conclusion: To improve health status, health policymakers should focus on the factors that lie inside the health care system. Therefore, since private and public health expenditures have different effects on health outcomes in each health care system, countries should choose an optimal combination of private and public health expenditures.
Health expenditures, Health outcomes, Healthcare system, Panel data method
205
209
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3273-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/15
1395/11/27
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/17
1396/10/27
Pouran
Raeesi
Department of Health Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
raeissi2009@yahoo.com
00319475328460038808
00319475328460038808
No
Touraj
Harati-Khalilabad
Department of Health Economics, School of Health Management and Information Science, Iran University of Medical Sciences, Tehran, Iran.
toorajharati@gmail.com
00319475328460038809
00319475328460038809
Yes
Aziz
Rezapour
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
rezapoor_a57@yahoo.com
00319475328460038810
00319475328460038810
No
Samad
Azari
Department of Health Economics, School of Health Management and Information Science, Iran University of Medical Sciences, Tehran, Iran.
samadazari1010@gmail.com
00319475328460038811
00319475328460038811
No
Javad
Javan-Noughabi
Dezful University of Medical Sciences, Dezful, Iran.
javadjavan_68@yahoo.com
00319475328460038812
00319475328460038812
No
en
A double blind randomized clinical trial to investigate the effect of vitamin D supplementation on metabolic and hepato-renal markers in type 2 diabetes and obesity
Background: According to the recent studies, vitamin D deficiency has been correlated with progress in type 2 Diabetes and Metabolic Syndrome. The aim of this study was to assess the effect of vitamin D supplementation on glucose and lipid profiles, blood pressure, and biomarkers of liver and kidney in type 2 diabetic patients.
Methods: In this Double blinded randomized clinical trial, 90 patients with type 2 diabetes and serum 25-Hydroxy vitamin D levels of less than 30 ng/ml recruited from “Besat Diabetes Clinic” in Rasht, North of Iran. The subjects took 50000 IU vitamin D supplements or placebo for 8 weeks. We assessed the levels of serum 25 (OH) vitamin D, glucose and lipid profiles, oxidative and inflammatory indices, liver and kidney biomarkers, blood pressure, and sun exposure time, physical activity before and after intervention, and compared them between cases and controls.
Results: Vitamin D supplementation significantly increased serum vitamin D level, Superoxide Dismutase (SOD) activity, and significantly decreased serum HbA1C (Glycosylated Hemoglobin) level (p<0.001). High Density Lipoprotein (HDL) Cholesterol increased significantly (p=0.016), and Erythrocyte Sedimentation Rate (ESR) significantly decreased (p=0.039) after the intervention.
Conclusion: Our results represented that weekly supplementation with 50000 IU vitamin D for 8 weeks may be effective by improving HbA1C and lipid profile in type 2 diabetes mellitus.
Vitamin D, Glucose, Diabetes, Lipid, Diet, Nutrition, Liver, Kidney, Type 2 diabetes, Inflammation
201
204
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3755-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/23
1396/10/2
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/28
1396/12/9
Peivasteh
Safarpour
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Peivastehsafarpour@yahoo.com
00319475328460038797
00319475328460038797
No
Mohammad Reza
Vafa
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Rezavafa@yahoo.com
00319475328460038798
00319475328460038798
Yes
Fatemehsadat
Amiri
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
f.amiri58@yahoo.com
00319475328460038799
00319475328460038799
No
Leila
Janani
Department of Biostatistics, School of Public Health, Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran.
Leila_Janani@yahoo.com
00319475328460038800
00319475328460038800
No
Mitra
Noorbakhsh
Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Nourbakhsh.m@iums.ac.ir
00319475328460038801
00319475328460038801
No
Ensieh
Rajabpour Nikoo
ncnikoo2@gmail.com
00319475328460038802
00319475328460038802
No
Homa
Sadeghi
Department of Epidemiology, School of Massachusetts Lowell, Massachusetts, USA.
homa.sadeghi@gmail.com
00319475328460038803
00319475328460038803
No
en
Postural stability in patients with non-specific chronic neck pain: A comparative study with healthy people
Background: Impairment of cervical sensory input in patients with neck pain may disturb postural stability. The purpose of present study was to assess the dynamic postural stability of subjects with chronic neck pain compared to a matched control group.
Methods: In this case-control study, 22 chronic non-specific neck pain and 22 healthy individuals participated. Postural stability was measured with Techno-body Prokin tilting platform. Subjects performed balance tests under two conditions: eyes opened and closed. The parameters for assessment of postural stability were total stability index (TSI), anteroposterior stability index (APSI), mediolateral stability index (MLSI), and trunk deviation which demonstrated total trunk sway in medio-lateral and antero-posterior. We used a separate 2 (group) by 2 (postural difficulty) mixed-design analysis of variance (ANOVA) for analysis of postural performance.
Results: There were significant differences between the chronic neck pain and matched control groups in APSI, MLSI, and TSI, p<0.001 in both eyes opened and closed conditions. The trunk deviation was greater for non-specific neck pain in comparison to healthy subjects, p<0.05 in both conditions of eyes open and closed.
Conclusion: The results of this study showed that patients with chronic neck pain have poorer postural control than healthy subjects. The findings suggest that clinicians take into account the importance of dynamic postural stability assessment in patients with chronic non-specific neck pain and consider the application of intervention programs for improvement of the dynamic balance.
Chronic neck pain, Dynamic stability, Posture, Balance
196
200
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3882-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/30
1396/9/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/24
1396/12/5
Maryam
Saadat
Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
maryamsaadat2008@yahoo.com
00319475328460037628
00319475328460037628
No
Reza
Salehi
Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Rehabilitation Research Center, and Department of Rehabilitation Management, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
salehi200@yahoo.com
00319475328460037629
00319475328460037629
Yes
Hossein
Negahban
Department of Physical Therapy, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran & Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
honegahban@yahoo.com
00319475328460037630
00319475328460037630
No
Mohammad Jafar
Shaterzadeh
Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
shaterzadeh.pt@gmail.com
00319475328460037631
00319475328460037631
No
Mohammad
Mehravar
Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
mohammad.mehravar@gmail.com
00319475328460037632
00319475328460037632
No
Masumeh
Hessam
Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
hessam_ pt81@yahoo.com
00319475328460037633
00319475328460037633
No
en
The impact of rural health insurance and the family physician program on hospitalizations, a before- after study at the county level conducted in Tehran province, Iran
Background: The health insurance and family physician reform in Iran were implemented in 2005. This study was conducted to assess the effect of these reforms on avoidable hospitalizations among the rural population of Eslam-shahr County, Iran.
Methods: We conducted a before-after study in Eslam-shahr County’s single existing hospital. This county is a part of the Tehran Province of Iran. The demographic characteristics and diagnostic codes of the rural population that were hospitalized during the 2 years leading to, and after the reforms were extracted from the hospital’s electronic information system. A list of 61 three-character and 131 four-character AHs codes were developed based on the literature review. We estimated a logistic regression model which included gender and age as independent variables to assess changes in the probability of avoidable hospitalizations following reform implementation. Analyses were carried out using STATA version 13.
Results: We recorded 817 rural hospitalizations before and 967 hospitalizations after reform implementation, suggesting that hospitalization growth after the reforms was almost 18.4%. The logistic regression results show that the probability of avoidable hospitalizations after the interventions had decreased compared to before the interventions were put into place (OR: 0.46; 95% CI: 0.24-0.88). Also, the probability of AHs among the 60< year-old age group was considerably higher compared to other age groups. No statistical relationship was found between avoidable hospitalizations and gender.
Conclusion: The reforms may have had a mixed effect on hospitalization. They may result in increased hospitalizations due to responding to the unmet needs of the population, and simultaneously they may lead to a decrease in avoidable hospitalizations and eliminate the costs imposed by them upon the health system.
Family physician, Health insurance, Hospitalization, Rural health
191
195
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3235-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/30
1395/11/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/6
1396/5/15
Sedigheh
Salavati
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.
sadan.salavati.85@gmail.com
00319475328460037490
00319475328460037490
No
Arash
Rashidian
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.
arashidian@gmail.com
00319475328460037491
00319475328460037491
Yes
Sara
Emamgholipour
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.
s-emamgholipour@tums.ac.ir
00319475328460037492
00319475328460037492
No
Vida
Varahrami
Department of Economics, School of Economics and Political Sciences, Shahid Be-heshti University, Tehran, Iran.
vida.varahrami@gmail.com
00319475328460037493
00319475328460037493
No
en
Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies
Background: Various treatments are used to prolong survival and improve quality of life (QOL). The purpose of this study was to assess the change in QOL scores in patients with Oesophagogastric (OG) cancer undergoing curative intent and palliative therapy.
Methods: This was a mix-designed cohort study with a consecutive sampling of patients with OG cancer who underwent curative or palliative treatment regimens. The QOL, as a determinant of efficacy and impact of cancer care, was evaluated using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires. QOL data were collected from the eligible subjects at three points of time. The repeated measurement test was used to compare the significance of change in scores.
Results: Overall, 149 patients (54.4% male, 61.1% curative intent, 52.3% esophageal, 37.6 % gastric, 10.1% OG junction cancer; with mean age 62 year) with OG cancer were eligible for inclusion in the study. Compared to the palliative group, the curative group was more likely to have an esophageal tumor site, Squamous Cell Carcinoma, and stage 2 (versus stomach, Adenocarcinoma, and stage 4 in the palliative group). In comparing the patients' functional, global health status, and cancer symptom, considering time, group of treatment, and their mutual effect the result indicated significant difference between the intervention groups.
Conclusion: Most patients with Oesophagogastric cancer are diagnosed with an incurable form of the disease. Hence in absence of curative treatment, palliative therapy is the most effective therapy to maintain patient independency and relieve pain and symptom in order to improve their QOL. The present study has shown that palliative similar to curative intervention can improve the QOL in cancer patient especially in short term.
Oesophagogastric cancer, Health-related quality of life, EORTC QLQ-OG25, EORTC QLQ-C30, Repeated measurement analysis, Iran.
182
190
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3009-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/11
1395/10/22
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/29
1396/9/8
Mohsen
Asadi-Lari
Department of Epidemiology and Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
asadilari@iums.ac.ir
00319475328460037494
00319475328460037494
No
Fatemeh
Homaei-Shandiz
Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
homaeef@mums.ac.ir
00319475328460037495
00319475328460037495
No
Ali
Esmaeili-Hesari
Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
esmaeilia1@mums.ac.ir
00319475328460037496
00319475328460037496
Yes
en
Short-term effects of air pollution on respiratory mortality in Ahvaz, Iran
Background: Urban air pollutants may affect respiratory mortality. This study was conducted to investigate this effect in Ahvaz, one of the most polluted cities in the world.
Methods: The impact of 7 major air pollutants including O3, PM10, NO2, CO, and SO2 were evaluated on respiratory mortality in different gender and age groups using a quasi-Poisson, second degree polynomial constrained, distributed lag model, with single and cumulative lag structures adjusted by trend, seasonality, temperature, relative humidity, weekdays, and holiday. Data were analyzed using the dlnm package in R x64 3.2.5 software. Significance level was set at less than 0.05.
Results: In adjusted models, for each IQR increase of O3 in the total population, the risk ratio (RR) for respiratory deaths in 0 to 14- day lags was, respectively, 1.009 (95% CI:1.001-1.016) and 1.009 (95% CI:1.002-1.017), and it was 1.021 (95% CI: 1.002-1.040) in cumulative 0 to 14- day lags. For PM10, in the total population and in adjusted models after 0 to 14- day lags and in cumulative lags of 0 to 14 for an IQR increase in the mean concentration of PM10, the RR for respiratory deaths increased significantly and was, respectively, 1.027 (95% CI:1.002-1.051), 1.029 (95% CI:1.006-1.052), and 1.065 (95% CI:1.005-1.128). NO2 showed a significant association with respiratory deaths only in the 18 to 60 year- old age group and in 9- day lags (RR= 1.318, 95% CI:1.002-1.733). Finally, the results showed that for an IQR increase in the mean concentration of CO and SO2, the adjusted RR for respiratory deaths in 9- day lags in the total population was, respectively, RR= 1.058 (95% CI:1.008-1.111) and 1.126 (95% CI:1.034-1.220).
Conclusion: Air pollution in Ahvaz is probably causing increased respiratory mortality.
Short-term effects, Air pollution, Respiratory mortality, Ahvaz
173
181
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-922-8&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/20
1395/11/1
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/9
1396/8/18
Maryam
Dastoorpoor
Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
mdastoorpour@yahoo.com
00319475328460037497
00319475328460037497
No
Narges
Khanjani
Environmental Health Engineering Research Center, Kerman University of Medical Sciences, Kerman, Iran.
nkhanjani@kmu.ac.ir
00319475328460037498
00319475328460037498
No
Abbas
Bahrampour
Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
00319475328460037499
00319475328460037499
No
Gholamreza
Goudarzi
Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Environmental Technologies Research Center (ETRC), Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
gh.goodarzi@ajums.ac.ir
00319475328460037500
00319475328460037500
No
Hamidreza
Aghababaeian
Nursing and Emergency Department, Dezful University of Medical Sciences, Dezful, Iran.
hamidrezaaghababaeian@yahoo.com
00319475328460037501
00319475328460037501
No
Esmaeil
Idani
Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
esmaileidani@gmail.com
00319475328460037502
00319475328460037502
Yes
en
Effects of vitamin D optimization on quality of life of patients with fibromyalgia: A randomized controlled trial
Background: Numerous studies have been conducted to evaluate the frequency of hypovitaminosis D in patients with fibromyalgia syndrome (FMS) and its association with FMS symptoms. This study aimed at assessing the effect of hypovitaminosis D on the symptoms and quality of life of patients with fibromyalgia.
Methods: A total of 74 FMS patients with hypovitaminosis D were randomly assigned into group A (Trazodone 25 mg at bedtime + vitamin D 50 000 IU weekly) and group B (Trazodone 25 mg at bedtime + placebo). Serum vitamin D level, Widespread Pain Index (WPI), Fibromyalgia Impact Questionnaire (FIQ), Pittsburgh Sleep Quality Index (PSQI), and Short Form Health Survey (SF-36) were used at the beginning of the treatment and 4 and 8 weeks post treatment.
Results: Significant improvements were observed in WPI, FIQ, and PSQI scores in both groups. Moreover, combination of vitamin D and Trazodone resulted in significant improvement of SF-36 scores compared to Trazodone therapy. Improvement in pain-related indices including the WPI and the physical component score (PCS) fraction of SF-36 was more noticeable in vitamin D/Trazodone combination therapy.
Conclusion: This study suggests that vitamin D supplementation has significant therapeutic benefits in the management of FMS, especially in pain reduction of patients with fibromyalgia. According to our results, a combination of vitamin D supplements and a conventional antidepressant, when given to vitamin D-deficient fibromyalgia patients, could significantly improve both physical and psychological symptoms.
Fibromyalgia syndrome, Vitamin D, Pain, Quality of life
167
172
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2649-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/13
1396/2/23
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/15
1396/5/24
Alireza
Mirzaei
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
mirzaeialireza26@gmail.com
00319475328460037503
00319475328460037503
No
Mozhdeh
Zabihiyeganeh
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
Mozhdehzabihi@gmail.com
00319475328460037504
00319475328460037504
Yes
Seyed Adel
Jahed
Research Center for Prevention of Cardiovascular Diseases, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
adeljahed@yahoo.com
00319475328460037505
00319475328460037505
No
Elnaz
Khiabani
Hematology- Oncology Department, Emam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
khiabani_e@yahoo.com
00319475328460037506
00319475328460037506
No
Marzieh
Nojomi
Preventive Medicine & Public Health Research Center, Department of Community Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mnojomi@gmail.com
00319475328460037507
00319475328460037507
No
Salman
Ghaffari
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
orthosalman@yahoo.com
00319475328460037508
00319475328460037508
No
en
Designing a model of hospital information system acceptance: Organizational culture approach
Background: The significance and influence of organizational culture on Information Technology acceptance, especially in healthcare field, has been recognized as a source of organizational inertia. This study aimed at developing a model of Hospital Information System (HIS) acceptance for non-teaching hospitals of Iran University of Medical Sciences to encourage the authorities to promote organizational culture and successful application of HIS.
Methods: The proposed model was developed according to Michigan Organizational Assessment Questionnaire (MOAQ), Harrison, Hofstede models, and Comparative Values Framework (CVF). The questionnaires were designed based on the model and distributed among 400 HIS users in the hospitals under study, who were selected using stratified random sampling. The structural equation modeling method was used for data analysis in LISREL software.
Results: According to the final model, the influences of developmental culture on perceived usefulness, the relationship of 4 types of organizational culture with mandatoriness according to CVF, and the relationships of hierarchical and developmental culture with system use were attested. The relationships between supervision and 4 variables of HIS acceptance were confirmed. Furthermore, the influence of process/ result oriented culture on user satisfaction was demonstrated. The normed chi square index (2.60) revealed that the final model was fitted to the data. The indices were as follow: GFI= 0.95, CFI= 0.97, AGFI= 0.88, RMSEA= 0.064.
Conclusion: The components and structural relationships in the model of this study are applicable in the related hospitals, and using this model can promote organizational culture and acceptance of HIS by the users.
Hospital information system, Hospitals, Technology, Organizational culture
158
164
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1797-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/10
1395/1/22
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/20
1396/3/30
Seyed Jamaledin
Tabibi
Department of Health Services Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.
sjtabibi@yahoo.com
00319475328460037468
00319475328460037468
No
Parvin
Ebrahimi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran & Department of Health Services Management, School of Health Management and Medical Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
parvin_eb@yahoo.com
00319475328460037469
00319475328460037469
Yes
Mozhgan
Fardid
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
mfardid@gmail.com
00319475328460037470
00319475328460037470
No
Mir Sajad
Amiri
Statistics and Information Technology Office, Iran University of Medical Sciences, Tehran, Iran.
amiri.s@iums.ac.ir
00319475328460037471
00319475328460037471
No
en
The effect of hormone therapy on bone mineral density and cardiovascular factors among Iranian female athletes with amenorrhea/oligomenorrhea: A randomized clinical trial
Background: Functional hypothalamic menstrual disorder (FHMD) has a destructive effect on the athlete’s bone mineral density and cardiovascular system. Utilizing hormone replacement therapy to treat FHMD in athletes is controversial.
This study was conducted to examine the effect of hormone therapy on bone density and the cardiovascular system of professional female athletes with FHMD.
Methods: In this study, 18 female athletes with at least a 2- year history of FHMD were recruited in a 9-month single blind randomized clinical intervention (RCT) and randomly classified into 2 groups: the oral contraceptive pills (OCP) group, who received a low-dose combined oral contraceptive (OC) containing 30 µg ethinyl estradiol and 150 µg levonorgestrel (n= 10), and the control group (n = 8). Bone mineral densitometry (BMD) and certain cardiovascular risk factors were measured before and after the 9-month trial. The Chi square test was used to compare the quantitative and qualitative results.
Results: Bone mineral density did not change significantly in either group. Very low density lipoprotein (VLDL) (p= 0.035) and Apolipoprotein B (Apo B) (p= 0.04) reduced significantly in the OCP group. An increase was observed in the serum levels of Apolipoprotein A (Apo A) (p= 0.01) in the control group. Changes in the Apo B to Apo A ratio was significant in both groups (OCP group: p= 0.018, control group: p= 0.040). No significant changes were observed in the other measured factors.
Conclusion: Although the administration of estrogen did not significantly increase bone mineral density, it had positive effects on the cardiovascular system and lipid profile.
Functional hypothalamic menstrual disorder (FHMD), Hypoestrogenism, Bone density, Cardiovascular risk factor, Hormone therapy, OCP (oral contraceptive pills)
151
157
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1121-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/24
1392/12/5
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/11
1396/3/21
Haleh
Dadgostar
Department of Sports and Exercise Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
hldadgostar@gmail.com
00319475328460037472
00319475328460037472
No
Ghazaleh
Soleimany
Department of Sports and Exercise Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
hldadgostar@gmail.com
00319475328460037473
00319475328460037473
Yes
Shafieh
Movaseghi
Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
movaseghi@gmail.com
00319475328460037474
00319475328460037474
No
Elham
Dadgostar
Sports Medicine Federation of Islamic Republic of Iran, Tehran, Iran.
edadgostar@gmail.com
00319475328460037475
00319475328460037475
No
Sara
Lotfian
Department of Sports and Exercise Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
saralotfiyan@yahoo.com
00319475328460037476
00319475328460037476
No
en
Developing attributes and levels for a discrete choice experiment on basic health insurance in Iran
Background: Nonmarket stated preferences valuation, especially discrete choice experiments (DCEs), is one of the commonly used techniques in the health sector. The primary purpose of this approach is to help select attributes and attributes-levels that are able to properly describe health care products or services. This study aimed at developing attributes and attributes-levels for basic health insurance system in Iran.
Methods: This study was conducted in 3 phases. First, narrative review was performed to identify related attributes. Also, 9 experts were interviewed to identify relevant attributes of health insurance in context. Other 36 experts rated the attributes and levels. Then, the research team decided on the inclusion of attributes and levels in the final design. The design was constructed using generic and D-efficient method with SAS 9.1. The design was divided into 3 blocks, each having 8 choice sets. Finally, the choice set was piloted with 45 participants.
Results: Public hospitals, and private hospitals benefits, dental insurance coverage, inpatient benefits, rehabilitation therapy, and paraclinical benefits, long-term care, medical devices benefits (Ortez, Protez, etc.), and monthly premium were identified and included in the final attribute design (D-efficiency = 98.16). The pilot study revealed that participants could easily understand and answer all the choice sets.
Conclusion: The results of our study indicated that health insurance service benefit packages and premium were among the most important attributes that need to be included in the final attribute design for Iranians. The policymakers and health insurance organizations should emphasize these attributes in the benefit packages to make improvements. The emphasis on these attributes can help elicit people’s preferences and willingness to pay for attributes.
Discrete choice experiment (DCE), Conjoint analysis, Attributes, Attribute-levels, Health insurance, Iran
147
150
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2917-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/2
1395/6/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/10
1396/4/19
Ali
Kazemi Karyani
Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
alikazemi.k20@gmail.com
00319475328460042560
00319475328460042560
No
Arash
Rashidian
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences. Tehran, Iran.
arashrashidian@gmail.com
00319475328460042561
00319475328460042561
Yes
Ali
Akbari Sari
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences. Tehran, Iran.
akbarisari@tums.ac.ir
00319475328460042562
00319475328460042562
No
Sara
Emamgholipour Sefiddashti
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences. Tehran, Iran.
s-emamgholipour@tums.ac.ir
00319475328460042563
00319475328460042563
No
en
The effect of low-frequency repetitive transcranial magnetic stimulation (rTMS) on the treatment of aphasia caused by cerebrovascular accident (CVA)
Background: Aphasia is a common outcome of Cerebrovascular Accident (CVA) in which clinical interventions have limited effectiveness. Some evidence suggests that noninvasive stimulation of the brain can have beneficial effects in the treatment of CVA induced aphasia. In patients with motor aphasia, repetitive Transcranial Magnetic Stimulation (rTMS) is used to facilitate long-term improvement in speech ability. Since identifying effective methods for treating CVA induced aphasia can be very important in subsequent decision-making and treatment interventions, the objective of this study was to evaluate the effect of low-frequency TMS in Broca’s area in the right hemisphere on the treatment of CVA induced motor aphasia.
Methods: This clinical trial enrolled 24 patients with a clinical diagnosis of motor aphasia caused by CVA using convenient sampling. In this study, the effect of stimulation of Broca’s area in the right hemisphere was examined by low-frequency rTMS (one Hz) on aphasia caused by CVA. To conduct verbal fluency test in patients, their correct responses to the selected images before and after rTMS during a certain time were recorded and compared by non-parametric Wilcoxon test using SPSS16 and the significance level was considered <0.05. Registration ID of this research in IRCT is IRCT2014052417814N1.
Results: The study findings suggested a significant difference between Wilcoxon test results of patients before and after rTMS (z= -4.401), and it was found that using low-frequency rTMS in the right hemisphere was effective on improving dysarthria in the study population with 95 percent confidence interval (p<0.001).
Conclusion: According to the findings, low-frequency rTMS has the potential to be considered as a treatment for patients with non-fluent aphasia caused by CVA.
Repetitive Transcranial Magnetic Stimulation (rTMS), Aphasia, Cerebrovascular Accident (CVA)
142
146
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1797-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/29
1394/6/7
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/3
1396/5/12
Manouchehr
Ilkhani
Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
00319475328460042574
00319475328460042574
No
Hassan
Shojaie Baghini
School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
00319475328460042575
00319475328460042575
No
Gohar
Kiamarzi
Dr. Ilkhani Electroneurodiagnostic Center, Tehran, Iran.
00319475328460042576
00319475328460042576
No
Alipasha
Meysamie
Community and Preventive Medicine Department, Medical Faculty, Tehran University of Medical Sciences, Tehran, Iran.
00319475328460042577
00319475328460042577
No
Parvin
Ebrahimi
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran, & Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
parvin_eb@yahoo.com
00319475328460042578
00319475328460042578
Yes
en
Bayesian Zero- Inflated Poisson model for prognosis of demographic factors associated with using crystal meth in Tehran population
Background: Use of methamphetamine (MA) and other stimulants has increased steadily over the past 10 years. Risk factor evaluation to reduce the problem in the community is one solution to protect people from addiction. This study aimed at using Bayesian zero- inflated Poisson (ZIP) model to investigate the relationship between the number of using crystal meth and some demographic factors in Tehran population.
Methods: A cross-sectional study was conducted to investigate crystal meth abuse in Tehran, the capital of Iran, in 2012. Stratified sampling method was used to select samples from 22 urban areas of Tehran. Trained researchers referred to the public places, such as streets, parks, squares, and libraries, to perform face-to-face interviews with the randomly selected samples. Bayesian ZIP model was used to perform the analysis, and SAS 9.3 program was used for data analysis.
Results: A total of 993 individuals were studied. According to Bayesian ZIP model, sex (mean= -0.27, 95%CI (-0.485, -0.061)), age (mean= 0.03, 95%CI (0.018, 0.043)), high school level education (mean= 1.276, 95%CI (0.699, 01.9)), diploma level education (mean= 10.4, 95%CI (0.511, 1.69)), and university level education (mean= 0.69, 95%CI (0.142, 1.33)) were all found to have significant associations with crystal meth usage, being the dependent variable.
Conclusion: Males, those with higher education levels, and older people in Tehran population are more likely to use crystal meth. This demographic information may be useful in designing preventive programs. Moreover, it is better to analyze count data with excessive zeroes using Bayesian zero- inflated model instead of the usual count models.
Bayesian analysis, Crystal meth, Zero-inflated Poisson, Tehran population
136
141
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2882-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/16
1395/5/26
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/23
1396/7/1
Asma
Pourhoseingholi
Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Department of Biostatistics, Faculty of Paramedical Sciences, Students’ Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
asma.phg@gmail.com
00319475328460042550
00319475328460042550
No
Ahmad Reza
Baghestani
Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
baghestani.ar@gmail.com
00319475328460042551
00319475328460042551
No
Erfan
Ghasemi
Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ghasemi.erfan@gmail.com
00319475328460042552
00319475328460042552
No
Alireza
Akbarzadeh Baghban
Proteomics Research Center, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
akbarzad@sbmu.ac.ir
00319475328460042553
00319475328460042553
Yes
Mariet
Ghazarian
Deputy of Drug Prevention and Treatment, State Welfare Organization, Tehran, Iran.
mariet_gh@yahoo.co.uk
00319475328460042554
00319475328460042554
No
en
Expression of Cytokeratin 19 in the epithelial cell of Azo-exposed buccal mucosa
Background: Azo is a synthetic dye used in batik industries. It can be toxic to the tissue when exposed via inhalation, swallowing, or direct contact. Expression of cytokeratin will change in hyperplastic and cancer of the oral mucosa. Expression of Cytokeratin 8, 18, 19 is strong in the epithelial cells that undergo excessive hyperproliferation and oral mucosal changes in leukoplakia and squamous stratification carcinoma. The present study was conducted to analyze the expression of Cytokeratin 19 in the epithelial cells of azo-exposed buccal mucosa.
Methods: A total of 30 males were divided into 2 groups of azo-exposed and controls equally. Criterion for azo-exposed participants was working at batik coloring division for at least 5 years, while the controls were the ones who were not exposed to azo dyes. Exfoliative cytology using cytobrush was the method of collecting buccal mucosal epithelial cells. Expression of Cytokeratin 19 was analyzed using Cytokeratin 19 monoclonal antibody and immunohistochemical staining. Data were analyzed using independent samples t test in SPSS 13.0 software.
Results: There was a negative expression on the controls, while positive expression was observed in the exposed group. T test analysis showed significant differences (p<0.001) in the positive expression of the exposed group (97.600±2.063) compared to controls (3.133±1.641).
Conclusion: Azo dye could increase the expression of Cytokeratin 19 on buccal mucosa epithelial cells.
Buccal mucosa, Cytokeratin 19, Epithelial cell, Exposed-azo dye
132
135
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3616-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/8
1396/5/17
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/9
1396/8/18
Juni
Handajani
Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Indonesia.
junihandajani@ugm.ac.id
00319475328460037059
00319475328460037059
Yes
Lisdrianto
Hanindriyo
Department of Preventive and Community Dentistry, Faculty of Dentistry, Universi-tas Gadjah Mada, Indonesia.
00319475328460037060
00319475328460037060
No
en
Primary development and validation of a quantitative health policy impact assessment tool (HEPIAT): The case of Iranian targeted subsidy plan
Background: As a primary phase of a Health Impact Assessment (HIA) on the Iranian Targeted Subsidy Plan (TSP), this study was conducted to assess the psychometric properties of a newly developed quantitative Health Policy Impact Assessment Tool (HEPIAT).
Methods: In 2014, multistage cluster sampling was employed to recruit 509 key informants in Sanandaj, Iran, to participate in this cross-sectional study. A comprehensive literature review was conducted to develop the initial draft of HEPIAT. Content validity was determined by a consensus panel of experts, and construct validity and factor structure of the HEPIAT were assessed using Exploratory Factor Analysis (EFA). Reliability was assessed utilizing the Cronbach’s alpha coefficient and the test– retest reliability coefficient.
Results: Applying EFA, the optimal solution including 35 items and 6 factors was emerged, which accounted for 64.94% of the total variance. The mean items’ relevancy, clarity, simplicity, and their total mean±SD score were 88.3±0.2, 90.1±0.5, 86.1±0.7, and 89.6±0.4, respectively. The scores of intra-class correlation coefficients (ICC) and internal consistency reliability for all the factors were ranged from 0.67 to 0.89. HEPIAT demonstrated an appropriate validity, reliability, functionality, and simplicity.
Conclusion: Although further works in different settings are warranted, HEPIAT may be a practical and useful quantitative instrument in socioeconomic-related HIAs aimed to inform policymakers and stakeholders on the health impacts of their decisions and plans.
Health impact assessment, Targeted subsidy plan, Instrumentation, Health determinants, Healthy public policy
124
131
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2714-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/14
1395/2/25
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/24
1396/5/2
Haidar
Nadrian
Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran & Department of Health Education and Promotion, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
haidarnadrian@gmail.com
00319475328460036843
00319475328460036843
Yes
Towhid
Babazadeh
Department of Health Education and Promotion, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
towhidbabazadeh@gmail.com
00319475328460036844
00319475328460036844
No
Nadia
Nadrian
School of Psychology and Training Sciences, Islamic Azad University-Sanandaj Branch, Sanandaj, Iran.
nadia.nadrian@gmail.com
00319475328460036845
00319475328460036845
No
Hassan
Mahmoodi
Department of Health Education and Promotion, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
hassanmahmoodi@gmail.com
00319475328460036846
00319475328460036846
No
Anvar
Khosravi
School of Human Sciences, Islamic Azad University-Sanandaj Branch, Sanandaj, Iran.
khosravi_a@yahoo.com
00319475328460036847
00319475328460036847
No
en
Mutation analysis of Phenylalanine hydroxylase gene in Iranian patients with Phenylketonuria
Background: Phenylketonuria as the most common genetic metabolic disorder is the result of disruption of the phenylalanine hydroxylase gene. This study was carried out to explore the phenylalanine hydroxylase gene mutation status of Iranian phenylketonuria patients.
Methods: Blood samples were collected from 30 patients, and hot spot areas of the phenylalanine hydroxylase gene, including exons 6, 7, 8, 11, and 12 were studied through polymerase chain reaction and sequencing techniques.
Results: Eight different mutations, including 5 missense mutations, 1 splice mutation, 1 nonsense mutation, and 1 Silent/Splice mutation were detected. These mutations were R243X, R261Q, R261X, P281L, R241C, V399V, E280K, and IVS11+1G>C. V399V and R241C were reported for the first time in Iranian population. Three polymorphisms including Q232Q, V245V and L385L and 3 novel intronic variants including IVS10-15A>C, IVS6+44T>G, and IVS6+36 T>G were also detected in this study.
Conclusion: The results of this study prove the heterogeneous status of phenylalanine hydroxylase gene mutations in the Iranian population, which can be useful in carrier testing and genetic counseling.
Phenylketonuria, Phenylalanine hydroxylase gene, Sequencing, Mutation, Iran
119
123
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3612-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/2
1396/5/11
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/30
1396/6/8
Mahsa
Rastegar Moghadam
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
mmoghadam76@yahoo.com
00319475328460036838
00319475328460036838
No
Azadeh
Shojaei
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
a_shojaei2007@yahoo.com
00319475328460036839
00319475328460036839
No
Vahid
Babaei
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Vahidbabaei2012@yahoo.com
00319475328460036840
00319475328460036840
No
Farzaneh
Rohani
Department of Pediatrics Endocrinology and Metabolism, Ali Asghar Children’s Hospi-tal, Iran University of Medical Sciences, Tehran, Iran.
dr_rohani@yahoo.com
00319475328460036841
00319475328460036841
No
Farideh
Ghazi
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ghazi.f@iums.ac.ir
00319475328460036842
00319475328460036842
Yes
en
The prophylactic effect of different levels of positive end-expiratory pressure on the incidence rate of atelectasis after cardiac surgery: A Randomized Controlled Trial
Background: The use of positive end-expiratory pressure (PEEP) can have an important role as one of the ways to prevent and treat atelectasis, but it seems that there is still no consensus about its beneficial level. The aim of this study was to determine the effect of different levels of PEEP on the incidence of atelectasis after heart surgery.
Methods: This is a double-blind randomized controlled trial that was adopted from a research project recorded in the Iranian Registry of Clinical Trials. This paper is the result of a research project undertaken at Fatemeh Zahra Hospital (Mazandaran Heart Center) in 2015. 180 patients underwent open heart surgery were selected and were divided randomly into three groups: control, PEEP=8, and PEEP=10 (60 in each group). The patients in the two PEEP8 and PEEP10 intervention groups separately received 8 cm H2O and 10 cm H2O PEEP, respectively, 30 minutes after admission to the ICU for 4 hours and then received 5 cm H2O PEEP until extubation. Atelectasis was examined two hours after the extubation and on the third day after surgery.
Results: The incidence rates of atelectasis two hours after extubation on the first day of surgery were 22 (36.7%), 20 (33.3%) and 10 (16.7%) patients in the control, PEEP8 and PEEP10 groups, respectively. The differences were statistically significant among the three groups (p=0.035). The incidence rates of atelectasis on the third day after surgery were 39 (65%), 36 (60%) and 21 (35%) patients in the control, PEEP8 and PEEP10 groups, respectively. The differences were also statistically significant among the three groups (p=0.003).
Conclusion: The use of 10 cm H2O PEEP can lead to a reduction in the incidence of atelectasis, intubation time at the ICU and length of ICU and hospital stay. Given that this level of PEEP is effective, this method is recommended to be used in postoperative care of patients.
Positive End-Expiratory Pressure, Postoperative pulmonary complications, Atelectasis, Cardiac Surgery, Hemodynamic indices, Oxygenation indices.
111
118
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3353-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/24
1396/1/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/30
1396/7/8
Mostafa
Setak Berenjestanaki
Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
mostafa.sattak.cn@gmail.com
00319475328460036832
00319475328460036832
No
Masoumeh
Bagheri-Nesami
Pediatric Infectious Diseases Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Anna3043@gmail.com
00319475328460036833
00319475328460036833
Yes
Afshin
Gholipour Baradari
Department of Anesthesiology and Critical Care, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
gholipourafshin@yahoo.com
00319475328460036834
00319475328460036834
No
Seyed Nouraddin
Mousavinasab
Associate Professor, Department of Biostatistics, Faculty of Hygiene, Mazandaran University of Medical Sciences , Sari, Iran
snmn1337@yahoo.com
00319475328460036835
00319475328460036835
No
Rahman
Ghaffari
Department of Biostatistics, Faculty of Hygiene, Mazandaran University of Medical Sciences, Sari, Iran.
rahman.ghaffari@gmail.com
00319475328460036836
00319475328460036836
No
Manije
Darbheshti
Department of Radiology, Mazandaran Heart Center, Sari, Iran.
m.darbeheshti@gmail.com
00319475328460036837
00319475328460036837
No
en
Utilization and out of pocket (OOP) payment for physiotherapy services in public hospitals of Shahid Beheshti University of Medical Sciences
Background: Physiotherapy services constitute a principle part of health care systems, and interest in their use has increased in the recent decades. This study was conducted to investigate the utilization and OOP payment for physiotherapy services in public hospitals of Shahid Beheshti University of Medical Sciences in Tehran, Iran.
Methods: This cross-sectional study was conducted using the data of physiotherapy department of three public hospitals. The study sample included 6528 patients who had received 7257 episodes of care. Data were extracted through hospital information systems and analyzed using multivariate regression analysis by SPSS17.
Results: The average episode per patient was 1.11 and 12.6 session per episode. The average cost of each episode and treatment session was 1 784 660 IRR (USD 59) and 142 023 IRR (USD 4.7), respectively. The OOP payment share for physiotherapy was 31%. Age, OOP amount, having insurance coverage, insurance type, and service type significantly affected physiotherapy utilization. Number of treatment sessions, having insurance coverage, type of insurance coverage, and gender were related to OOP payment.
Conclusion: There is a large variety in utilization and OOP payment in the insurance funds, which could restrict the accessibility and utilization of services by patients, leading to inequalities in utilization. Therefore, policymakers should conduct an overall review on the tariffs and service packages of insurer organizations to provide better conditions for the elderly, unhealthy, and vulnerable population to mitigate inequality in service utilization and decrease OOP payment.
Utilization, Out of pocket (OOP) payment, Physiotherapy, Outpatient service, Public hospitals
105
110
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2049-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/15
1395/10/26
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/17
1396/6/26
Ehsan
Zarei
Department of Public Health, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
zarei_1980@yahoo.com
00319475328460036773
00319475328460036773
No
Adeleh
Nikkhah
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
adele_nickhah@yahoo.com
00319475328460036774
00319475328460036774
No
Behrouz
Pouragha
Department of Public Health, School of Health, Alborz University of Medical Sciences, Karaj, Iran.
pouragha@gmail.com
00319475328460036775
00319475328460036775
Yes
en
Recurrence rate of radial deviation following the centralization surgery of radial club hand
Background: Congenital radial club hand (RCH), as a rare congenital deformity of the upper extremity, is characterized by a wide spectrum of malformations including radial deviation. Centralization surgery is the standard treatment for severe cases that have been associated with a high rate of recurrence. This study reports the long-term results and recurrence rate of radial deviation following the centralization surgery of RCH.
Methods: The medical records of 13 congenital RCH patients (16 hands), who underwent centralization surgery, were reviewed retrospectively. Hand-forearm angle (HFA), hand-forearm position (HFP), and ulnar bow (UB) were used to assess forearm angles.
Results: The mean age of the patients was 19.4±8.9 months, and their mean follow-up was 62.1±39.9 months. The mean HFA correction was 29.4°±23.9°, the mean HFA recurrence was 13.3°±13.7°, the mean correction of HFP was 13.4±7.3 mm, and the mean recurrence of HFP was 1.4±2.8 mm. The mean UB showed 7.6°±12.5° correction immediately after surgery and a further 3.6°±7.3° at the last follow-up (overall 11.2°±17.6°). A number of 12 out of 13 parents were completely satisfied with the results.
Conclusion: According to our results, an acceptable long-term result is expected after the centralization surgery of RCH. However, the risk of the recurrent radial deviation is high and needs to be optimized in future investigations.
Radial club hand, Radial deviation, Centralization, Recurrence
100
104
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3409-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/28
1396/2/8
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/22
1396/4/31
Farid
Najd Mazhar
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
fnajdmazhar@yahoo.com
00319475328460037172
00319475328460037172
No
Hooman
Shariatzadeh
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
shariatzadeh_h@hotmail.com
00319475328460037173
00319475328460037173
No
Morteza
Balvardi
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
dr.balvardi62@yahoo.com
00319475328460037174
00319475328460037174
No
Morteza
Nakhaei Amroodi
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
drmna@yahoo.com
00319475328460037175
00319475328460037175
No
Alireza
Mirzaei
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
mirzaeialireza26@gmail.com
00319475328460037176
00319475328460037176
Yes
en
Knee osteoarthritis at the early stage: The four-week effect of lateral wedge insole on pain and risk of falls
Background: Knee osteoarthritis (KOA) is associated with a decrease in function, increase in pain and risk of falls. Lateral wedge insole (LWI) is commonly prescribed in KOA to improve pain and function. Our study aimed to 1) evaluate the clinical symptoms and risk of falls in early KOA and compare with controls; 2) evaluate the immediate and four-week effect of LWI.
Methods: A sample of 20 Persian dwelling individuals with early KOA and 19 matched controls were recruited. Pain with Visual Analogue Scale (VAS), Quality of life (QOL) with the knee injury and osteoarthritis outcome score, risk of falls with the Timed Up and Go (TUG) and static One-leg Balance (OLB) tests were assessed. The four-week effect of 5º LWI was considered for individuals with KOA. Independent t-test was done to report the between-group differences, and paired t-test was used to report the four-week effect of LWI.
Results: At baseline, statistically significant higher scores for pain, lower scores for QOL, and higher risk of falls were observed in KOA compared to controls (p< 0.001). A significant statistical decrease was observed in pain, and risk of falls, and an increase in QOL in KOA after four-week effect of LWI compared to baseline (p< 0.001).
Conclusion: People with early KOA showed higher pain and lower level of QOL that were associated with higher risk of falls. LWI may have the potential to improve clinical symptoms and reduce the risk of falls at the early stage of KOA.
Osteoarthritis, Knee, Symptoms, Accidental falls, Foot orthoses
94
99
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3394-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/21
1396/2/1
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/7
1396/5/16
Elham
Esfandiari
Department of Orthotics and Prosthetics, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
elham.esfandiari@alumni.ubc.ca
00319475328460036753
00319475328460036753
No
Mohammad Ali
Sanjari
Department of Basic Rehabilitation Sciences, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
sanjarima@alum.sharif.edu
00319475328460036754
00319475328460036754
Yes
Ali Ashraf
Jamshidi
Department of Physical Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran
jamshidi.a@iums.ac.ir
00319475328460036755
00319475328460036755
No
Mojtaba
Kamyab
Department of Orthotics and Prosthetics, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
kamyab.m@iums.ac.ir
00319475328460036756
00319475328460036756
No
Hamid Reza
Yazdi
Department of Orthopaedic Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
dr.yazdi88@yahoo.com
00319475328460036757
00319475328460036757
No
en
A new ultrasound sign in the diagnosis of pediatric maxillary sinusitis
Background: Computed tomography scans (CT scan) and X-rays are used to diagnose paediatric maxillary sinusitis. This study aimed at exploring the diagnostic value of the conventional and colour Doppler ultrasounds and their specific findings in cases of paediatric sinusitis.
Methods: A total of 60 children diagnosed with sinusitis were included in this study. The conventional and colour Doppler ultrasounds of the sinus were performed on each of them. The symptoms that suggested increased blood flow to the sinuses were interpreted as positive findings on the colour Doppler ultrasound and were named “Ghasemi signs” for the purpose of this study. Such symptoms included unilateral artery bumps on the front artery, reduction of arterial resistive index (RI) to less than 0.5, and diameter of 2 mm or above for maxillary arteries. Sensitivity, specificity, and positive and negative predictive values, and accuracy of the conventional and colour Doppler ultrasounds were also calculated.
Results: Compared to CT scan, the conventional ultrasound showed sensitivity and specificity of 73.4% and 100%, respectively. Sensitivity and specificity for the colour Doppler ultrasound were 89.36% and 100%, respectively. The maxillary artery diameter in normal and affected maxillary sinuses were, respectively, 2.4 mm (2.1–2.6, 95% CI) and 1.7 mm (1.6–1.9, 95% CI), with p<0.001. The RI of the affected sinuses were 0.47 (0.45–0.49, 95% CI), and those of the normal sinuses were 0.58 (0.54–0.61, 95% CI), with p<0.001.
Conclusion: The findings of this study revealed that the conventional ultrasound agrees with the CT scans in the diagnosis of paediatric maxillary sinusitis. This diagnostic modality becomes even more valuable when the colour Doppler is used, particularly when considering the specific symptoms (Ghasemi signs) suggested by this study.
Sinusitis, Pediatric, Ultrasound, Colour Doppler, Ghasemi sign
89
93
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2127-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/5
1395/7/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/20
1396/3/30
Ahmad
Ghasemi
Department of Radiology, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
dr.aghasemi90@gmail.com
00319475328460036750
00319475328460036750
No
Atabak
Allafasghari
Department of Radiology, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
atabak.asghari@gmail .com
00319475328460036751
00319475328460036751
No
Mani
Mofidi
Emergency Medicine Department, Rasoul Akram Hospital, Emergency Management Research Center, Iran University of Medical Sciences, Tehran. Iran.
manimofidi@yahoo.com
00319475328460036752
00319475328460036752
Yes
en
Assessment of research systems in universal health coverage-related organizations
Background: Universal health coverage (UHC) is the desired goal of achieving universal access to health services without having to endure pain and financial difficulties. Multiple factors can help steer countries toward UHC. One of the most important factors is the production of valid quality evidence that can be achieved through research. The present study aimed at outlining the status of research systems in UHC–related organizations and identifying the barriers faced by research.
Methods: The key individuals and organizations that could provide rich, relevant, and diverse data in response to the research question were purposively selected for the interviews. Thematic analysis was used to analyze the interviews. Categories and subcategories were deductively extracted from the text based on research system performance as follows: resource provision, production and utilization of knowledge, existing resources, and stewardship. Then, the themes were inductively extracted from the interviews.
Results: Many barriers existed for performing research in UHC–related organizations. The stewardship barrier seemed to play a key role such that structural changes in organizations affected the production & utilization of evidence. Limited financial and human resources were evident in most of the organizations. Research questions were not comprehensively identified. The conducted studies either were not designed to answer the relevant questions and/or were not appropriately reported to policy makers. As a result, their implementation in decision- making did not reach the ideal status.
Conclusion: Research utilization aimed at achieving UHC will come to realize only when and if research is conducted to produce evidence required for decision–making and implementation. Therefore, in addition to the interventions recommended by the World Health Organization, we should design and implement interventions tailored to the local barriers and needs of UHC–related organizations.
Universal Health Coverage, Research Systems, Iran
83
88
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1899-2&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/30
1394/6/8
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/17
1395/10/28
Bahareh
Yazdizadeh
Knowledge Utilization Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
byazdizadeh@tums.ac.ir
00319475328460036748
00319475328460036748
No
Farideh
Mohtasham
Knowledge Utilization Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
f-mohtasham@farabi.tums.ac.ir
00319475328460036749
00319475328460036749
Yes
en
ATP2B1 rs2681472 and STK39 rs35929607 polymorphisms and risk of Hypertension in Iranian Population
Background: ATP2B1 and STK39 have been introduced as essential hypertension candidate genes. The association of these genes’ variations have not been studied in Iranian population yet. Here we aimed to investigate the association of ATP2B1 rs2681472 and STK39 rs35929607 polymorphisms with the risk of hypertension in an Iranian population.
Methods: We included 400 individuals in our case-control study: 200 cases with essential hypertension and 200 healthy sex and age matched controls. All subjects were genotyped for rs2681472 and rs35929607 using a PCR-RFLP method. Genotype and allele frequencies were compared between the two groups using chi-squared test. The association was further assessed under log-additive, dominant and recessive genetic models.
Results: There was no association between rs2681472 and rs35929607 polymorphisms and risk of essential hypertension in our population (p>0.05). There was also no association between the studied polymorphisms and hypertension under different genetic models.
Conclusion: Our study indicated that rs2681472 of ATP2B1 and rs35929607 of STK39 may not have a significant effect on the risk of essential hypertension in Iranian population. More studies are still needed to validate our results.
Essential hypertension, ATP2B1, STK39, Polymorphism, Association study
78
82
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3462-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/24
1396/3/3
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/6
1396/9/15
Javad
Jamshidi
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
j.jamshidi@fums.ac.ir
00319475328460036740
00319475328460036740
No
Ali
Asnaashari
Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
asnaashari7@gmail.com
00319475328460036741
00319475328460036741
No
Reza
Alipoor
Department of Biochemistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
alipoor901.fums@yahoo.com
00319475328460036742
00319475328460036742
No
Sina
Mohammadi
Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
sina.mohammadi.19958@gmail.com
00319475328460036743
00319475328460036743
No
Sara
Roostaei
Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
s.roustaee234@yahoo.com
00319475328460036744
00319475328460036744
No
Mohammad Mahdi
Samadian
Department of Medical Genetics, Mashhad University of Medical Sciences, Mash-had, Iran.
sa_soheidl@ymail.com
00319475328460036745
00319475328460036745
No
Saiedeh
Honamrmand Aliabadi
Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
s.honarmand.s12@gmail.com
00319475328460036746
00319475328460036746
No
Ehsan
Bahramali
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran & Department of Cardiology, Fasa University of Medical Sciences, Fasa, Iran.
ebahramali@fums.ac.ir
00319475328460036747
00319475328460036747
Yes
en
Low birth weight in Iran: Implications from a systematic review of the literature and meta-analysis in the period 1999-2017
Background: Low birth weight (LBW), a crucial determinant of neonatal complications, represents a major public health concern worldwide. Epidemiological research is of crucial importance for designing and implementing ad hoc interventions for this issue, helping and guiding decision- and policy-makers in each country to prevent the increased prevalence of LBW in infants through estimating the prevalence rate, identifying and controlling major risk factors. The present investigation aimed to systematically assess LBW prevalence rate in Iran and its determinants.
Methods: PubMed/Medline via Ovid, Embase, Web of Science and Scopus as well as Magiran, SID and Irandoc were searched from inception until November 2016. Also, the grey literature (via Google Scholar) was mined. The DerSimonian-Laird model was exploited. The I2 and Q-test tests were used to investigate heterogeneity between the studies. Sensitivity and subgroup analyses were performed to ensure the robustness and validity of our findings. Different cumulative meta-analyses were conducted stratifying according to the year of publication and sample size. Any potential bias in publication was assessed carrying out the Egger’s test.
Results: LBW prevalence rate was estimated to be 8% (95%CI: 7-9) in Iran. Sensitivity analysis confirmed the stability of finding. Studies were cumulated by the year of publication, and the results did not change pre- and post-cumulative meta-analysis. No publication bias could be observed.
Conclusion: LBW prevalence rate in Iran is well comparable with the prevalence figures of both developed and developing countries. This could be due to the health reforms implemented in Iran throughout the years.
Low birth weight, Systematic review and meta-analysis, Iran
68
77
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-2047-4&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/31
1396/3/10
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/30
1396/5/8
Faezeh
Ebadi
Student Research Committee, Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
ebadi.faezeh@yahoo.com
00319475328460038999
00319475328460038999
No
Ahmad
Ghashghaee
Student Research Committee, Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran,
ahmadbala@yahoo.com
00319475328460039000
00319475328460039000
No
Nicola
Luigi Bragazzi
School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
robertobragazzi@gmail.com
00319475328460039001
00319475328460039001
No
Mariano
Martini
Section of History of Medicine and Ethics, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
mariano.yy@gmail.com
00319475328460039002
00319475328460039002
No
Razieh
Sepehrian
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
sepehrian90@gmail.com
00319475328460039003
00319475328460039003
No
Mozhgan sadat
Ghaemmohamadi
Student Research Committee, Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Ghaemmohamadi.m@gmail.com
00319475328460039004
00319475328460039004
No
Sahar Sadat
Saeedi Shahri
Student Research Committee, Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
s.s.saeedi75@gmail.com
00319475328460039005
00319475328460039005
No
Meysam
Behzadifar
Department of Epidemiology, Faculty of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.
m_behzadifar67@yahoo.com
00319475328460039006
00319475328460039006
No
Aidin
Aryankhesal
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
aryankhesal.a@iums.ac.ir
00319475328460039007
00319475328460039007
No
Masoud
Behzadifar
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
masoudbehzadifard@gmail.com
00319475328460039008
00319475328460039008
Yes
en
Measuring the net profit of laboratory services: A case study in Iran
Background: Clinical laboratories need to manage resources properly and scientifically to survive in today's highly competitive environment. In this context, scientific-economic principles should be considered to determine the profitability or loss of laboratories. Thus, in this study, the net profit of laboratory services was measured based on scientific-economic principles.
Methods: This was an applied research with descriptive-retrospective approach. A laboratory was selected from 61 laboratories of Kerman, Iran, which performed the highest number of tests among the laboratories of this city. In addition, due to easy access, it was the most visited laboratory by patients. The present study had 2 main phases: (1) measuring the price of services and (2) calculating the net profit of the studied laboratory. Data analysis was performed using activity- based costing (ABC) as an econometric model and Excel software.
Results: The highest charges were related to direct costs (78.28%); consumable goods (47.26%) and professional and logistic human resources (46.31%) had the highest share of these costs. In the test groups, the most expensive tests belonged to the hormones (23.03%) and clinical chemistry (20.84%). Total cost, revenue, and the net profit of the studied laboratory were 641 645, 1 390 942, and 749 297 USD, respectively. After doing sensitivity analysis (50% increase in the frequency of tests), the following values were obtained: 987 071, 2 086 413, and 1 099 342, respectively.
Conclusion: Some test groups in the studied laboratory were not profitable, and this was due to the high cost of these tests and illogical tariffs. One way to overcome this problem is to increase the frequency of laboratory tests.
Cost price, Direct and indirect costs, Net profit, Clinical laboratories, Tariffs
62
67
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3291-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/24
1395/12/6
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/5
1396/7/13
Ali
Mouseli
Social Determinants in Health Promotion Research Center, Hormozgan Health Insti-tute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, & Department of Health Management, Policy and Economics, Kerman University of Medical Sciences, Kerman, Iran.
mouseli136025@gmail.com
00319475328460036664
00319475328460036664
No
Mohsen
Barouni
Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
mohsenbarooni@gmail.com
00319475328460036665
00319475328460036665
No
Mohammadreza
Amiresmaili
Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
mohammadreza.amiresmaili@gmail.com
00319475328460036666
00319475328460036666
No
Siamak
Mirab Samiee
Health Reference Laboratory Research Center, Ministry of Health and Medical Educa-tion, Iran.
samieai@health.gov.ir
00319475328460036667
00319475328460036667
No
Leila
Vali
Environmental Health Engineering Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Leilavali1386@gmail.com
00319475328460036668
00319475328460036668
Yes
en
Investigation of adherent-invasive E. coli in patients with Crohn's disease
Background: Crohn's disease and Ulcerative colitis are known as inflammatory bowel disease with high morbidity which are as a result of increasing immune responses to intestinal microbiota in genetically susceptible individuals. The association of adherent invasive Escherichia coli with Crohn's disease in human has been discussed for decades. The principal aim of this study was to assess the relationship between adherent invasive Escherichia coli in Iranian patients with Crohn's disease.
Methods: The presence of adherent invasive Escherichia coli DNA and viable adherent invasive Escherichia coli cells were identified through PCR and conventional culture methods, respectively. All the specimens were subsequently cultured in Hi Chrome Agar medium.
Results: Using molecular assay, the invasive plasmid antigen H and invasion-association locus genes were detected from tissue samples confirming the presence of adherent-invasive Escherichia coli. The invasive plasmid antigen H was detected in 46.7% of CD and 13.3% of healthy peoples. The invasion-association locus gene was found in 36.7% of patients with Crohn's disease and 10% in individuals without IBD.
Conclusion: This study demonstrated an increased frequency of adherent invasive E. coli with invasive plasmid antigen H and invasion-association locus genes from patients with CD in comparison to control individuals. Moreover, it was shown that adherent invasive E. coli with the invasive plasmid antigen H and invasion-association locus genes can act as a predisposing factor in the development of IBD.
Crohn Disease, Inflammatory bowel disease, Escherichia coli, PCR
57
61
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3650-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/25
1396/6/3
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/27
1396/10/6
Akram
Sarabi Asiabar
Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran.
Sarabi_e25@yahoo.com
00319475328460036659
00319475328460036659
No
Hamid
Asadzade Aghdaei
Basic and Molecular Epidemiology of Gastroenterology Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamid.asadzadeh@gmail.com
00319475328460036660
00319475328460036660
No
Azar
Sabokbar
Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran.
sabokbarr@kiau.ac.ir
00319475328460036661
00319475328460036661
No
Mohammd Reza
Zali
Department of Inflammatory Bowel Disease, Research Center for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
nnzali@hotmail.com
00319475328460036662
00319475328460036662
No
Mohammad Mehdi
Feizabadi
Department of Microbiology, School of Medicine, Tehran University of Medical Science, Tehran, Iran, & Thoracic Research Center, Imam Khomeini Hospital, Tehran, Iran.
mfeizabadi@tums.ac.ir
00319475328460036663
00319475328460036663
Yes
en
Resveratrol suppresses hyperglycemia-induced activation of NF-κB and AP-1 via c-Jun and RelA gene regulation
Background: Resveratrol (RSV) provides several important biological functions in wide variety of cells. In this study, we investigated the molecular mechanisms underlying anti-inflammatory effect of RSV on HepG2 cells by assessing the gene expression of RelA and c-Jun- subunits of NF-κB and AP-1 transcription factors.
Methods: HepG2 cells were settled in a serum- free medium with high concentrations of glucose (30 mM) and insulin (1 µM) overnight and were then incubated with RSV (5, 10, and 20 µM) for 24 and 48 hours. Real time quantitative polymerase chain reaction (qRT-PCR) was used to determine RelA and c-Jun expression.
Results: RSV diminished hyperglycemia/hyperinsulinemia stimulated expression of c-Jun dose- dependently after 24 and 48 hours (p<0.05). In addition, RelA gene expression was decreased dose-dependently in all RSV doses after 48-hour incubation (p<0.05). Our results indicated that RSV may reduce NF-κB and AP-1 activity via RelA and c-Jun gene regulation.
Conclusion: The findings of the present study demonstrated that RSV may be considered as a preventative and therapeutic agent for antagonizing inflammation in Hepatocellular carcinoma (HCC).
AP-1, c-Jun, Hyperglycemia, Hyperinsulinemia, Inflammation, Resveratrol, NF kappa B, MAPK
51
56
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3693-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/12
1396/7/20
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/6
1396/9/15
Zinat
Mohammadpour
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran & Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
znt.mohamadpur@yahoo.com
00319475328460036650
00319475328460036650
No
Fatemehsadat
Amiri
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
sadafamiri.2011@yahoo.com
00319475328460036651
00319475328460036651
No
Ali Akbar
Saboor-Yaraghi
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
saboor_a@yahoo.com
00319475328460036652
00319475328460036652
No
Fariba
Koohdani
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran.
fkoohdan@tums.ac.ir
00319475328460036653
00319475328460036653
No
Marjan
Norouzzadeh
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran.
marjan_dietition@yahoo.com
00319475328460036654
00319475328460036654
No
Loghman
Sharifi
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran.
loghmansharifi@yahoo.com
00319475328460036655
00319475328460036655
No
Monireh Sadat
Seyyed Salehi
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran.
salehy.monir@yahoo.com
00319475328460036656
00319475328460036656
No
Amirpasha
Ebrahimi
Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
ebrahimi.amirpasha@yahoo.com
00319475328460036657
00319475328460036657
No
Maryam
Mahmoudi
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran & Pediatric Gastroenterology and Hepatology Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran & Dietetics and Nutrition Experts Team (DiNET), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
m-mahmoudi@sina.tums.ac.ir
00319475328460036658
00319475328460036658
Yes
en
Influence of high-dose oral erythromycin on feeding intolerance in preterm neonates: A randomized controlled trial
Background: Feeding intolerance is a common complication in preterm neonates and is responsible for prolonged hospitalization. This study aimed at assessing the effects of high-dose oral erythromycin on feeding intolerance in preterm infants.
Methods: A randomized, double blinded, placebo-controlled trial was performed during 2014 and 2015 (Tehran-Iran). Preterm neonates aged >14 days, who met the feeding intolerance criteria were selected for the study and their medical records were randomly assigned into 2 groups by simple randomization. Infants in group A received 10 mg/kg oral erythromycin every 6 hours for 2 days, followed by 4 mg/kg oral erythromycin every 6 hours for 5 days; and infants in group B received placebo with the same route. The number of days until reaching complete oral feeding, day of discharge from NICU, and complications related to intervention were recorded and compared between the 2 groups. Independent samples t test, Mann-Whitney, Fischer exact test, and Chi square were used to analyze the relationships between variables. P-value less than 0.05 was considered statistically significant.
Results: A total of 20 infants in group A received erythromycin and 20 infants in group B received placebo. Erythromycin could not alter the mean volume of feeding, duration of parental feeding, length of hospitalization, and frequency of feeding discontinuity (p>0.05); however, mean days to reach complete feeding in group A was significantly shorter than in group B (9.80 vs. 16.80 days; p=0.001).
Conclusion: High-dose erythromycin as a rescue measure with no potential adverse effect is beneficial in reducing the time taken to achieve full enteral feeding. However, more extensive investigations are needed to determine the best administration dosage.
Erythromycin, High-dose, Feeding intolerance, Preterm neonates
47
50
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-787-3&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/2
1395/11/14
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/1
1396/5/10
Maryam
Saboute
Department of Pediatrics, Akbarabadi Hospital, Iran University of Medical Sciences, Tehran, Iran.
saboutem@yahoo.com
00319475328460038499
0000000321463752
No
Ali
Mazouri
Department of Pediatrics, Akbarabadi Hospital, Iran University of Medical Sciences, Tehran, Iran.
mfnhrc@tums.ac.ir
00319475328460038500
0000000330078477
No
استادیار
Fatemeh
Naimi Dehnavi
Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran.
fetuspapyrus@gmil.com
00319475328460038501
00319475328460038501
No
Nasrin
Khalesi
Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran.
nasrinkhalessi@yahoo.com
00319475328460038502
0000000222774862
Yes
Zahra
Farahani
Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.
z.farahani@shirazu.ac.ir
00319475328460038503
00319475328460038503
No
en
Prevalence of food addiction among Iranian children and adolescents: Associations with sociodemographic and anthropometric indices
Background: Food addiction has been defined as consuming palatable foods leading to addictive-like behaviors. Little studies have assayed food addiction in children and adolescents. Thus, we aimed at identifying the prevalence of food addiction and the relationship between food addiction, sociodemographic and anthropometric indicators among children and adolescents in southwestern Iran.
Methods: This cross-sectional study was conducted on 222 elementary school students aged 7 to 13 years in Ahvaz, Iran, using a random sampling method. Sociodemographic and anthropometric indicators were obtained. The 25-item child version of the Yale Food Addiction Scale (YFAS-C) was applied to provide food addiction diagnosis and symptoms. A nonparametric analysis was used for data analysis.
Results: The prevalence of food addiction was 17.3%. Also, the most common symptoms associated with food addiction were (1) inability to cut down, (2) withdrawal, and (3) tolerance. The students with food addiction diagnosis were older than the undiagnosed (p=0.04). The males and students older than 8 years showed a higher food addiction score than females and students under 8 years (p<0.05). In females, significant positive correlations were found between anthropometric indicators, including body mass index and body mass index z-score, with food addiction score (p<0.01).
Conclusion: Food addiction diagnosis was more prevalent in males and students over 8 years. Females with higher YFAS-C scores had elevated body mass index z-scores, suggesting that food addiction may be a remarkable problem in childhood and early adolescence and may also be related to a risk of overweight/obesity in Iranian students.
Food addiction, Body mass index, Demography, Student, Iran
37
46
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3326-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/26
1396/7/4
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/6
1396/9/15
Mahshid
Naghashpour
Abadan School of Medical Sciences, Abadan, Iran & Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
mnaghashpour@gmail.com
00319475328460036627
00319475328460036627
No
Rouhollah
Rouhandeh
Abadan School of Medical Sciences, Abadan, Iran
r.rouhandeh@gmail.com
00319475328460036628
00319475328460036628
No
Marzieh
Karbalaipour
Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Department of Nutrition, School of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
kp.marzieh@yahoo.com
00319475328460036629
00319475328460036629
No
Mahsa
Miryan
Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Department of Nutrition, School of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
miryanm2014@gmail.com
00319475328460036630
00319475328460036630
Yes
en
Validation of the verbal autopsy questionnaire for adult deaths in Iran
Background: Verbal Autopsy Questionnaire (VA) is an important tool to estimate the cause of death among those populations lacking an appropriate death registration system. In this study, the validity and reliability of verbal autopsy were assessed.
Methods: The Persian version of the questionnaire was prepared using the translation and back- translation method. In the first and second phases of the study, 213 and 198 families of deceased persons accepted an invitation to complete the questionnaire. A physician determined the cause of death. These causes were compared with the registered cause of death on the death certificate. Sensitivity, specificity, positive predictive value (PPV), as well as the kappa statistic (between the first verbal autopsy questioning and death registry) were calculated to determine the validity of the questionnaire. Kappa statistic was also used to determine the reliability between the first and second questioning.
Results: The sensitivity of the questionnaire varied from 75% among deaths due to diabetes to 100% Due to breast cancer. The specificity of the questionnaire for all causes of death was higher than 97%. PPV varied from 62.5% to 100% for all causes of death. The kappa statistic between causes of death derived from death certificate, and the first VA questioning for all causes of death was above 0.7 (p<0.001), and it was above 0.78 for the first and second verbal autopsy questioning (p<0.001).
Conclusion: Although the Verbal Autopsy Questionnaire does not fully identify all causes of death, it can be a useful tool for diagnosing causes of death for those deceased persons who have no death certificate.
Validation, Reliability, Verbal autopsy, Mortality
33
36
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3154-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/13
1395/10/24
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/10
1396/8/19
Azizallah
Dehghan
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveil-lance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran & Social Medicine Department, School of Medicine, Fasa University of Medical sciences, Fasa, Iran.
dehghan.aziz@yahoo.com
00319475328460036614
00319475328460036614
No
Maryam
Nasirian
Epidemiology and Biostatistics Department, Health School; and Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran & HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
maryamnasirian27@gmail.com
00319475328460036615
00319475328460036615
No
Ali Akbar
Haghdoost
Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical sciences, Kerman, Iran.
ahaghdoost@gmail.com
00319475328460036616
00319475328460036616
No
Ehsan
Bahramali
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
ebahramali@gmail.com
00319475328460036617
00319475328460036617
No
Hamid
Sharifi
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran & Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran.
sharifihami@gmail.com
00319475328460036618
00319475328460036618
Yes
en
Factors affecting the leadership effectiveness of hospital managers: A systematized review
Background: Effective leadership is regarded as an important factor in organizational success. This study aimed at performing a systematic review on leadership effectiveness among hospital managers.
Methods: A search was conducted in ScienceDirect, ProQuest, Web of Science, Ovid, and Scopus databases on the factors related to effectiveness of hospital managers’ leadership during 1990 and 2016. The initial results included 2795 papers, but after further investigation and qualitative evaluation using CASP-19, a total of 8 papers were included in the systematic review. Then, summarizing, classification, and comparison were used for data analysis and synthesis.
Results: From among the 8 investigated papers, 4 were conducted in different regions of the US and the other 4 studies were done in Canada, India, Turkey, and South Africa. The latest and oldest studies were conducted in 2016 and 1992, respectively. The papers included 4 reviews, 3 cross-sectional studies, and 1 qualitative study. Effective factors on the effectiveness of managers’ leadership were identified and classified into 4 categories of self-management, people management, health services provision management, and nuclear management skills.
Conclusion: Despite the emphasis of various studies on the existence of different effective factors on hospital managers’ leadership, all these factors can be categorized as people management skills, self-management skills, nuclear management skills, and health services provision skills.
Leadership effectiveness, Self-management, Organizational success, Systematic review
27
32
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1481-8&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/5
1395/12/15
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/6
1396/11/17
Ali
Sarabi Asiabar
PhD Candidate of Public Administration, Islamic Azad University, Tehran Central Branch, Faculty of Management, Tehran, Iran.
ali.sarabi_asiabar.mng@iauctb.ac.ir
00319475328460036530
00319475328460036530
No
Abbas
Saleh Ardestani
Faculty of Management, Islamic Azad University, Tehran Central Branch, Tehran, Iran.
abb.saleh_ardestani@iauctb.ac.ir
00319475328460036531
00319475328460036531
Yes
en
A novel PKP2 mutation and intrafamilial phenotypic variability in ARVC/D
Background: Arrhythmogenic ventricular cardiomyopathy (AVC) is an inherited cardiac disorder affecting 1 in 1000 individuals worldwide. The mean diagnosed age of disease is 31 years. In this article, an Iranian family reported that they were affected by ARVC due to a novel PKP2 mutation.
Methods: Clinical evaluations, 12-lead ECG, CMR, and signal-averaged ECG were performed. After DNA extraction, genetic testing was done, and PCR-sequencing was applied to find causal mutations. Segregation analysis was also performed for the family.
Results: ARVC criteria were documented in the patients. Genetic testing revealed a novel chain termination mutation (p.Tyr168Ter) in PKP2 gene; this mutation was transmitted from the mother to her 23-year-old son, but only the son was affected with ARVC.
Conclusion: Modifier genes were indicated using interactome analysis of Plakophilin 2 protein (PKP2); they might have led to phenotypic variability through cellular mechanisms, such as nonsense-mediated mRNA decay. At least, 9 proteins were identified that might have affected Plakophilin 2 protein function, and consequently, rationalizing this intrafamilial phenotypic variability. This study highlighted the role of modifier genes involved in ARVC as well as the major role of PKP2 mutation in developing the disease in our population.
ARVC/D, PKP2 gene, Phenotypic variability
22
26
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3658-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/52017/08/31
1396/6/9
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/62017/12/6
1396/9/15
Nejat
Mahdieh
Cardiogenetic Research Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran & Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
nmahdieh@gmail.com
00319475328460036712
00319475328460036712
No
Sedigheh
Saedi
Cardiogenetic Research Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran & Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
saedised@gmail.com
00319475328460036713
00319475328460036713
No
Mahdieh
Soveizi
Cardiogenetic Research Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
MAHTA_SH2@GMAIL.COM
00319475328460036714
00319475328460036714
No
Bahareh
Rabbani
Cardiogenetic Research Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran & Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran & Growth and development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
baharehrabbani@yahoo.com
00319475328460036715
00319475328460036715
No
Nasim
Najafi
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Scienc-es, Tehran, Iran.
nasnajafi@gmail.com
00319475328460036716
00319475328460036716
No
Majid
Maleki
Cardiogenetic Research Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran & Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
mmcardiacrhc@gmail.com
00319475328460036717
00319475328460036717
Yes
en
The association of FokI and ApaI polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of Iran
Background: Some genetic factors are involved in the etiology of Hashimoto thyroiditis and Graves’ disease as autoimmune thyroid diseases (AITDs). Effects of vitamin D receptor gene polymorphisms in AITDs development have already been investigated in some previous studies. However, no study has been done on the association between VDR FokI and ApaI polymorphisms and AITDs in an Iranian population. In this study, the possible effects of FokI and ApaI polymorphisms on AITDs were investigated in the population of northwest of Iran.
Methods: A total of 121 AITDs adult patients and 117 healthy controls matched by age and sex in the same population were included in this study. FokI and ApaI polymorphisms were genotyped by polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP). Chi-square test and odds ratio (OR) with 95% CI were used to analyze the data.
Results: FokI and ApaI genotypes frequencies were not significantly different between the 2 groups (p= 0.06, p= 0.73, respectively). However, FokI "CC" and "CT" genotypes were related to AITDs risk (p= 0.03; OR= 3.75; 95% CI, 1.16-12.17 and p= 0.04; OR= 3.41; 95% CI, 1.03-11.28, respectively).
Conclusion: These data suggest that FokI polymorphisms are involved in AITDs susceptibility in the population of northwest of Iran.
Vitamin D receptor, Genetic polymorphisms, Hashimoto disease, Graves’ disease
18
21
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3770-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/52017/08/312017/10/15
1396/7/23
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/62017/12/62017/11/29
1396/9/8
Rasoul
Zarrin
Department of Nutrition, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
rasoul.zarrin@uqconnect.edu.au
00319475328460036519
00319475328460036519
No
Morteza
Bagheri
Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
mortezabagheri@umsu.ac.ir
00319475328460036520
00319475328460036520
No
Alireza
Mehdizadeh
Department of Endocrinology, Urmia University of Medical Sciences, Urmia, Iran.
Alireza_mehdizadeh@yahoo.com
00319475328460036521
00319475328460036521
No
Parvin
Ayremlou
Clinical Researches Development Unit of Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran.
p.ayremlou@gmail.com
00319475328460036522
00319475328460036522
No
Amir Hossein
Faghfouri
Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
amir.nut89@gmail.com
00319475328460036523
00319475328460036523
Yes
en
Overuse and underuse of pulmonary CT angiography in patients with suspected pulmonary embolism
Background: The aim of the present study was to evaluate the utilization and diagnostic yields of CT pulmonary angiography (CTPA) using the Revised Geneva score and Wells’ criteria, in patients with suspected pulmonary embolism (PE).
Methods: One hundred and twelve adult patients underwent CTPA for suspected PE were participated in this study. The outcome was positive or negative CTPA for PE. Revised Geneva and Wells’ scores were calculated. The relationship between the results obtained from these two scores and the available risk factors were compared.
Descriptive analysis such as frequency and mean as well as analytical statistics including chi-square were done. The data analysis was performed using SPSS (v. 22).
Results: In this study, according to the Wells’ criteria calculated for the patients, 33.9% of the patients had low clinical, 56.3% intermediate and 9.8% high clinical probability. Among the 11 high clinical patients, 9(81.8%) were CTPA positive. Based on the revised Geneva score, 65 patients (58%) had low clinical, 36 (32.1%) intermediate and 11(9.8%) high clinical probability. Among the 11 high clinical patients, 8 were CTPA positive. Positive predictive value of the low clinical patients based on Wells’ criteria and the revised Geneva score was 18.4% and 30.8%, respectively. Also, positive predictive value for high clinical probability of Wells’ criteria and the revised Geneva score was 81.8% and 72.8% respectively.
Conclusion: Under/overuse of CTPA in diagnosing PTE is a common problem especially in university hospitals. It is possible to avoid unnecessary CTPA requests using scholarly investigations and more accurate clinical risk assessments.
Pulmonary Embolism, Pulmonary CT angiography, Wells’ score, Revised Geneva score
13
17
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-922-9&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/52017/08/312017/10/152017/05/2
1396/2/12
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/62017/12/62017/11/292017/10/9
1396/7/17
Hanieh
Raji
Air pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
dr.raji.h@gmail.com
00319475328460036514
00319475328460036514
No
Seyed Ali Javad
Moosavi
Faculty of Medicine, Iran University of Medical Sciences and Health Services, Tehran, Iran.
dr_moosavi_pul@yahoo.com
00319475328460036515
00319475328460036515
No
Maryam
Dastoorpoor
Air pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
mdastoorpour@yahoo.com
00319475328460036516
00319475328460036516
No
Zahra
Mohamadipour
Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
dr.raji.h@yahoo.com
00319475328460036517
00319475328460036517
No
Parvin
Mousavi Ghanavati
Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
sp.mg90@yahoo.com
00319475328460036518
00319475328460036518
Yes
en
In vitro evaluation of decontamination effects on mechanical properties of fibrin membrane
Background: Tissue engineering has been investigated as a potential method for healing traumatized tissues. Biomaterials are material devices or implants used to repair or replace native body tissues and organs. The present study was conducted to evaluate the effects of decontamination methods on biological/mechanical properties and degradation/adhesion test of the platelet‑-rich fibrin (PRF) membranes to compare these properties with intact membranes as a biological biomaterial.
Methods: The in vitro degradation tests were conducted by placing the equal sizes of (i) intact PRF membrane, (ii) PRF membrane sterilized by autoclave (iii), ultraviolet (UV), and (iiii) gamma irradiation in phosphate buffer solution on a shaker. The degradation profiles were expressed. Adhesion test was performed by counting adhered mouse fibroblast and sterilized fibrin membrane was compared to normal fibrin membrane by different sterilization methods.
Results: The preliminary findings of sterilized PRF membranes showed that UV exposure (p<0.05) and autoclaved fibrin membranes (p<0.01) have significantly lower degradability compared to normal fibrin membranes. Gamma irradiation is similar to normal membrane in degradability. Cell adherence in all groups of fibrin membrane was significantly lower than the group without membrane, but there was no significant difference between intact and sterilized groups of fibrin membranes.
Conclusion: Sterilization of fibrin membrane with different protocols does not have any adverse effects on cell adhesion; however, cell adherence is naturally very weak even in normal membranes. Also, it seems that ultraviolet ray polymerizes fibrin filaments and merges them to each other and increases the ability of fibrin membrane against degradation. Autoclaved fibrin membrane content proteins are denatured because of pressure and heat and show an increase in hardness and stability against degradation.
Fibrin, Tissue, Membrane, Mechanical phenomena, Biological phenomena, Decontamination
6
12
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3097-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/52017/08/312017/10/152017/05/22016/12/6
1395/9/16
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/62017/12/62017/11/292017/10/92017/11/21
1396/8/30
Taher
Akbari Saeed
Student Research Committee, Department of Medical Laboratory Sciences, Faculty of Sirjan Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran.
t.ak.sa@hotmail.com
00319475328460036510
00319475328460036510
No
Meysam
Ahmadi ZeydAbadi
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
meysamcell@yahoo.com
00319475328460036511
00319475328460036511
No
Ahmad
Fatemi
Department of Hematology and Blood Bank, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.
ahmad.fatemi2@gmail.com
00319475328460036512
00319475328460036512
No
Alireza
Farsinezhad
Department of Hematology and Laboratory Sciences, Faculty of Allied medicine, Kerman University of Medical Sciences, Kerman, Iran.
farsinezhad239@yahoo.com
00319475328460036513
00319475328460036513
Yes
en
Characteristics and outcomes of patients with multiple myeloma : Data from a developing country
Background: Multiple myeloma (MM) is a plasma cell disorder characterized by presence of monoclonal protein in serum or urine or both, increased bone marrow plasma cells, osteolytic lesion, hypercalcemia, and anemia. Several combination regimens are commonly recommended for treatment of multiple myeloma. The present study aimed at determining the characteristics and outcomes of patients with multiple myeloma treated at our centre.
Methods: During July 2012 and December 2015, all patients with proven diagnosis of MM were included in this study. Data were collected from hospital information system. The characteristics and outcomes of all patients were analyzed. Progression- free survival and overall survival of patients were also estimated. Kaplan-Meier curves and Log-rank test were applied and SPSS Version19 was used for data analysis.
Results: A total of 82 patients, with the median age of 51 years (Range: 23-64 yrs.) were available for final analysis. The number of patients with IgG and IgA type was 48 (58.5%) and 15(18.3%), respectively. There were 7 (8.5%) patients with non-secretory type. Most of the patients (n= 59; 71.9%) were treated with CTD regimen and 13 (15.8%) received bortezomib-based treatment. The median progression-free survival time was 30 months, and overall survival time was 48 months. The cumulative probability of survival at 36 months was 85%.
Conclusion: Based on our results, the onset of multiple myeloma occurs in relatively younger age groups. A small number of patients received bortezomib due to cost issues. PFS and OS in our study were comparable with published literature.
Multiple myeloma, Survival, Anemia, Bone disease, Plasma cells
1
5
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3466-1&slc_lang=en&sid=1
2018/01/162018/07/102018/03/122018/09/122017/09/22016/12/32017/12/302018/05/302018/08/152018/04/52017/05/132018/02/102017/11/132017/05/62017/11/282017/08/22017/11/52017/02/42017/03/172016/01/132015/09/272018/02/112018/04/152017/01/12017/05/282017/10/52016/11/272017/11/142018/08/122017/11/102017/10/172017/08/312018/01/232018/11/102016/12/152018/08/292017/09/302017/08/22017/12/192018/01/292017/09/52018/02/252017/02/102018/11/202017/09/232017/09/122016/12/152018/06/102018/03/302017/07/32017/01/162016/05/32018/02/162017/12/32017/07/202017/04/232017/11/282016/06/172018/04/82017/02/72017/11/202016/11/242017/01/142017/04/272017/12/252018/02/82017/03/12017/04/252017/12/92017/07/222018/01/152016/04/272016/07/102017/12/52017/02/72017/11/162017/10/172017/11/52017/06/252017/11/22018/03/152017/01/152017/08/12017/09/232016/12/22017/01/222017/05/312018/02/82017/07/232018/03/72017/01/232017/06/112017/12/152017/06/162017/07/32017/01/162017/09/272017/03/42017/09/122017/10/222017/02/152017/12/232017/11/302017/01/302017/01/112017/01/202017/05/132016/04/102014/02/242016/09/22015/08/292016/08/162017/08/82016/05/142017/08/22017/03/242017/01/152017/04/282017/04/212016/10/52015/08/302017/05/242017/05/312017/02/242017/08/252017/10/122017/02/22017/09/262017/01/132017/03/52017/08/312017/10/152017/05/22016/12/62017/06/9
1396/3/19
2018/03/52018/10/312018/07/282019/01/292018/10/22017/09/272018/09/82018/09/112018/09/252018/10/152018/10/52018/10/282018/05/302017/09/132018/10/292018/04/222018/07/102017/06/262017/08/72017/06/262016/08/222018/05/82018/06/122018/08/42018/06/182017/11/112017/10/82018/07/162018/09/92018/09/162018/05/202018/02/272018/08/252018/12/232017/08/32018/10/292018/04/92018/01/302018/05/192018/05/72018/01/62018/07/162018/07/92018/11/202018/07/22018/09/222017/06/122018/08/12018/09/52018/01/222017/11/292017/01/142018/08/212018/05/162018/01/212017/11/92018/01/172017/08/292018/10/12017/10/82018/02/212017/08/12017/10/52018/01/72018/06/32018/07/282018/04/222018/01/72018/02/152017/10/82018/03/112017/08/232018/02/272018/01/212017/08/302018/02/242018/04/112017/12/82018/01/72018/01/282018/06/102018/01/22018/02/32017/10/272017/10/52017/08/32018/03/252018/05/162017/11/92018/05/262017/11/102018/04/282017/08/62017/09/262018/02/282018/01/192017/07/42017/12/272018/01/302018/01/172018/02/282018/02/242017/08/62017/11/292017/11/92017/08/152017/06/202017/06/112017/07/102017/08/32017/09/232017/11/92017/07/242017/08/302017/09/302017/09/172017/07/222017/08/72017/06/202017/01/172017/12/62017/07/302017/10/52017/12/272017/12/62017/08/12017/12/62017/11/102018/02/62017/12/62017/11/292017/10/92017/11/212017/11/5
1396/8/14
Abdul
Hameed
Department of Medical Oncology, Shaukat Khanum Cancer Hospital and Research Centre, Pakistan.
hamiid34@gmail.com
00319475328460036504
00319475328460036504
Yes
Jamshed
Ali
Department of Medical Oncology, Shaukat Khanum Cancer Hospital and Research Centre, Pakistan.
jamshed.ali09@gmail.com
00319475328460036505
00319475328460036505
No
Kiran
Munawar
Department of Medical Oncology, Shaukat Khanum Cancer Hospital and Research Centre, Pakistan.
kiranmunawar@hotmail.com
00319475328460036506
00319475328460036506
No
Farah
Arshad
Department of Medical Oncology, Shaukat Khanum Cancer Hospital and Research Centre, Pakistan.
moresidents@skm.org.pk
00319475328460036507
00319475328460036507
No
Farhana
Badar
Deapartment of Cancer Registry and Data Management, Shaukat Khanum Cancer Hospital and Research Centre, Lahore, Pakistan.
farhana@skm.org.pk
00319475328460036508
00319475328460036508
No
Neelam
Siddiqui
Department of Medical Oncology, Shaukat Khanum Cancer Hospital and Research Centre, Pakistan.
neelam@skm.org
00319475328460036509
00319475328460036509
No